data_2ew3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ew3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.799 0.25 . . . . 1.32 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.2 m -133.67 166.88 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.02 111.284 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.458 ' HG ' HG22 ' A' ' 55' ' ' VAL . 21.9 p -145.86 174.84 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 1.26 110.615 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -141.79 132.17 25.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.983 0.421 . . . . 3.8 111.347 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.54 135.08 18.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.882 -0.675 . . . . 0.28 112.934 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 56' ' ' GLU . 4.4 mm? -84.35 -31.55 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.072 0.463 . . . . 1.96 110.469 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -131.26 146.06 52.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 3.55 110.476 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.5 p-10 -74.76 161.88 29.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.374 0.607 . . . . 2.01 111.892 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 127.73 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.018 -0.992 . . . . 1.49 111.094 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.08 128.62 49.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.609 -0.515 . . . . 3.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 38.0 Cg_endo -66.29 130.56 24.25 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.08 1.853 . . . . 1.56 112.316 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.02 -16.61 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 3.06 111.24 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -115.04 134.49 55.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 2.52 110.797 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.35 135.82 57.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 2.68 111.101 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.65 -26.86 22.65 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.829 -0.7 . . . . 0.59 112.726 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.56 166.68 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 1.82 110.676 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 HD13 HG23 ' A' ' 43' ' ' ILE . 20.1 tp -117.25 127.08 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 1.76 110.987 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -89.27 149.75 20.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.85 112.534 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -174.68 169.72 3.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.645 0.259 . . . . 4.94 110.796 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -124.87 -167.79 1.72 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.481 0.657 . . . . 3.35 111.894 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.34 125.83 27.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.937 -1.029 . . . . 2.24 110.692 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.45 81.94 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.37 112.593 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.06 122.22 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 2.3 111.088 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.4 121.76 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.97 -0.559 . . . . 1.94 110.603 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.93 142.33 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.314 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.3 p -96.35 113.17 24.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 1.13 110.069 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.28 144.61 25.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.5 0.667 . . . . 2.37 112.698 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.5 t -167.47 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.766 -1.106 . . . . 1.12 110.475 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.6 m-20 -144.01 -179.51 6.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.151 -1.055 . . . . 1.95 108.151 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.22 150.18 1.13 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 113.518 0.933 . . . . 1.82 113.518 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.547 HG12 ' HG3' ' A' ' 40' ' ' GLU . 30.9 mm -101.0 -45.72 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.787 -1.097 . . . . 1.7 110.449 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -167.96 -170.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.531 -0.759 . . . . 1.73 110.623 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.36 -5.13 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.081 0.4 . . . . 2.93 112.081 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -98.28 -56.12 2.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.628 0.232 . . . . 2.74 111.628 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 p90 -120.97 133.86 55.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.174 0.512 . . . . 3.6 111.733 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.2 m-30 -93.24 -177.16 4.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.458 -0.792 . . . . 3.57 111.25 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 34' ' ' ILE . 25.3 mt-10 -141.31 144.62 34.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 1.58 111.764 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.43 -163.73 21.84 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.362 -0.836 . . . . 0.26 111.444 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.81 154.78 49.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.294 0.569 . . . . 2.44 111.588 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG23 HD13 ' A' ' 20' ' ' LEU . 4.8 tp -140.21 123.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.185 -0.916 . . . . 2.1 110.042 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.8 t60 67.38 -75.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.069 -0.514 . . . . 3.85 110.773 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.43 30.64 0.47 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 1.68 112.735 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -144.03 147.32 33.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.975 0.417 . . . . 2.76 111.503 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.6 m -108.02 161.4 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 1.61 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.83 174.03 39.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.958 -0.639 . . . . 0.33 112.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -104.28 153.85 20.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.862 0.331 . . . . 1.93 111.101 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 p90 -153.74 103.96 2.51 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.162 -0.472 . . . . 5.33 111.817 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -49.3 144.76 16.77 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.98 2.454 . . . . 0.7 112.429 177.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.91 -22.69 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.612 -0.722 . . . . 1.41 111.633 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -73.9 12.96 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 2.76 111.775 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -132.92 -9.3 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 4.83 111.109 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.458 HG22 ' HG ' ' A' ' 6' ' ' CYS . 34.1 m -140.01 174.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 1.14 111.212 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' HB2' HD22 ' A' ' 9' ' ' LEU . 40.1 tt0 -133.99 101.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 2.09 109.676 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 57.8 t -60.4 116.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.077 -0.511 . . . . 1.84 111.383 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.66 -48.11 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.688 -0.687 . . . . 1.9 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.43 106.13 54.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 2.07 111.115 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.499 2.133 . . . . 1.96 112.296 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HA ' HG12 ' A' ' 59' ' ' VAL . 46.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.709 0.212 . . . . 1.32 112.271 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.2 m -135.79 178.83 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.972 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.5 p -161.08 174.63 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 1.26 111.025 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.54 135.45 33.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.88 -0.6 . . . . 3.8 111.408 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 128.78 9.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.839 -0.696 . . . . 0.28 112.705 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 56' ' ' GLU . 3.8 mm? -78.24 -36.68 46.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 1.96 110.84 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.49 148.87 50.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 3.55 110.953 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.6 p-10 -65.35 167.98 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.221 0.534 . . . . 2.01 111.684 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.86 118.3 1.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 1.49 111.265 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.74 113.68 59.55 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.78 -0.646 . . . . 3.0 110.059 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.64 130.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.485 2.124 . . . . 1.56 112.803 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.96 -28.97 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 3.06 110.667 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -110.63 131.39 55.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 2.52 110.79 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.85 124.65 21.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.68 110.931 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.09 -26.57 11.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 0.59 112.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -76.51 165.91 24.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 1.82 110.763 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 40.3 tp -112.56 135.33 53.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 1.76 111.174 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.61 149.26 18.14 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.919 -0.657 . . . . 0.85 112.092 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -175.0 156.38 2.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 4.94 111.274 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -107.72 179.54 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 3.35 111.052 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -63.48 138.71 58.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.517 -0.765 . . . . 2.24 110.796 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.11 -5.56 66.23 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.948 -0.644 . . . . 0.37 113.085 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.65 147.93 45.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 2.3 111.053 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.27 134.07 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 1.94 111.217 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.468 HD11 HD11 ' A' ' 43' ' ' ILE . 39.3 mm -126.22 141.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 1.73 110.83 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.8 p -89.67 128.82 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.587 -0.278 . . . . 1.13 110.445 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' N ' ' A' ' 31' ' ' THR . 2.6 tt -96.14 127.25 41.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 2.37 110.772 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.539 HG22 ' ND2' ' A' ' 32' ' ' ASN . 7.8 t -166.2 17.62 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.07 0.462 . . . . 1.12 111.171 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.594 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 56.1 m-80 -150.89 -179.46 7.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.942 -0.762 . . . . 1.95 108.942 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.6 mt-30 -174.75 149.77 1.24 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.644 0.609 . . . . 1.82 112.644 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.23 -29.59 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.315 -0.857 . . . . 1.7 111.54 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -156.91 170.3 22.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.259 -0.428 . . . . 1.73 110.831 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -61.34 -26.14 67.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 2.93 111.085 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.43 -38.66 8.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.27 -0.423 . . . . 2.74 111.28 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.704 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -96.36 125.67 41.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 3.6 110.815 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 18.6 m-30 -105.97 171.93 7.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.267 -0.424 . . . . 3.57 110.087 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 40.0 tt0 -139.97 137.73 34.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 1.58 111.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.43 -176.14 23.15 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.04 -0.982 . . . . 0.26 111.745 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -134.17 160.41 37.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.526 0.679 . . . . 2.44 111.896 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.468 HD11 HD11 ' A' ' 28' ' ' ILE . 14.0 tt -155.91 140.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.684 -1.143 . . . . 2.1 109.745 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 64.31 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 3.85 110.839 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.54 30.68 0.41 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.488 -0.863 . . . . 1.68 113.134 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -159.34 149.13 18.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.01 0.433 . . . . 2.76 111.537 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 41.7 t -110.01 170.06 8.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 1.61 111.477 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . -176.49 166.1 36.83 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.904 -0.589 . . . . 0.33 112.065 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -99.07 157.34 16.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.822 0.344 . . . . 1.93 111.318 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 24.6 p90 -175.78 111.83 0.26 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 5.33 111.428 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 6.1 Cg_endo -52.67 156.89 8.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.55 2.167 . . . . 0.7 112.26 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.01 -18.69 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.662 . . . . 1.41 111.389 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.13 -5.32 6.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 2.76 111.885 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -117.64 -8.36 10.92 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.125 0.417 . . . . 4.83 112.125 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.85 176.76 3.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.28 0.562 . . . . 1.14 112.003 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 9.9 pt-20 -134.23 101.56 5.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 2.09 109.989 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.13 114.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 1.84 111.263 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.12 -41.41 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 1.9 110.985 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 4' ' ' PRO . 2.7 p -143.71 123.43 7.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 2.07 110.955 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.356 2.037 . . . . 1.96 112.314 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 61.1 Cg_endo . . . . . 0 N--CA 1.466 -0.108 0 CA-C-O 120.724 0.219 . . . . 1.32 112.238 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p -141.29 151.51 43.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 2.02 110.863 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' SG ' HD13 ' A' ' 30' ' ' LEU . 12.9 p -131.91 174.92 9.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 1.26 110.986 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.498 ' HE ' HD13 ' A' ' 58' ' ' ILE . 12.4 ptp180 -142.15 136.74 30.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 3.8 110.945 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.45 137.49 20.39 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.73 -0.747 . . . . 0.28 112.838 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 56' ' ' GLU . 3.8 mm? -92.13 -33.07 14.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 1.96 110.734 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -125.36 146.2 49.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 3.55 110.787 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 p-10 -77.76 161.76 27.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.308 0.575 . . . . 2.01 111.835 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 133.02 2.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.101 -0.954 . . . . 1.49 111.453 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.1 86.75 11.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.65 134.87 39.66 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.515 2.143 . . . . 1.56 112.752 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 6.62 38.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 3.06 110.636 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -115.75 134.31 55.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 2.52 110.793 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.13 139.59 58.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 2.68 111.107 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.8 -25.72 12.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.925 -0.655 . . . . 0.59 112.529 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.83 161.86 16.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 1.82 110.708 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -100.25 122.12 42.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 1.76 110.522 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.08 134.97 12.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.85 112.952 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -175.7 -170.3 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.693 0.282 . . . . 4.94 110.703 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -132.55 172.87 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 3.35 111.505 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -49.7 148.44 3.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 2.24 110.818 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.77 -2.73 82.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.938 -0.649 . . . . 0.37 112.942 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.7 145.66 45.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 2.3 111.153 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -120.36 123.07 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 1.94 110.252 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.44 141.68 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.552 -0.294 . . . . 1.73 111.454 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.3 p -85.52 129.99 34.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.36 -0.382 . . . . 1.13 110.085 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD13 ' SG ' ' A' ' 6' ' ' CYS . 10.9 mp -96.24 132.86 41.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.121 0.486 . . . . 2.37 111.708 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.538 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.4 t -167.09 17.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.571 -0.741 . . . . 1.12 110.739 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.571 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 57.9 m-80 -152.3 175.8 12.28 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.642 -0.873 . . . . 1.95 108.642 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 4.0 mt-30 -175.12 150.05 1.14 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.072 0.767 . . . . 1.82 113.072 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.4 mm -103.65 -37.37 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.076 -0.966 . . . . 1.7 110.915 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -168.08 175.94 6.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.616 . . . . 1.73 110.516 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.51 -10.96 5.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 2.93 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.0 -54.99 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.463 . . . . 2.74 111.19 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.15 134.96 38.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 3.6 111.257 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.2 m-85 -110.74 168.13 9.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 3.57 110.253 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 35.5 mt-10 -137.71 142.31 41.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.504 0.668 . . . . 1.58 112.076 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.2 -173.35 34.53 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.019 -0.991 . . . . 0.26 111.474 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ptm -143.35 161.1 39.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.447 0.642 . . . . 2.44 111.558 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.58 133.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.144 -0.935 . . . . 2.1 110.36 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.3 t60 65.24 -78.81 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.104 -0.498 . . . . 3.85 110.974 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.76 30.1 0.55 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 1.68 112.89 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.25 143.08 25.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.358 . . . . 2.76 111.233 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 83.6 p -117.82 170.05 9.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 1.61 111.322 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.78 166.18 30.91 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.33 111.896 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -100.1 159.7 14.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.896 0.379 . . . . 1.93 111.154 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.51 112.0 0.4 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.942 -0.572 . . . . 5.33 110.725 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.693 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.3 Cg_endo -58.07 157.55 24.71 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.618 2.212 . . . . 0.7 112.569 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 mt -61.01 -18.42 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 1.41 111.403 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.49 4.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 2.76 111.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -135.42 -5.77 2.28 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.629 0.233 . . . . 4.83 111.629 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 1.14 111.32 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HB2' HD23 ' A' ' 9' ' ' LEU . 37.9 tt0 -135.01 102.78 5.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 2.09 109.996 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.46 101.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.84 110.912 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.498 HD13 ' HE ' ' A' ' 7' ' ' ARG . 59.4 mt -61.97 -35.91 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 1.9 111.126 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 35.5 t -125.38 97.82 36.31 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 2.07 111.161 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.446 2.097 . . . . 1.96 112.265 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HA ' HG11 ' A' ' 59' ' ' VAL . 51.3 Cg_exo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.705 0.211 . . . . 1.32 112.248 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.9 m -127.25 176.29 7.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 2.02 111.074 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 p -155.46 174.73 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 1.26 110.747 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -141.94 144.58 33.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.084 -0.507 . . . . 3.8 111.23 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 135.66 16.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.929 -0.653 . . . . 0.28 112.811 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.16 -36.56 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 1.96 110.563 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -140.92 147.0 38.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.652 . . . . 3.55 110.496 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -58.17 159.45 5.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.235 0.54 . . . . 2.01 111.698 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -160.64 127.05 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.205 -0.907 . . . . 1.49 111.28 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -98.43 133.3 22.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 3.0 109.493 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 73.6 Cg_endo -74.77 133.65 17.23 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.965 1.777 . . . . 1.56 112.449 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -83.33 -38.41 22.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 3.06 110.896 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -132.06 173.64 11.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 2.52 110.789 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -73.89 144.53 45.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 2.68 110.946 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.24 -27.19 11.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.804 -0.712 . . . . 0.59 112.62 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.91 171.1 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.345 . . . . 1.82 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -109.81 123.28 49.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 1.76 110.95 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.591 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -113.4 124.85 6.72 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.804 -0.712 . . . . 0.85 112.598 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 13.3 m-85 -163.89 -169.66 1.94 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.69 0.281 . . . . 4.94 110.662 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -125.06 173.02 8.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.456 0.646 . . . . 3.35 112.018 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.91 149.2 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.068 -0.969 . . . . 2.24 111.042 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.24 69.4 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.756 -0.656 . . . . 0.37 112.916 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -79.73 132.21 36.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 2.3 110.824 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.42 128.13 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 1.94 111.324 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 mm -128.54 142.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.73 110.791 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.6 p -89.87 135.39 33.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.59 -0.277 . . . . 1.13 110.519 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 39' ' ' TYR . 15.2 tp -96.33 132.92 41.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.325 -0.398 . . . . 2.37 110.781 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.403 HG22 ' OD1' ' A' ' 32' ' ' ASN . 8.9 t -166.72 17.24 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.038 0.447 . . . . 1.12 111.378 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.578 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 20.5 m120 -151.35 170.22 20.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.682 -0.859 . . . . 1.95 108.682 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.2 mt-30 -174.94 149.62 1.15 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.689 0.625 . . . . 1.82 112.689 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 34' ' ' ILE . 2.6 mp -105.66 -32.88 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.184 -0.916 . . . . 1.7 110.655 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -167.93 -170.92 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.81 -0.632 . . . . 1.73 110.785 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.46 -14.41 61.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 2.93 111.419 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -101.3 -54.29 2.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 2.74 111.62 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -95.22 126.57 40.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.853 0.359 . . . . 3.6 111.035 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB3' HD12 ' A' ' 30' ' ' LEU . 14.4 m-30 -108.73 175.4 5.48 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.069 -0.514 . . . . 3.57 110.501 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -150.76 143.86 24.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.47 0.652 . . . . 1.58 111.974 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.18 -171.0 24.42 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.26 111.855 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -143.3 163.13 33.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.393 0.616 . . . . 2.44 111.531 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 tp -144.58 126.12 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.009 -0.996 . . . . 2.1 110.415 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t60 64.98 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 3.85 111.106 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.89 31.51 0.67 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.596 -0.812 . . . . 1.68 112.874 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.36 135.12 19.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 2.76 111.159 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -106.8 170.28 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.61 111.5 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.01 150.1 8.14 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.33 111.88 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -113.08 160.17 18.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.351 . . . . 1.93 111.404 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 177.29 132.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.625 -0.716 . . . . 5.33 110.841 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.6 Cg_endo -47.2 160.89 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.172 2.581 . . . . 0.7 112.965 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 54' ' ' TYR . 24.8 mt -58.03 -20.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.397 -0.819 . . . . 1.41 111.693 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -66.12 7.26 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.564 -0.289 . . . . 2.76 111.35 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 52' ' ' ILE . 9.7 t80 -116.41 -30.89 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.365 -0.38 . . . . 4.83 111.233 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.48 175.61 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.39 0.614 . . . . 1.14 111.861 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.43 113.37 8.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.248 -0.887 . . . . 2.09 109.604 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -55.04 120.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 1.84 111.181 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.8 mt -80.83 -47.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.737 -0.665 . . . . 1.9 111.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 4' ' ' PRO . 3.2 p -126.74 111.41 22.51 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.254 -0.43 . . . . 2.07 111.038 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.518 2.145 . . . . 1.96 112.487 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 59' ' ' VAL . 32.8 Cg_exo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.659 0.191 . . . . 1.32 112.185 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.83 169.46 19.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 2.02 111.337 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' A' ' 30' ' ' LEU . 16.3 p -150.17 175.19 11.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 1.26 110.64 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.465 ' HD2' ' HA2' ' A' ' 25' ' ' GLY . 37.4 ttp180 -139.67 121.44 15.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 3.8 111.178 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -70.41 135.58 25.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 0.28 112.542 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -84.27 -31.26 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.96 110.717 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -125.53 154.04 42.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.81 -0.632 . . . . 3.55 110.857 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.93 147.88 24.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.203 -0.453 . . . . 2.01 110.341 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.93 133.58 17.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 1.49 111.366 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -94.19 132.02 30.17 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 3.0 109.801 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.49 129.54 26.76 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.317 2.012 . . . . 1.56 112.331 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.04 -34.13 3.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 3.06 110.924 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -111.21 159.38 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 2.52 110.972 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -77.95 124.08 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 2.68 110.936 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.33 -20.14 35.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.938 -0.649 . . . . 0.59 112.561 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.62 165.28 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 1.82 110.541 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 38.3 tp -113.49 134.59 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 1.76 111.126 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.55 148.37 16.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 0.85 112.03 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -170.07 -172.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 4.94 111.219 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -133.68 -179.7 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 3.35 111.425 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.05 138.78 58.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.28 -0.873 . . . . 2.24 110.15 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 7' ' ' ARG . . . 81.57 -19.13 9.43 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.729 . . . . 0.37 112.623 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.75 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 2.3 111.077 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -93.77 126.69 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 1.94 110.958 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.98 143.85 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 1.73 111.24 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.6 p -92.69 127.73 38.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.359 -0.382 . . . . 1.13 110.464 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.4 HD13 ' SG ' ' A' ' 6' ' ' CYS . 8.4 mp -96.59 133.3 41.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 2.37 111.484 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -166.97 14.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.276 -0.42 . . . . 1.12 111.591 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.9 m-20 -151.09 179.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.53 -0.915 . . . . 1.95 108.53 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 5.4 mt-30 -174.76 149.89 1.24 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.871 0.693 . . . . 1.82 112.871 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.436 ' HB ' ' CD1' ' A' ' 38' ' ' TRP . 47.9 mm -109.66 -32.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.057 -0.974 . . . . 1.7 111.018 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.11 167.38 12.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.73 110.627 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.17 -8.84 6.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.41 -0.359 . . . . 2.93 110.875 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -96.19 -52.77 3.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.133 -0.485 . . . . 2.74 110.981 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.76 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -115.58 134.47 55.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 3.6 111.257 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 39.8 p90 -100.32 -177.98 3.68 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.986 -0.552 . . . . 3.57 111.221 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 38.2 tt0 -144.67 137.02 26.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.396 0.617 . . . . 1.58 111.563 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.31 -161.81 10.97 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.26 111.734 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 23.6 ptp -143.37 156.68 44.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 2.44 111.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.77 132.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.261 -0.881 . . . . 2.1 110.306 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 65.38 -77.27 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.09 -0.504 . . . . 3.85 111.275 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.53 31.58 0.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.568 -0.825 . . . . 1.68 112.997 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.14 144.76 23.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 2.76 111.343 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 44.7 t -107.5 168.73 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 1.61 111.278 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . 172.45 170.06 35.82 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.793 -0.639 . . . . 0.33 111.875 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 24.5 p90 -111.61 158.55 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 1.93 111.29 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -173.06 122.79 0.43 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.217 -0.447 . . . . 5.33 111.713 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 84.2 Cg_exo -44.85 139.17 8.0 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.18 2.587 . . . . 0.7 113.258 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.04 -18.64 23.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.328 -0.851 . . . . 1.41 111.581 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.61 -6.57 3.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 2.76 112.213 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -117.37 12.07 14.15 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.298 0.481 . . . . 4.83 112.298 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 23.0 m -144.7 175.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.21 0.529 . . . . 1.14 111.457 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.2 tp10 -133.49 96.47 3.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 2.09 109.804 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 p -55.82 118.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 1.84 111.226 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -73.16 -36.34 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 1.9 110.968 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 4' ' ' PRO . 7.1 p -150.76 131.71 7.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 2.07 110.865 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.355 2.037 . . . . 1.96 112.248 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.596 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.745 0.227 . . . . 1.32 112.205 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.4 m -144.81 179.43 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 2.02 111.087 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 20.6 p -155.45 174.33 15.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.912 -0.585 . . . . 1.26 110.491 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HE ' HD13 ' A' ' 58' ' ' ILE . 8.1 ptp180 -142.49 133.19 25.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 3.8 111.46 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.23 137.63 24.13 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.839 -0.696 . . . . 0.28 112.894 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -87.55 -28.76 21.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.399 . . . . 1.96 110.754 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -136.92 146.8 45.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 3.55 110.685 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 t70 -67.61 160.31 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 2.01 111.602 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.18 119.4 1.52 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.014 -0.994 . . . . 1.49 110.835 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.73 135.54 49.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 3.0 109.841 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 45.9 Cg_endo -69.4 138.7 39.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 1.56 112.431 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -126.0 -45.85 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 3.06 110.996 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.62 153.33 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.927 0.394 . . . . 2.52 111.121 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -77.51 124.97 28.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 2.68 111.023 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.07 -2.62 35.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.716 . . . . 0.59 112.807 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -95.81 165.75 12.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 1.82 110.813 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -106.91 119.22 38.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 1.76 111.059 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -105.76 135.39 12.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.835 -0.698 . . . . 0.85 112.559 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.99 -173.55 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.734 0.302 . . . . 4.94 110.935 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -121.0 174.67 6.48 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.363 0.601 . . . . 3.35 111.962 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.21 149.36 12.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 2.24 110.983 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.64 -11.31 62.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.962 -0.637 . . . . 0.37 112.586 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.02 126.32 30.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.817 0.342 . . . . 2.3 110.606 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 41.6 mt -100.34 108.22 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 1.94 111.382 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 20' ' ' LEU . 77.9 mt -96.46 139.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.105 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.8 p -90.67 120.3 31.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 1.13 110.321 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -95.61 142.66 27.67 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.381 0.61 . . . . 2.37 112.512 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.457 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.7 t -167.65 17.42 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.069 -0.969 . . . . 1.12 110.748 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.572 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 58.2 m-80 -149.6 176.37 10.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.473 -0.936 . . . . 1.95 108.473 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.3 mt-30 -175.28 149.8 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.751 0.649 . . . . 1.82 112.751 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 34' ' ' ILE . 3.7 mp -109.21 -28.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.435 -0.802 . . . . 1.7 110.488 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.87 166.68 21.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 1.73 110.485 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.12 -12.16 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 2.93 111.09 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.92 -57.7 1.99 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 2.74 110.979 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.2 m95 -87.55 125.52 34.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.415 -0.357 . . . . 3.6 110.571 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.553 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.3 m-85 -102.78 178.48 4.56 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.832 0.349 . . . . 3.57 110.67 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -151.27 140.1 20.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 1.58 111.834 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.4 -159.04 11.61 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.464 -0.789 . . . . 0.26 111.736 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.97 156.93 46.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.332 0.587 . . . . 2.44 111.442 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.02 128.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.186 -0.916 . . . . 2.1 110.07 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 67.29 -76.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 3.85 110.688 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.31 29.7 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 1.68 112.804 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -144.83 147.69 33.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 2.76 111.465 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -109.33 162.99 13.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 1.61 111.15 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.465 ' HA3' ' HG ' ' A' ' 20' ' ' LEU . . . 172.75 173.16 39.05 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.926 -0.654 . . . . 0.33 112.386 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.17 162.34 13.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.735 0.302 . . . . 1.93 111.187 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -178.36 106.05 0.21 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.903 -0.59 . . . . 5.33 110.812 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.5 Cg_endo -59.46 159.94 21.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.725 2.283 . . . . 0.7 113.3 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.77 -18.35 22.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.427 -0.806 . . . . 1.41 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.87 -2.27 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 2.76 111.78 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -131.71 -4.48 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.749 0.277 . . . . 4.83 111.749 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.83 174.32 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.16 0.505 . . . . 1.14 111.216 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HB2' HD23 ' A' ' 9' ' ' LEU . 10.0 tp10 -134.34 105.0 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 2.09 109.91 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 45.9 t -55.69 122.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 1.84 111.179 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.485 HD13 ' HE ' ' A' ' 7' ' ' ARG . 58.0 mt -85.04 -38.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 1.9 111.222 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 39.6 t -110.22 115.57 54.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.07 111.205 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.426 2.084 . . . . 1.96 112.28 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.754 0.231 . . . . 1.32 112.342 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.73 179.64 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 2.02 110.825 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 p -163.18 174.78 11.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 1.26 110.963 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -142.13 134.39 27.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.8 111.305 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -76.56 139.11 23.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.28 112.609 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -97.32 -32.06 12.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 1.96 110.893 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -122.67 146.48 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.904 -0.589 . . . . 3.55 110.728 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.82 167.21 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.405 0.622 . . . . 2.01 111.956 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.99 119.44 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.015 -0.993 . . . . 1.49 110.963 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -81.9 128.49 68.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 3.0 110.298 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.06 129.91 33.99 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.315 2.01 . . . . 1.56 112.496 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 11.8 pt-20 -151.64 -35.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 3.06 110.681 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 15' ' ' GLU . 39.5 m-80 -90.83 137.13 32.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.115 -0.493 . . . . 2.52 110.772 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.0 121.57 21.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 2.68 110.996 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.23 14.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.59 112.626 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 29.1 tt0 -81.23 168.21 18.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 1.82 110.713 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 ' H ' ' HG2' ' A' ' 19' ' ' GLU . 30.8 tp -116.72 132.58 56.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 1.76 110.853 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.42 141.71 16.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.671 -0.776 . . . . 0.85 112.725 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.24 -176.11 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.433 -0.21 . . . . 4.94 110.433 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -118.78 169.79 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.27 0.557 . . . . 3.35 112.034 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -48.76 149.38 1.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.162 -0.926 . . . . 2.24 111.34 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.23 -6.0 69.75 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.37 113.023 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -73.94 124.17 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 2.3 111.117 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -92.79 125.18 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 1.94 110.74 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.538 HG12 ' HB ' ' A' ' 43' ' ' ILE . 62.5 mt -123.92 135.5 63.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 1.73 111.401 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -95.9 116.67 29.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 1.13 109.928 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 pp -94.94 149.56 21.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.369 0.604 . . . . 2.37 112.393 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 t -167.48 17.13 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.029 -0.987 . . . . 1.12 110.787 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.581 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 14.0 m120 -147.99 -179.99 7.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.437 -0.949 . . . . 1.95 108.437 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.28 149.85 1.09 Allowed 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.523 0.564 . . . . 1.82 112.523 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.58 -23.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.404 -0.816 . . . . 1.7 111.032 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -166.95 165.06 16.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 1.73 110.464 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -7.1 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 2.93 110.79 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.22 -51.99 2.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 2.74 110.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.63 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 m95 -92.67 125.94 37.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.472 -0.331 . . . . 3.6 110.525 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HH ' HD12 ' A' ' 52' ' ' ILE . 4.0 m-30 -100.08 177.16 5.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.887 0.375 . . . . 3.57 110.918 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -147.4 137.41 23.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.96 -0.563 . . . . 1.58 111.265 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.33 -158.9 14.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.585 -0.734 . . . . 0.26 111.859 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 mtm -141.12 148.94 40.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 2.44 111.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' HB ' HG12 ' A' ' 28' ' ' ILE . 12.3 tt -126.43 118.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 2.1 110.08 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.9 t60 67.89 -73.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 3.85 110.716 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.01 27.5 0.51 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.663 -0.78 . . . . 1.68 112.832 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -136.68 142.05 43.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.71 0.29 . . . . 2.76 111.222 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.6 p -105.8 155.54 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 1.61 111.016 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.8 169.59 38.29 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.796 -0.716 . . . . 0.33 112.552 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -97.6 151.14 20.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.55 0.214 . . . . 1.93 110.566 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 16.0 p90 -167.93 103.97 0.56 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.002 0.371 . . . . 5.33 112.002 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 10.5 Cg_endo -57.64 165.1 6.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.516 2.144 . . . . 0.7 112.415 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.614 HD12 ' HH ' ' A' ' 39' ' ' TYR . 19.0 mt -66.26 -20.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 1.41 111.64 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -69.89 2.06 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.59 -0.277 . . . . 2.76 111.555 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -124.62 -11.8 7.25 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 4.83 111.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 34.7 m -140.21 177.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.309 0.576 . . . . 1.14 111.772 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.535 ' HB2' HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -137.64 102.39 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 2.09 109.749 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.37 117.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.84 111.244 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.68 -47.08 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 1.9 111.146 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.83 97.68 9.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.371 -0.377 . . . . 2.07 111.317 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.58 2.186 . . . . 1.96 112.174 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.482 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.8 0.25 . . . . 1.32 112.182 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.7 m -140.71 169.82 16.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 2.02 111.196 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 21.1 p -144.93 174.67 10.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 1.26 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HG2' HG12 ' A' ' 27' ' ' ILE . 91.1 mtt180 -138.9 137.43 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 3.8 111.414 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -74.61 136.47 21.03 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.952 -0.642 . . . . 0.28 112.921 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -82.85 -29.78 29.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.96 110.724 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -149.11 155.04 40.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 3.55 110.859 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.8 p30 -70.55 166.36 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.586 0.708 . . . . 2.01 112.8 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.33 130.76 2.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.589 -1.187 . . . . 1.49 111.06 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -111.7 88.86 10.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.641 -0.709 . . . . 3.0 109.961 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 156.78 6.56 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.747 2.298 . . . . 1.56 112.576 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.52 9.03 10.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 3.06 110.794 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' ND2' ' H ' ' A' ' 17' ' ' GLN . 2.8 t-20 -138.94 154.66 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 2.52 110.827 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.478 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 7.5 tt0 -78.37 141.8 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 2.68 110.922 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.29 -27.45 10.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.995 -0.622 . . . . 0.59 112.299 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.18 163.58 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.167 -0.308 . . . . 1.82 110.167 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 HD22 HD13 ' A' ' 28' ' ' ILE . 17.3 tp -107.66 113.13 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 1.76 111.044 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.56 140.75 15.21 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.935 -0.65 . . . . 0.85 112.641 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.82 -170.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 4.94 110.942 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -132.14 168.11 18.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 3.35 111.546 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.71 148.6 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.606 -0.724 . . . . 2.24 110.935 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.48 78.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.826 -0.625 . . . . 0.37 112.908 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.8 p-10 -76.98 138.69 39.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.677 0.275 . . . . 2.3 110.774 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.496 HG12 ' HG2' ' A' ' 7' ' ' ARG . 66.5 mt -107.61 127.58 63.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.94 110.836 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 HD13 HD22 ' A' ' 20' ' ' LEU . 37.9 mt -123.57 139.83 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 1.73 111.508 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -86.19 127.94 34.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 1.13 110.2 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 39' ' ' TYR . 24.2 tp -96.29 127.81 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 2.37 111.513 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.52 HG23 ' ND2' ' A' ' 32' ' ' ASN . 12.5 t -166.99 17.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.369 -0.378 . . . . 1.12 111.586 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.579 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 57.8 m-80 -149.7 175.19 11.8 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.775 -0.824 . . . . 1.95 108.775 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 4.3 mt-30 -175.1 150.34 1.18 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.085 0.772 . . . . 1.82 113.085 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.04 -32.03 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.194 -0.912 . . . . 1.7 110.917 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -165.51 170.92 13.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 1.73 110.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.28 -10.88 5.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 2.93 111.106 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.11 -55.34 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 2.74 111.109 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -91.86 127.37 37.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.432 -0.349 . . . . 3.6 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 2.8 m-85 -106.89 172.17 6.97 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.274 -0.421 . . . . 3.57 111.082 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -140.58 145.69 37.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.526 0.679 . . . . 1.58 112.11 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.04 -171.69 28.49 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.157 -0.929 . . . . 0.26 111.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 17.3 mtm -134.4 156.78 47.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.234 0.54 . . . . 2.44 111.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -146.97 131.44 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.298 -0.864 . . . . 2.1 109.952 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.531 ' N ' HD13 ' A' ' 43' ' ' ILE . 73.3 t60 64.33 -78.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 3.85 111.007 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.08 31.62 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.758 . . . . 1.68 112.917 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.57 148.41 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 2.76 111.211 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' A' ' 42' ' ' MET . 85.9 p -105.75 169.71 8.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 1.61 111.481 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.58 169.55 42.06 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.745 -0.661 . . . . 0.33 111.941 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -114.37 158.66 21.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.888 0.344 . . . . 1.93 111.326 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER 176.06 119.97 0.14 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.735 -0.666 . . . . 5.33 111.312 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 9.2 Cg_endo -52.66 162.83 2.17 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.7 113.418 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 54' ' ' TYR . 25.7 mt -62.98 -23.29 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 115.369 -0.832 . . . . 1.41 112.116 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -69.57 8.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.654 0.264 . . . . 2.76 111.523 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' H ' ' C ' ' A' ' 52' ' ' ILE . 45.0 t80 -114.63 -24.55 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.333 . . . . 4.83 111.09 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 27.8 m -138.15 179.5 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.397 0.618 . . . . 1.14 111.785 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HB2' HD23 ' A' ' 9' ' ' LEU . 11.2 tp10 -134.36 102.07 5.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.244 -0.889 . . . . 2.09 109.896 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 40.0 t -64.59 112.63 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 1.84 111.201 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.08 -49.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 1.9 111.06 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 59.9 t -100.38 123.83 45.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 2.07 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.421 2.081 . . . . 1.96 112.257 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.849 0.27 . . . . 1.32 112.36 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.8 m -128.48 161.08 30.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 2.02 110.804 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 19.7 p -150.67 174.08 13.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.089 0.471 . . . . 1.26 111.252 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.409 ' NE ' HD11 ' A' ' 58' ' ' ILE . 34.3 ptt180 -141.68 128.03 19.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.689 -0.687 . . . . 3.8 110.977 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.15 144.7 35.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.984 -0.626 . . . . 0.28 113.007 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mt -100.46 -38.95 8.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.123 0.487 . . . . 1.96 111.468 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -135.02 147.94 49.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 3.55 110.475 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.3 p-10 -64.59 161.07 18.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.418 0.628 . . . . 2.01 112.126 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.83 121.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.799 -1.091 . . . . 1.49 110.807 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' OE2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 tp10 -92.75 125.1 56.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 3.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 71.5 Cg_exo -46.38 135.49 15.72 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.42 2.08 . . . . 1.56 112.565 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 45.5 mt-10 -133.28 -38.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.06 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -111.73 133.36 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 2.52 110.746 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 2.68 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.89 -27.29 15.01 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.784 -0.722 . . . . 0.59 112.372 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.52 165.32 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.67 0.271 . . . . 1.82 110.411 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.3 tp -108.08 134.25 51.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 1.76 111.304 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.517 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -125.05 132.67 8.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.841 -0.695 . . . . 0.85 112.668 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -166.92 -173.9 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.581 0.229 . . . . 4.94 110.437 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -120.4 166.77 13.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.236 0.541 . . . . 3.35 111.818 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.53 148.8 3.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.305 -0.862 . . . . 2.24 111.352 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.55 -5.69 67.88 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 115.72 -0.673 . . . . 0.37 113.118 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -76.48 132.27 39.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 2.3 111.006 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.5 mt -93.95 133.07 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 1.94 110.352 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.6 mt -128.24 138.95 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 1.73 111.584 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -95.57 126.25 40.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 1.13 109.881 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.54 143.97 27.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 2.37 111.872 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -167.1 13.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.75 . . . . 1.12 111.202 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.57 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 90.5 m-20 -148.82 167.58 25.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.442 -0.947 . . . . 1.95 108.442 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.0 mt-30 -174.43 149.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.962 0.727 . . . . 1.82 112.962 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.71 -35.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.206 -0.906 . . . . 1.7 110.528 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -167.79 177.0 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.301 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.24 -5.77 3.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.588 -0.278 . . . . 2.93 111.211 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -105.51 -60.36 1.63 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.282 . . . . 2.74 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -91.89 127.37 37.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.486 -0.325 . . . . 3.6 110.824 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 11.4 m-30 -110.96 171.57 7.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.803 0.335 . . . . 3.57 110.986 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.0 mt-10 -142.85 147.76 35.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.218 0.532 . . . . 1.58 111.578 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.99 -169.09 35.12 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.634 -0.712 . . . . 0.26 112.195 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 27.0 ptt? -143.26 160.91 39.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.265 0.555 . . . . 2.44 111.285 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.56 144.18 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.261 -0.882 . . . . 2.1 110.662 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 65.62 -79.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.018 -0.537 . . . . 3.85 110.954 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.76 31.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.67 -0.776 . . . . 1.68 112.91 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -162.45 149.05 13.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 2.76 111.514 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 90.9 p -115.02 169.93 8.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 1.61 110.728 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.65 172.76 44.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.847 -0.692 . . . . 0.33 112.33 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -110.51 155.06 22.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.659 0.266 . . . . 1.93 111.306 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.91 121.47 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.738 -0.664 . . . . 5.33 111.361 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 18.0 Cg_endo -59.5 170.16 3.53 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.812 2.341 . . . . 0.7 113.196 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 54' ' ' TYR . 39.4 mt -58.49 -18.93 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.535 -0.757 . . . . 1.41 111.28 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.31 7.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 2.76 111.74 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 52' ' ' ILE . 31.4 t80 -124.68 -23.34 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 4.83 111.479 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.1 176.87 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.279 0.561 . . . . 1.14 111.908 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -125.47 97.22 5.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.284 -0.871 . . . . 2.09 109.8 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 48.6 t -61.45 108.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 1.84 111.366 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 ' NE ' ' A' ' 7' ' ' ARG . 50.0 mm -70.68 -35.51 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 1.9 110.772 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -130.49 97.41 21.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 2.07 110.768 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.404 2.069 . . . . 1.96 112.256 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.23 0.114 0 CA-C-O 120.881 0.284 . . . . 1.32 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.5 m -137.96 165.4 26.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.595 . . . . 2.02 110.422 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 p -146.27 174.97 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 1.26 111.118 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -141.8 136.88 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.85 -0.614 . . . . 3.8 111.161 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.53 143.52 30.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.867 -0.682 . . . . 0.28 112.926 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -102.64 -31.58 10.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.865 0.364 . . . . 1.96 110.895 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -115.57 146.41 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.55 110.794 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.7 t70 -79.06 157.97 27.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.522 0.677 . . . . 2.01 112.038 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.26 119.39 1.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.678 -1.146 . . . . 1.49 110.881 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.18 121.56 72.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.352 -0.385 . . . . 3.0 110.289 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 135.82 29.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.987 1.791 . . . . 1.56 112.233 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.81 -13.31 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 3.06 110.989 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -133.55 130.92 39.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.232 -0.44 . . . . 2.52 110.862 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -61.59 141.37 57.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 2.68 111.128 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.44 -22.44 17.51 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.985 -0.626 . . . . 0.59 112.336 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt-10 -102.97 160.1 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 1.82 110.634 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 HD12 HD11 ' A' ' 28' ' ' ILE . 15.0 mt -99.09 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.76 110.515 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.17 130.32 9.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.85 112.977 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.43 -179.13 1.23 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 4.94 110.688 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.29 174.99 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.198 0.523 . . . . 3.35 111.591 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -53.34 148.91 8.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.394 -0.821 . . . . 2.24 110.981 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.94 65.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.977 -0.63 . . . . 0.37 112.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.24 139.47 46.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 2.3 110.82 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.62 130.29 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 1.94 110.744 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.5 HD11 HD12 ' A' ' 20' ' ' LEU . 62.8 mt -127.86 145.57 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.379 -0.373 . . . . 1.73 110.788 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.9 p -87.48 133.5 33.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 1.13 110.974 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 39' ' ' TYR . 20.3 tp -96.34 130.56 43.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 2.37 110.99 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.55 HG23 ' ND2' ' A' ' 32' ' ' ASN . 5.5 t -166.88 16.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.023 0.439 . . . . 1.12 111.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.583 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 58.1 m-80 -153.68 175.73 12.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.966 -0.753 . . . . 1.95 108.966 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.5 mt-30 -175.29 149.71 1.07 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.533 0.568 . . . . 1.82 112.533 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 mm -108.37 -34.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.355 -0.838 . . . . 1.7 110.916 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -157.86 171.19 20.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.722 -0.672 . . . . 1.73 110.422 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.94 -10.01 8.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.387 -0.369 . . . . 2.93 111.112 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.58 -55.84 2.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.342 -0.39 . . . . 2.74 111.128 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.2 m95 -86.91 125.22 33.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.519 -0.31 . . . . 3.6 110.235 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.553 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 6.4 m-30 -102.0 177.78 4.8 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.938 0.399 . . . . 3.57 111.095 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 27.8 mt-10 -146.82 138.42 24.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.363 0.601 . . . . 1.58 111.284 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.19 -168.41 19.68 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.443 -0.799 . . . . 0.26 111.66 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 8.1 mtt -137.93 155.19 49.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.506 0.669 . . . . 2.44 111.372 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' GLY . 7.5 tp -140.31 153.83 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.837 -1.074 . . . . 2.1 109.166 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.452 ' N ' HG13 ' A' ' 43' ' ' ILE . 85.2 m-70 -30.81 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.653 0.596 . . . . 3.85 111.951 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ILE . . . -78.93 -60.09 2.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.784 -0.722 . . . . 1.68 113.06 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.39 173.73 7.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.697 0.76 . . . . 2.76 112.101 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 93.6 p -105.19 148.66 26.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.6 -1.182 . . . . 1.61 111.273 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.46 -172.6 36.26 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.33 111.916 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 19' ' ' GLU . 52.2 p90 -105.26 158.1 16.84 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.974 0.387 . . . . 1.93 111.181 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -174.38 104.74 0.28 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.924 -0.58 . . . . 5.33 110.836 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 13.1 Cg_endo -58.45 163.46 10.48 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.733 2.289 . . . . 0.7 112.97 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.426 HD13 ' HH ' ' A' ' 39' ' ' TYR . 19.7 mt -65.97 -18.76 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.54 -0.755 . . . . 1.41 111.204 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.07 -5.06 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 2.76 111.642 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.17 -5.51 6.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.046 0.388 . . . . 4.83 112.046 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.69 175.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.161 0.505 . . . . 1.14 111.592 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 106.53 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.453 -0.794 . . . . 2.09 109.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.22 123.8 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.84 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mt -76.91 -53.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.985 -0.552 . . . . 1.9 110.958 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -103.69 108.17 58.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 2.07 110.974 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.361 2.041 . . . . 1.96 112.383 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.898 0.38 . . . . 6.87 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -161.85 133.0 5.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 5.1 110.702 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -134.33 87.55 32.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 3.98 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.99 158.56 14.05 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.541 2.16 . . . . 1.32 112.229 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.2 m -133.67 166.88 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.02 111.284 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' HG ' HG22 ' A' ' 55' ' ' VAL . 21.9 p -145.86 174.84 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 1.26 110.615 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -141.79 132.17 25.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.983 0.421 . . . . 3.8 111.347 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.54 135.08 18.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.882 -0.675 . . . . 0.28 112.934 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 56' ' ' GLU . 4.4 mm? -84.35 -31.55 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.072 0.463 . . . . 1.96 110.469 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -131.26 146.06 52.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 3.55 110.476 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.5 p-10 -74.76 161.88 29.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.374 0.607 . . . . 2.01 111.892 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 127.73 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.018 -0.992 . . . . 1.49 111.094 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.08 128.62 49.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.609 -0.515 . . . . 3.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 38.0 Cg_endo -66.29 130.56 24.25 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.08 1.853 . . . . 1.56 112.316 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.02 -16.61 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 3.06 111.24 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -115.04 134.49 55.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 2.52 110.797 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.35 135.82 57.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 2.68 111.101 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.65 -26.86 22.65 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.829 -0.7 . . . . 0.59 112.726 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.56 166.68 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 1.82 110.676 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 HD13 HG23 ' A' ' 43' ' ' ILE . 20.1 tp -117.25 127.08 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 1.76 110.987 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -89.27 149.75 20.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.85 112.534 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -174.68 169.72 3.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.645 0.259 . . . . 4.94 110.796 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -124.87 -167.79 1.72 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.481 0.657 . . . . 3.35 111.894 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.34 125.83 27.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.937 -1.029 . . . . 2.24 110.692 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.45 81.94 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.37 112.593 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.06 122.22 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 2.3 111.088 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.4 121.76 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.97 -0.559 . . . . 1.94 110.603 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.93 142.33 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.314 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.3 p -96.35 113.17 24.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 1.13 110.069 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.28 144.61 25.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.5 0.667 . . . . 2.37 112.698 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.5 t -167.47 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.766 -1.106 . . . . 1.12 110.475 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.6 m-20 -144.01 -179.51 6.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.151 -1.055 . . . . 1.95 108.151 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.22 150.18 1.13 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 113.518 0.933 . . . . 1.82 113.518 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.547 HG12 ' HG3' ' A' ' 40' ' ' GLU . 30.9 mm -101.0 -45.72 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.787 -1.097 . . . . 1.7 110.449 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -167.96 -170.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.531 -0.759 . . . . 1.73 110.623 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.36 -5.13 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.081 0.4 . . . . 2.93 112.081 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -98.28 -56.12 2.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.628 0.232 . . . . 2.74 111.628 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 p90 -120.97 133.86 55.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.174 0.512 . . . . 3.6 111.733 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.2 m-30 -93.24 -177.16 4.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.458 -0.792 . . . . 3.57 111.25 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG3' HG12 ' A' ' 34' ' ' ILE . 25.3 mt-10 -141.31 144.62 34.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 1.58 111.764 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.43 -163.73 21.84 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.362 -0.836 . . . . 0.26 111.444 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.81 154.78 49.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.294 0.569 . . . . 2.44 111.588 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG23 HD13 ' A' ' 20' ' ' LEU . 4.8 tp -140.21 123.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.185 -0.916 . . . . 2.1 110.042 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.8 t60 67.38 -75.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.069 -0.514 . . . . 3.85 110.773 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.43 30.64 0.47 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 1.68 112.735 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -144.03 147.32 33.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.975 0.417 . . . . 2.76 111.503 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.6 m -108.02 161.4 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 1.61 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.83 174.03 39.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.958 -0.639 . . . . 0.33 112.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -104.28 153.85 20.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.862 0.331 . . . . 1.93 111.101 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 p90 -153.74 103.96 2.51 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.162 -0.472 . . . . 5.33 111.817 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -49.3 144.76 16.77 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.98 2.454 . . . . 0.7 112.429 177.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.91 -22.69 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.612 -0.722 . . . . 1.41 111.633 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -73.9 12.96 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 2.76 111.775 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -132.92 -9.3 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 4.83 111.109 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.458 HG22 ' HG ' ' A' ' 6' ' ' CYS . 34.1 m -140.01 174.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 1.14 111.212 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' HB2' HD22 ' A' ' 9' ' ' LEU . 40.1 tt0 -133.99 101.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 2.09 109.676 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 57.8 t -60.4 116.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.077 -0.511 . . . . 1.84 111.383 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.66 -48.11 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.688 -0.687 . . . . 1.9 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.43 106.13 54.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 2.07 111.115 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.499 2.133 . . . . 1.96 112.296 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.976 0.417 . . . . 6.87 110.676 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.87 135.66 37.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.035 -0.529 . . . . 5.1 110.941 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -69.17 152.32 96.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 3.98 110.95 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HA ' HG12 ' A' ' 59' ' ' VAL . 46.8 Cg_endo -68.62 124.33 11.44 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.48 2.12 . . . . 1.32 112.271 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.2 m -135.79 178.83 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.972 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.5 p -161.08 174.63 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 1.26 111.025 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.54 135.45 33.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.88 -0.6 . . . . 3.8 111.408 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 128.78 9.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.839 -0.696 . . . . 0.28 112.705 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 56' ' ' GLU . 3.8 mm? -78.24 -36.68 46.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 1.96 110.84 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.49 148.87 50.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 3.55 110.953 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.6 p-10 -65.35 167.98 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.221 0.534 . . . . 2.01 111.684 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.86 118.3 1.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 1.49 111.265 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.74 113.68 59.55 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.78 -0.646 . . . . 3.0 110.059 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.64 130.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.485 2.124 . . . . 1.56 112.803 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.96 -28.97 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 3.06 110.667 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -110.63 131.39 55.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 2.52 110.79 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.85 124.65 21.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.68 110.931 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.09 -26.57 11.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 0.59 112.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -76.51 165.91 24.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 1.82 110.763 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 40.3 tp -112.56 135.33 53.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 1.76 111.174 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.61 149.26 18.14 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.919 -0.657 . . . . 0.85 112.092 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -175.0 156.38 2.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 4.94 111.274 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -107.72 179.54 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 3.35 111.052 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -63.48 138.71 58.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.517 -0.765 . . . . 2.24 110.796 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.11 -5.56 66.23 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.948 -0.644 . . . . 0.37 113.085 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.65 147.93 45.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 2.3 111.053 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.27 134.07 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 1.94 111.217 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.468 HD11 HD11 ' A' ' 43' ' ' ILE . 39.3 mm -126.22 141.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 1.73 110.83 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.8 p -89.67 128.82 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.587 -0.278 . . . . 1.13 110.445 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' N ' ' A' ' 31' ' ' THR . 2.6 tt -96.14 127.25 41.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 2.37 110.772 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.539 HG22 ' ND2' ' A' ' 32' ' ' ASN . 7.8 t -166.2 17.62 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.07 0.462 . . . . 1.12 111.171 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.594 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 56.1 m-80 -150.89 -179.46 7.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.942 -0.762 . . . . 1.95 108.942 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.6 mt-30 -174.75 149.77 1.24 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.644 0.609 . . . . 1.82 112.644 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.23 -29.59 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.315 -0.857 . . . . 1.7 111.54 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -156.91 170.3 22.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.259 -0.428 . . . . 1.73 110.831 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -61.34 -26.14 67.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 2.93 111.085 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.43 -38.66 8.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.27 -0.423 . . . . 2.74 111.28 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.704 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -96.36 125.67 41.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 3.6 110.815 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 18.6 m-30 -105.97 171.93 7.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.267 -0.424 . . . . 3.57 110.087 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 40.0 tt0 -139.97 137.73 34.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 1.58 111.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.43 -176.14 23.15 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.04 -0.982 . . . . 0.26 111.745 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -134.17 160.41 37.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.526 0.679 . . . . 2.44 111.896 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.468 HD11 HD11 ' A' ' 28' ' ' ILE . 14.0 tt -155.91 140.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.684 -1.143 . . . . 2.1 109.745 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 64.31 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 3.85 110.839 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.54 30.68 0.41 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.488 -0.863 . . . . 1.68 113.134 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -159.34 149.13 18.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.01 0.433 . . . . 2.76 111.537 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 41.7 t -110.01 170.06 8.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 1.61 111.477 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . -176.49 166.1 36.83 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.904 -0.589 . . . . 0.33 112.065 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -99.07 157.34 16.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.822 0.344 . . . . 1.93 111.318 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 24.6 p90 -175.78 111.83 0.26 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 5.33 111.428 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 6.1 Cg_endo -52.67 156.89 8.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.55 2.167 . . . . 0.7 112.26 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.01 -18.69 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.662 . . . . 1.41 111.389 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.13 -5.32 6.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 2.76 111.885 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -117.64 -8.36 10.92 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.125 0.417 . . . . 4.83 112.125 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.85 176.76 3.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.28 0.562 . . . . 1.14 112.003 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 56' ' ' GLU . 9.9 pt-20 -134.23 101.56 5.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 2.09 109.989 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.13 114.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 1.84 111.263 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.12 -41.41 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 1.9 110.985 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 4' ' ' PRO . 2.7 p -143.71 123.43 7.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 2.07 110.955 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.356 2.037 . . . . 1.96 112.314 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.844 0.354 . . . . 6.87 111.049 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -139.78 40.44 2.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 5.1 110.691 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -103.21 130.39 23.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 3.98 110.922 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 61.1 Cg_endo -72.28 127.84 13.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.416 2.077 . . . . 1.32 112.238 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p -141.29 151.51 43.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 2.02 110.863 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' SG ' HD13 ' A' ' 30' ' ' LEU . 12.9 p -131.91 174.92 9.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 1.26 110.986 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.498 ' HE ' HD13 ' A' ' 58' ' ' ILE . 12.4 ptp180 -142.15 136.74 30.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 3.8 110.945 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.45 137.49 20.39 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.73 -0.747 . . . . 0.28 112.838 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 56' ' ' GLU . 3.8 mm? -92.13 -33.07 14.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 1.96 110.734 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -125.36 146.2 49.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 3.55 110.787 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 p-10 -77.76 161.76 27.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.308 0.575 . . . . 2.01 111.835 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 133.02 2.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.101 -0.954 . . . . 1.49 111.453 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.1 86.75 11.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.65 134.87 39.66 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.515 2.143 . . . . 1.56 112.752 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 6.62 38.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 3.06 110.636 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -115.75 134.31 55.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 2.52 110.793 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.13 139.59 58.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 2.68 111.107 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.8 -25.72 12.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.925 -0.655 . . . . 0.59 112.529 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.83 161.86 16.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 1.82 110.708 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -100.25 122.12 42.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 1.76 110.522 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.08 134.97 12.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.85 112.952 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -175.7 -170.3 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.693 0.282 . . . . 4.94 110.703 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -132.55 172.87 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 3.35 111.505 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -49.7 148.44 3.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 2.24 110.818 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.77 -2.73 82.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.938 -0.649 . . . . 0.37 112.942 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.7 145.66 45.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 2.3 111.153 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -120.36 123.07 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 1.94 110.252 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.44 141.68 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.552 -0.294 . . . . 1.73 111.454 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.3 p -85.52 129.99 34.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.36 -0.382 . . . . 1.13 110.085 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD13 ' SG ' ' A' ' 6' ' ' CYS . 10.9 mp -96.24 132.86 41.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.121 0.486 . . . . 2.37 111.708 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.538 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.4 t -167.09 17.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.571 -0.741 . . . . 1.12 110.739 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.571 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 57.9 m-80 -152.3 175.8 12.28 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.642 -0.873 . . . . 1.95 108.642 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 4.0 mt-30 -175.12 150.05 1.14 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.072 0.767 . . . . 1.82 113.072 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.4 mm -103.65 -37.37 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.076 -0.966 . . . . 1.7 110.915 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -168.08 175.94 6.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.616 . . . . 1.73 110.516 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.51 -10.96 5.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 2.93 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.0 -54.99 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.463 . . . . 2.74 111.19 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.15 134.96 38.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 3.6 111.257 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.2 m-85 -110.74 168.13 9.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 3.57 110.253 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 35.5 mt-10 -137.71 142.31 41.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.504 0.668 . . . . 1.58 112.076 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.2 -173.35 34.53 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.019 -0.991 . . . . 0.26 111.474 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ptm -143.35 161.1 39.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.447 0.642 . . . . 2.44 111.558 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.58 133.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.144 -0.935 . . . . 2.1 110.36 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.3 t60 65.24 -78.81 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.104 -0.498 . . . . 3.85 110.974 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.76 30.1 0.55 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 1.68 112.89 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.25 143.08 25.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.358 . . . . 2.76 111.233 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 83.6 p -117.82 170.05 9.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 1.61 111.322 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.78 166.18 30.91 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.33 111.896 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -100.1 159.7 14.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.896 0.379 . . . . 1.93 111.154 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.51 112.0 0.4 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.942 -0.572 . . . . 5.33 110.725 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.693 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.3 Cg_endo -58.07 157.55 24.71 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.618 2.212 . . . . 0.7 112.569 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 mt -61.01 -18.42 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 1.41 111.403 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.49 4.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 2.76 111.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -135.42 -5.77 2.28 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.629 0.233 . . . . 4.83 111.629 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 1.14 111.32 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HB2' HD23 ' A' ' 9' ' ' LEU . 37.9 tt0 -135.01 102.78 5.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 2.09 109.996 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.46 101.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.84 110.912 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.498 HD13 ' HE ' ' A' ' 7' ' ' ARG . 59.4 mt -61.97 -35.91 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 1.9 111.126 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 35.5 t -125.38 97.82 36.31 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 2.07 111.161 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.446 2.097 . . . . 1.96 112.265 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.803 0.335 . . . . 6.87 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -99.82 13.63 33.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 5.1 110.776 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 61.21 102.49 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.907 -0.588 . . . . 3.98 111.26 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HA ' HG11 ' A' ' 59' ' ' VAL . 51.3 Cg_exo -53.82 135.68 63.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.442 2.094 . . . . 1.32 112.248 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.9 m -127.25 176.29 7.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 2.02 111.074 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 16.6 p -155.46 174.73 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 1.26 110.747 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -141.94 144.58 33.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.084 -0.507 . . . . 3.8 111.23 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 135.66 16.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.929 -0.653 . . . . 0.28 112.811 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.16 -36.56 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 1.96 110.563 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -140.92 147.0 38.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.652 . . . . 3.55 110.496 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -58.17 159.45 5.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.235 0.54 . . . . 2.01 111.698 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -160.64 127.05 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.205 -0.907 . . . . 1.49 111.28 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -98.43 133.3 22.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 3.0 109.493 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 73.6 Cg_endo -74.77 133.65 17.23 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.965 1.777 . . . . 1.56 112.449 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -83.33 -38.41 22.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 3.06 110.896 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -132.06 173.64 11.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 2.52 110.789 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -73.89 144.53 45.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 2.68 110.946 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.24 -27.19 11.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.804 -0.712 . . . . 0.59 112.62 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.91 171.1 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.345 . . . . 1.82 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -109.81 123.28 49.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 1.76 110.95 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.591 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -113.4 124.85 6.72 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.804 -0.712 . . . . 0.85 112.598 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 13.3 m-85 -163.89 -169.66 1.94 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.69 0.281 . . . . 4.94 110.662 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -125.06 173.02 8.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.456 0.646 . . . . 3.35 112.018 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.91 149.2 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.068 -0.969 . . . . 2.24 111.042 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.24 69.4 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.756 -0.656 . . . . 0.37 112.916 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -79.73 132.21 36.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 2.3 110.824 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.42 128.13 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 1.94 111.324 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 mm -128.54 142.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.73 110.791 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.6 p -89.87 135.39 33.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.59 -0.277 . . . . 1.13 110.519 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 39' ' ' TYR . 15.2 tp -96.33 132.92 41.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.325 -0.398 . . . . 2.37 110.781 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.403 HG22 ' OD1' ' A' ' 32' ' ' ASN . 8.9 t -166.72 17.24 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.038 0.447 . . . . 1.12 111.378 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.578 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 20.5 m120 -151.35 170.22 20.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.682 -0.859 . . . . 1.95 108.682 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.2 mt-30 -174.94 149.62 1.15 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.689 0.625 . . . . 1.82 112.689 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 34' ' ' ILE . 2.6 mp -105.66 -32.88 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.184 -0.916 . . . . 1.7 110.655 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -167.93 -170.92 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.81 -0.632 . . . . 1.73 110.785 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.46 -14.41 61.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 2.93 111.419 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -101.3 -54.29 2.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 2.74 111.62 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -95.22 126.57 40.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.853 0.359 . . . . 3.6 111.035 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB3' HD12 ' A' ' 30' ' ' LEU . 14.4 m-30 -108.73 175.4 5.48 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.069 -0.514 . . . . 3.57 110.501 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -150.76 143.86 24.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.47 0.652 . . . . 1.58 111.974 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.18 -171.0 24.42 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.26 111.855 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -143.3 163.13 33.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.393 0.616 . . . . 2.44 111.531 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 tp -144.58 126.12 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.009 -0.996 . . . . 2.1 110.415 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t60 64.98 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 3.85 111.106 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.89 31.51 0.67 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.596 -0.812 . . . . 1.68 112.874 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.36 135.12 19.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 2.76 111.159 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.7 p -106.8 170.28 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.61 111.5 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.01 150.1 8.14 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.33 111.88 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -113.08 160.17 18.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.351 . . . . 1.93 111.404 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 177.29 132.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.625 -0.716 . . . . 5.33 110.841 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.6 Cg_endo -47.2 160.89 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.172 2.581 . . . . 0.7 112.965 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 54' ' ' TYR . 24.8 mt -58.03 -20.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.397 -0.819 . . . . 1.41 111.693 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -66.12 7.26 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.564 -0.289 . . . . 2.76 111.35 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 52' ' ' ILE . 9.7 t80 -116.41 -30.89 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.365 -0.38 . . . . 4.83 111.233 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.48 175.61 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.39 0.614 . . . . 1.14 111.861 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.43 113.37 8.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.248 -0.887 . . . . 2.09 109.604 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -55.04 120.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 1.84 111.181 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.8 mt -80.83 -47.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.737 -0.665 . . . . 1.9 111.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 4' ' ' PRO . 3.2 p -126.74 111.41 22.51 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.254 -0.43 . . . . 2.07 111.038 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.518 2.145 . . . . 1.96 112.487 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.801 0.334 . . . . 6.87 110.836 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.04 117.98 11.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 5.1 110.885 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.597 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 56.3 tp60 -88.39 -49.39 0.42 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.082 -0.508 . . . . 3.98 111.565 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 3' ' ' GLN . 32.8 Cg_exo -59.51 123.88 14.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.109 1.872 . . . . 1.32 112.185 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.83 169.46 19.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 2.02 111.337 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' A' ' 30' ' ' LEU . 16.3 p -150.17 175.19 11.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 1.26 110.64 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.465 ' HD2' ' HA2' ' A' ' 25' ' ' GLY . 37.4 ttp180 -139.67 121.44 15.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 3.8 111.178 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -70.41 135.58 25.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 0.28 112.542 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -84.27 -31.26 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.96 110.717 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -125.53 154.04 42.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.81 -0.632 . . . . 3.55 110.857 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.93 147.88 24.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.203 -0.453 . . . . 2.01 110.341 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.93 133.58 17.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 1.49 111.366 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -94.19 132.02 30.17 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 3.0 109.801 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.49 129.54 26.76 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.317 2.012 . . . . 1.56 112.331 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.04 -34.13 3.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 3.06 110.924 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -111.21 159.38 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 2.52 110.972 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -77.95 124.08 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 2.68 110.936 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.33 -20.14 35.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.938 -0.649 . . . . 0.59 112.561 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.62 165.28 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 1.82 110.541 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 38.3 tp -113.49 134.59 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 1.76 111.126 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.55 148.37 16.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 0.85 112.03 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -170.07 -172.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 4.94 111.219 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -133.68 -179.7 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 3.35 111.425 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.05 138.78 58.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.28 -0.873 . . . . 2.24 110.15 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 7' ' ' ARG . . . 81.57 -19.13 9.43 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.729 . . . . 0.37 112.623 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.75 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 2.3 111.077 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -93.77 126.69 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 1.94 110.958 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.98 143.85 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 1.73 111.24 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.6 p -92.69 127.73 38.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.359 -0.382 . . . . 1.13 110.464 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.4 HD13 ' SG ' ' A' ' 6' ' ' CYS . 8.4 mp -96.59 133.3 41.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 2.37 111.484 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -166.97 14.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.276 -0.42 . . . . 1.12 111.591 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.9 m-20 -151.09 179.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.53 -0.915 . . . . 1.95 108.53 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 5.4 mt-30 -174.76 149.89 1.24 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.871 0.693 . . . . 1.82 112.871 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.436 ' HB ' ' CD1' ' A' ' 38' ' ' TRP . 47.9 mm -109.66 -32.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.057 -0.974 . . . . 1.7 111.018 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.11 167.38 12.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.73 110.627 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.17 -8.84 6.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.41 -0.359 . . . . 2.93 110.875 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -96.19 -52.77 3.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.133 -0.485 . . . . 2.74 110.981 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.76 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -115.58 134.47 55.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 3.6 111.257 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 39.8 p90 -100.32 -177.98 3.68 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.986 -0.552 . . . . 3.57 111.221 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 38.2 tt0 -144.67 137.02 26.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.396 0.617 . . . . 1.58 111.563 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.31 -161.81 10.97 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.26 111.734 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 23.6 ptp -143.37 156.68 44.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 2.44 111.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.77 132.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.261 -0.881 . . . . 2.1 110.306 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 65.38 -77.27 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.09 -0.504 . . . . 3.85 111.275 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.53 31.58 0.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.568 -0.825 . . . . 1.68 112.997 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.14 144.76 23.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 2.76 111.343 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 44.7 t -107.5 168.73 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 1.61 111.278 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . 172.45 170.06 35.82 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.793 -0.639 . . . . 0.33 111.875 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 24.5 p90 -111.61 158.55 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 1.93 111.29 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -173.06 122.79 0.43 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.217 -0.447 . . . . 5.33 111.713 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 84.2 Cg_exo -44.85 139.17 8.0 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.18 2.587 . . . . 0.7 113.258 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 mt -64.04 -18.64 23.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.328 -0.851 . . . . 1.41 111.581 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.61 -6.57 3.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 2.76 112.213 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -117.37 12.07 14.15 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.298 0.481 . . . . 4.83 112.298 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 23.0 m -144.7 175.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.21 0.529 . . . . 1.14 111.457 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.2 tp10 -133.49 96.47 3.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 2.09 109.804 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 p -55.82 118.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 1.84 111.226 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -73.16 -36.34 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 1.9 110.968 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 4' ' ' PRO . 7.1 p -150.76 131.71 7.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 2.07 110.865 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.355 2.037 . . . . 1.96 112.248 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.812 0.339 . . . . 6.87 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.5 t70 56.99 25.39 10.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 5.1 111.018 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.565 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 15.6 mm100 -94.81 -49.41 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.132 -0.485 . . . . 3.98 111.535 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.596 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.3 Cg_exo -54.9 132.86 54.61 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.151 1.9 . . . . 1.32 112.205 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.4 m -144.81 179.43 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 2.02 111.087 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 20.6 p -155.45 174.33 15.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.912 -0.585 . . . . 1.26 110.491 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HE ' HD13 ' A' ' 58' ' ' ILE . 8.1 ptp180 -142.49 133.19 25.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 3.8 111.46 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.23 137.63 24.13 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.839 -0.696 . . . . 0.28 112.894 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -87.55 -28.76 21.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.399 . . . . 1.96 110.754 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -136.92 146.8 45.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 3.55 110.685 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 t70 -67.61 160.31 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 2.01 111.602 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.18 119.4 1.52 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.014 -0.994 . . . . 1.49 110.835 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.73 135.54 49.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 3.0 109.841 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 45.9 Cg_endo -69.4 138.7 39.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 1.56 112.431 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -126.0 -45.85 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 3.06 110.996 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.62 153.33 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.927 0.394 . . . . 2.52 111.121 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -77.51 124.97 28.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 2.68 111.023 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.07 -2.62 35.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.716 . . . . 0.59 112.807 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -95.81 165.75 12.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 1.82 110.813 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -106.91 119.22 38.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 1.76 111.059 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -105.76 135.39 12.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.835 -0.698 . . . . 0.85 112.559 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.99 -173.55 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.734 0.302 . . . . 4.94 110.935 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -121.0 174.67 6.48 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.363 0.601 . . . . 3.35 111.962 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.21 149.36 12.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 2.24 110.983 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.64 -11.31 62.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.962 -0.637 . . . . 0.37 112.586 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.02 126.32 30.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.817 0.342 . . . . 2.3 110.606 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 41.6 mt -100.34 108.22 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 1.94 111.382 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 20' ' ' LEU . 77.9 mt -96.46 139.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.105 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.8 p -90.67 120.3 31.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 1.13 110.321 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -95.61 142.66 27.67 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.381 0.61 . . . . 2.37 112.512 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.457 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.7 t -167.65 17.42 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.069 -0.969 . . . . 1.12 110.748 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.572 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 58.2 m-80 -149.6 176.37 10.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.473 -0.936 . . . . 1.95 108.473 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.3 mt-30 -175.28 149.8 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.751 0.649 . . . . 1.82 112.751 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 34' ' ' ILE . 3.7 mp -109.21 -28.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.435 -0.802 . . . . 1.7 110.488 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.87 166.68 21.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 1.73 110.485 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.12 -12.16 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 2.93 111.09 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.92 -57.7 1.99 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 2.74 110.979 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.2 m95 -87.55 125.52 34.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.415 -0.357 . . . . 3.6 110.571 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.553 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.3 m-85 -102.78 178.48 4.56 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.832 0.349 . . . . 3.57 110.67 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -151.27 140.1 20.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 1.58 111.834 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.4 -159.04 11.61 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.464 -0.789 . . . . 0.26 111.736 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.97 156.93 46.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.332 0.587 . . . . 2.44 111.442 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 tp -145.02 128.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.186 -0.916 . . . . 2.1 110.07 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 67.29 -76.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 3.85 110.688 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.31 29.7 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 1.68 112.804 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -144.83 147.69 33.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 2.76 111.465 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -109.33 162.99 13.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 1.61 111.15 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.465 ' HA3' ' HG ' ' A' ' 20' ' ' LEU . . . 172.75 173.16 39.05 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.926 -0.654 . . . . 0.33 112.386 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.17 162.34 13.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.735 0.302 . . . . 1.93 111.187 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -178.36 106.05 0.21 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.903 -0.59 . . . . 5.33 110.812 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.5 Cg_endo -59.46 159.94 21.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.725 2.283 . . . . 0.7 113.3 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.77 -18.35 22.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.427 -0.806 . . . . 1.41 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.87 -2.27 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 2.76 111.78 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -131.71 -4.48 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.749 0.277 . . . . 4.83 111.749 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.83 174.32 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.16 0.505 . . . . 1.14 111.216 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HB2' HD23 ' A' ' 9' ' ' LEU . 10.0 tp10 -134.34 105.0 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 2.09 109.91 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 45.9 t -55.69 122.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 1.84 111.179 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.485 HD13 ' HE ' ' A' ' 7' ' ' ARG . 58.0 mt -85.04 -38.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 1.9 111.222 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 39.6 t -110.22 115.57 54.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.07 111.205 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.426 2.084 . . . . 1.96 112.28 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.735 0.302 . . . . 6.87 110.855 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 57.12 -161.31 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 5.1 111.002 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 66.87 143.62 0.09 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.041 -0.527 . . . . 3.98 111.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.39 132.58 27.81 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.425 2.084 . . . . 1.32 112.342 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.73 179.64 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 2.02 110.825 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 p -163.18 174.78 11.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 1.26 110.963 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -142.13 134.39 27.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.8 111.305 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -76.56 139.11 23.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.28 112.609 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -97.32 -32.06 12.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 1.96 110.893 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -122.67 146.48 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.904 -0.589 . . . . 3.55 110.728 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.82 167.21 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.405 0.622 . . . . 2.01 111.956 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.99 119.44 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.015 -0.993 . . . . 1.49 110.963 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -81.9 128.49 68.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 3.0 110.298 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.06 129.91 33.99 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.315 2.01 . . . . 1.56 112.496 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 11.8 pt-20 -151.64 -35.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 3.06 110.681 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 15' ' ' GLU . 39.5 m-80 -90.83 137.13 32.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.115 -0.493 . . . . 2.52 110.772 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.0 121.57 21.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 2.68 110.996 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.23 14.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.59 112.626 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 29.1 tt0 -81.23 168.21 18.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 1.82 110.713 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 ' H ' ' HG2' ' A' ' 19' ' ' GLU . 30.8 tp -116.72 132.58 56.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 1.76 110.853 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.42 141.71 16.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.671 -0.776 . . . . 0.85 112.725 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.24 -176.11 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.433 -0.21 . . . . 4.94 110.433 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -118.78 169.79 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.27 0.557 . . . . 3.35 112.034 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -48.76 149.38 1.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.162 -0.926 . . . . 2.24 111.34 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.23 -6.0 69.75 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.37 113.023 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -73.94 124.17 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 2.3 111.117 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -92.79 125.18 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 1.94 110.74 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.538 HG12 ' HB ' ' A' ' 43' ' ' ILE . 62.5 mt -123.92 135.5 63.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 1.73 111.401 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -95.9 116.67 29.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 1.13 109.928 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 pp -94.94 149.56 21.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.369 0.604 . . . . 2.37 112.393 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 t -167.48 17.13 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.029 -0.987 . . . . 1.12 110.787 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.581 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 14.0 m120 -147.99 -179.99 7.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.437 -0.949 . . . . 1.95 108.437 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.28 149.85 1.09 Allowed 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.523 0.564 . . . . 1.82 112.523 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.58 -23.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.404 -0.816 . . . . 1.7 111.032 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -166.95 165.06 16.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 1.73 110.464 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -7.1 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 2.93 110.79 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -110.22 -51.99 2.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 2.74 110.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.63 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 m95 -92.67 125.94 37.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.472 -0.331 . . . . 3.6 110.525 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HH ' HD12 ' A' ' 52' ' ' ILE . 4.0 m-30 -100.08 177.16 5.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.887 0.375 . . . . 3.57 110.918 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -147.4 137.41 23.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.96 -0.563 . . . . 1.58 111.265 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.33 -158.9 14.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.585 -0.734 . . . . 0.26 111.859 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 mtm -141.12 148.94 40.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 2.44 111.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' HB ' HG12 ' A' ' 28' ' ' ILE . 12.3 tt -126.43 118.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 2.1 110.08 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.9 t60 67.89 -73.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 3.85 110.716 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.01 27.5 0.51 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.663 -0.78 . . . . 1.68 112.832 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -136.68 142.05 43.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.71 0.29 . . . . 2.76 111.222 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.6 p -105.8 155.54 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 1.61 111.016 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.8 169.59 38.29 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.796 -0.716 . . . . 0.33 112.552 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -97.6 151.14 20.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.55 0.214 . . . . 1.93 110.566 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 16.0 p90 -167.93 103.97 0.56 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.002 0.371 . . . . 5.33 112.002 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 10.5 Cg_endo -57.64 165.1 6.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.516 2.144 . . . . 0.7 112.415 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.614 HD12 ' HH ' ' A' ' 39' ' ' TYR . 19.0 mt -66.26 -20.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 1.41 111.64 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -69.89 2.06 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.59 -0.277 . . . . 2.76 111.555 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -124.62 -11.8 7.25 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 4.83 111.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 34.7 m -140.21 177.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.309 0.576 . . . . 1.14 111.772 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.535 ' HB2' HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -137.64 102.39 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 2.09 109.749 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.37 117.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.84 111.244 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.68 -47.08 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 1.9 111.146 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.83 97.68 9.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.371 -0.377 . . . . 2.07 111.317 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.58 2.186 . . . . 1.96 112.174 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.71 0.291 . . . . 6.87 110.713 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.07 142.41 38.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 5.1 110.855 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.08 129.67 12.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 3.98 110.759 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.482 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 59.0 Cg_endo -71.21 132.73 21.54 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.405 2.07 . . . . 1.32 112.182 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.7 m -140.71 169.82 16.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 2.02 111.196 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 21.1 p -144.93 174.67 10.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 1.26 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HG2' HG12 ' A' ' 27' ' ' ILE . 91.1 mtt180 -138.9 137.43 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 3.8 111.414 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -74.61 136.47 21.03 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.952 -0.642 . . . . 0.28 112.921 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -82.85 -29.78 29.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.96 110.724 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -149.11 155.04 40.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 3.55 110.859 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.8 p30 -70.55 166.36 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.586 0.708 . . . . 2.01 112.8 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.33 130.76 2.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.589 -1.187 . . . . 1.49 111.06 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -111.7 88.86 10.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.641 -0.709 . . . . 3.0 109.961 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 156.78 6.56 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.747 2.298 . . . . 1.56 112.576 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.52 9.03 10.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 3.06 110.794 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' ND2' ' H ' ' A' ' 17' ' ' GLN . 2.8 t-20 -138.94 154.66 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 2.52 110.827 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.478 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 7.5 tt0 -78.37 141.8 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 2.68 110.922 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.29 -27.45 10.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.995 -0.622 . . . . 0.59 112.299 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.18 163.58 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.167 -0.308 . . . . 1.82 110.167 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 HD22 HD13 ' A' ' 28' ' ' ILE . 17.3 tp -107.66 113.13 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 1.76 111.044 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.56 140.75 15.21 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.935 -0.65 . . . . 0.85 112.641 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.82 -170.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 4.94 110.942 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -132.14 168.11 18.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 3.35 111.546 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.71 148.6 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.606 -0.724 . . . . 2.24 110.935 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.48 78.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.826 -0.625 . . . . 0.37 112.908 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.8 p-10 -76.98 138.69 39.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.677 0.275 . . . . 2.3 110.774 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.496 HG12 ' HG2' ' A' ' 7' ' ' ARG . 66.5 mt -107.61 127.58 63.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.94 110.836 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 HD13 HD22 ' A' ' 20' ' ' LEU . 37.9 mt -123.57 139.83 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 1.73 111.508 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -86.19 127.94 34.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 1.13 110.2 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 39' ' ' TYR . 24.2 tp -96.29 127.81 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 2.37 111.513 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.52 HG23 ' ND2' ' A' ' 32' ' ' ASN . 12.5 t -166.99 17.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.369 -0.378 . . . . 1.12 111.586 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.579 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 57.8 m-80 -149.7 175.19 11.8 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.775 -0.824 . . . . 1.95 108.775 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 4.3 mt-30 -175.1 150.34 1.18 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.085 0.772 . . . . 1.82 113.085 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.04 -32.03 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.194 -0.912 . . . . 1.7 110.917 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -165.51 170.92 13.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 1.73 110.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.28 -10.88 5.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 2.93 111.106 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.11 -55.34 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 2.74 111.109 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -91.86 127.37 37.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.432 -0.349 . . . . 3.6 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 2.8 m-85 -106.89 172.17 6.97 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.274 -0.421 . . . . 3.57 111.082 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -140.58 145.69 37.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.526 0.679 . . . . 1.58 112.11 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.04 -171.69 28.49 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.157 -0.929 . . . . 0.26 111.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 17.3 mtm -134.4 156.78 47.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.234 0.54 . . . . 2.44 111.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -146.97 131.44 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.298 -0.864 . . . . 2.1 109.952 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.531 ' N ' HD13 ' A' ' 43' ' ' ILE . 73.3 t60 64.33 -78.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 3.85 111.007 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.08 31.62 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.758 . . . . 1.68 112.917 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.57 148.41 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 2.76 111.211 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' A' ' 42' ' ' MET . 85.9 p -105.75 169.71 8.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 1.61 111.481 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.58 169.55 42.06 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.745 -0.661 . . . . 0.33 111.941 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -114.37 158.66 21.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.888 0.344 . . . . 1.93 111.326 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER 176.06 119.97 0.14 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.735 -0.666 . . . . 5.33 111.312 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 9.2 Cg_endo -52.66 162.83 2.17 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.7 113.418 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 54' ' ' TYR . 25.7 mt -62.98 -23.29 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 115.369 -0.832 . . . . 1.41 112.116 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -69.57 8.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.654 0.264 . . . . 2.76 111.523 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' H ' ' C ' ' A' ' 52' ' ' ILE . 45.0 t80 -114.63 -24.55 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.333 . . . . 4.83 111.09 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 27.8 m -138.15 179.5 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.397 0.618 . . . . 1.14 111.785 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HB2' HD23 ' A' ' 9' ' ' LEU . 11.2 tp10 -134.36 102.07 5.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.244 -0.889 . . . . 2.09 109.896 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 40.0 t -64.59 112.63 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 1.84 111.201 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.08 -49.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 1.9 111.06 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 59.9 t -100.38 123.83 45.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 2.07 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.421 2.081 . . . . 1.96 112.257 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.79 0.328 . . . . 6.87 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.13 130.54 53.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 5.1 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -135.75 86.77 26.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 3.98 110.871 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.64 124.63 12.63 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.49 2.127 . . . . 1.32 112.36 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.8 m -128.48 161.08 30.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 2.02 110.804 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 19.7 p -150.67 174.08 13.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.089 0.471 . . . . 1.26 111.252 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' NE ' HD11 ' A' ' 58' ' ' ILE . 34.3 ptt180 -141.68 128.03 19.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.689 -0.687 . . . . 3.8 110.977 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.15 144.7 35.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.984 -0.626 . . . . 0.28 113.007 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mt -100.46 -38.95 8.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.123 0.487 . . . . 1.96 111.468 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -135.02 147.94 49.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 3.55 110.475 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.3 p-10 -64.59 161.07 18.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.418 0.628 . . . . 2.01 112.126 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -164.83 121.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.799 -1.091 . . . . 1.49 110.807 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' OE2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 tp10 -92.75 125.1 56.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 3.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 71.5 Cg_exo -46.38 135.49 15.72 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.42 2.08 . . . . 1.56 112.565 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 45.5 mt-10 -133.28 -38.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.06 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -111.73 133.36 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 2.52 110.746 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 2.68 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.89 -27.29 15.01 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.784 -0.722 . . . . 0.59 112.372 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.52 165.32 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.67 0.271 . . . . 1.82 110.411 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.3 tp -108.08 134.25 51.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 1.76 111.304 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.517 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -125.05 132.67 8.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.841 -0.695 . . . . 0.85 112.668 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -166.92 -173.9 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.581 0.229 . . . . 4.94 110.437 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -120.4 166.77 13.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.236 0.541 . . . . 3.35 111.818 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.53 148.8 3.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.305 -0.862 . . . . 2.24 111.352 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.55 -5.69 67.88 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 115.72 -0.673 . . . . 0.37 113.118 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -76.48 132.27 39.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 2.3 111.006 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.5 mt -93.95 133.07 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 1.94 110.352 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.6 mt -128.24 138.95 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 1.73 111.584 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -95.57 126.25 40.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 1.13 109.881 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.54 143.97 27.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 2.37 111.872 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -167.1 13.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.75 . . . . 1.12 111.202 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.57 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 90.5 m-20 -148.82 167.58 25.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.442 -0.947 . . . . 1.95 108.442 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.0 mt-30 -174.43 149.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.962 0.727 . . . . 1.82 112.962 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.71 -35.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.206 -0.906 . . . . 1.7 110.528 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -167.79 177.0 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.301 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.24 -5.77 3.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.588 -0.278 . . . . 2.93 111.211 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -105.51 -60.36 1.63 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.282 . . . . 2.74 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -91.89 127.37 37.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.486 -0.325 . . . . 3.6 110.824 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 11.4 m-30 -110.96 171.57 7.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.803 0.335 . . . . 3.57 110.986 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.0 mt-10 -142.85 147.76 35.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.218 0.532 . . . . 1.58 111.578 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.99 -169.09 35.12 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.634 -0.712 . . . . 0.26 112.195 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 27.0 ptt? -143.26 160.91 39.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.265 0.555 . . . . 2.44 111.285 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.56 144.18 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.261 -0.882 . . . . 2.1 110.662 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 65.62 -79.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.018 -0.537 . . . . 3.85 110.954 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.76 31.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.67 -0.776 . . . . 1.68 112.91 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -162.45 149.05 13.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 2.76 111.514 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 90.9 p -115.02 169.93 8.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 1.61 110.728 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.65 172.76 44.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.847 -0.692 . . . . 0.33 112.33 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -110.51 155.06 22.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.659 0.266 . . . . 1.93 111.306 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.91 121.47 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.738 -0.664 . . . . 5.33 111.361 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 18.0 Cg_endo -59.5 170.16 3.53 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.812 2.341 . . . . 0.7 113.196 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 54' ' ' TYR . 39.4 mt -58.49 -18.93 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.535 -0.757 . . . . 1.41 111.28 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.31 7.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 2.76 111.74 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 52' ' ' ILE . 31.4 t80 -124.68 -23.34 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 4.83 111.479 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.1 176.87 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.279 0.561 . . . . 1.14 111.908 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -125.47 97.22 5.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.284 -0.871 . . . . 2.09 109.8 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 48.6 t -61.45 108.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 1.84 111.366 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 ' NE ' ' A' ' 7' ' ' ARG . 50.0 mm -70.68 -35.51 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 1.9 110.772 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -130.49 97.41 21.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 2.07 110.768 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.404 2.069 . . . . 1.96 112.256 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttm . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.949 0.404 . . . . 6.87 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -76.22 126.05 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 5.1 110.823 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -103.84 135.32 19.37 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 3.98 110.842 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.29 150.25 52.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.433 2.089 . . . . 1.32 112.566 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.5 m -137.96 165.4 26.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.595 . . . . 2.02 110.422 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 p -146.27 174.97 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 1.26 111.118 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -141.8 136.88 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.85 -0.614 . . . . 3.8 111.161 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.53 143.52 30.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.867 -0.682 . . . . 0.28 112.926 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -102.64 -31.58 10.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.865 0.364 . . . . 1.96 110.895 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -115.57 146.41 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.55 110.794 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.7 t70 -79.06 157.97 27.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.522 0.677 . . . . 2.01 112.038 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.26 119.39 1.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.678 -1.146 . . . . 1.49 110.881 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.18 121.56 72.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.352 -0.385 . . . . 3.0 110.289 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 135.82 29.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.987 1.791 . . . . 1.56 112.233 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.81 -13.31 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 3.06 110.989 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -133.55 130.92 39.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.232 -0.44 . . . . 2.52 110.862 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -61.59 141.37 57.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 2.68 111.128 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.44 -22.44 17.51 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.985 -0.626 . . . . 0.59 112.336 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt-10 -102.97 160.1 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 1.82 110.634 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD12 HD11 ' A' ' 28' ' ' ILE . 15.0 mt -99.09 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.76 110.515 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.17 130.32 9.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.85 112.977 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.43 -179.13 1.23 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 4.94 110.688 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.29 174.99 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.198 0.523 . . . . 3.35 111.591 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -53.34 148.91 8.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.394 -0.821 . . . . 2.24 110.981 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.94 65.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.977 -0.63 . . . . 0.37 112.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.24 139.47 46.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 2.3 110.82 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.62 130.29 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 1.94 110.744 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.5 HD11 HD12 ' A' ' 20' ' ' LEU . 62.8 mt -127.86 145.57 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.379 -0.373 . . . . 1.73 110.788 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.9 p -87.48 133.5 33.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 1.13 110.974 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 39' ' ' TYR . 20.3 tp -96.34 130.56 43.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 2.37 110.99 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.55 HG23 ' ND2' ' A' ' 32' ' ' ASN . 5.5 t -166.88 16.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.023 0.439 . . . . 1.12 111.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.583 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 58.1 m-80 -153.68 175.73 12.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.966 -0.753 . . . . 1.95 108.966 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.5 mt-30 -175.29 149.71 1.07 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.533 0.568 . . . . 1.82 112.533 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 mm -108.37 -34.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.355 -0.838 . . . . 1.7 110.916 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -157.86 171.19 20.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.722 -0.672 . . . . 1.73 110.422 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.94 -10.01 8.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.387 -0.369 . . . . 2.93 111.112 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.58 -55.84 2.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.342 -0.39 . . . . 2.74 111.128 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.2 m95 -86.91 125.22 33.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.519 -0.31 . . . . 3.6 110.235 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.553 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 6.4 m-30 -102.0 177.78 4.8 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.938 0.399 . . . . 3.57 111.095 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 27.8 mt-10 -146.82 138.42 24.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.363 0.601 . . . . 1.58 111.284 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.19 -168.41 19.68 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.443 -0.799 . . . . 0.26 111.66 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 8.1 mtt -137.93 155.19 49.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.506 0.669 . . . . 2.44 111.372 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' GLY . 7.5 tp -140.31 153.83 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.837 -1.074 . . . . 2.1 109.166 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.452 ' N ' HG13 ' A' ' 43' ' ' ILE . 85.2 m-70 -30.81 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.653 0.596 . . . . 3.85 111.951 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ILE . . . -78.93 -60.09 2.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.784 -0.722 . . . . 1.68 113.06 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.39 173.73 7.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.697 0.76 . . . . 2.76 112.101 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 93.6 p -105.19 148.66 26.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.6 -1.182 . . . . 1.61 111.273 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.46 -172.6 36.26 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.33 111.916 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 19' ' ' GLU . 52.2 p90 -105.26 158.1 16.84 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.974 0.387 . . . . 1.93 111.181 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -174.38 104.74 0.28 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.924 -0.58 . . . . 5.33 110.836 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 13.1 Cg_endo -58.45 163.46 10.48 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.733 2.289 . . . . 0.7 112.97 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.426 HD13 ' HH ' ' A' ' 39' ' ' TYR . 19.7 mt -65.97 -18.76 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.54 -0.755 . . . . 1.41 111.204 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.07 -5.06 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 2.76 111.642 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.17 -5.51 6.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.046 0.388 . . . . 4.83 112.046 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.69 175.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.161 0.505 . . . . 1.14 111.592 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 106.53 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.453 -0.794 . . . . 2.09 109.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.22 123.8 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.84 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mt -76.91 -53.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.985 -0.552 . . . . 1.9 110.958 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -103.69 108.17 58.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 2.07 110.974 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.361 2.041 . . . . 1.96 112.383 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.799 0.25 . . . . 0.93 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.2 m -133.67 166.88 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 1.34 111.284 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 21.9 p -145.86 174.84 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 0.27 110.615 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -141.79 132.17 25.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.983 0.421 . . . . 3.13 111.347 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.54 135.08 18.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.882 -0.675 . . . . 0.27 112.934 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.4 mm? -84.35 -31.55 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.072 0.463 . . . . 1.34 110.469 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -131.26 146.06 52.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 3.28 110.476 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.5 p-10 -74.76 161.88 29.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.374 0.607 . . . . 2.01 111.892 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 127.73 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.018 -0.992 . . . . 1.27 111.094 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.08 128.62 49.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.609 -0.515 . . . . 3.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 38.0 Cg_endo -66.29 130.56 24.25 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.08 1.853 . . . . 1.3 112.316 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.02 -16.61 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 3.06 111.24 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -115.04 134.49 55.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 2.12 110.797 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.35 135.82 57.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 2.27 111.101 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.65 -26.86 22.65 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.829 -0.7 . . . . 0.54 112.726 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.56 166.68 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 1.51 110.676 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.501 HD11 HG22 ' A' ' 43' ' ' ILE . 20.1 tp -117.25 127.08 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.987 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -89.27 149.75 20.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.85 112.534 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -174.68 169.72 3.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.645 0.259 . . . . 4.08 110.796 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -124.87 -167.79 1.72 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.481 0.657 . . . . 2.84 111.894 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 125.83 27.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.937 -1.029 . . . . 2.24 110.692 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.45 81.94 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.37 112.593 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.06 122.22 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 2.3 111.088 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.4 121.76 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.97 -0.559 . . . . 1.09 110.603 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.93 142.33 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 1.19 111.314 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.3 p -96.35 113.17 24.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.48 110.069 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.28 144.61 25.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.5 0.667 . . . . 1.8 112.698 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.5 t -167.47 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.766 -1.106 . . . . 0.49 110.475 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.6 m-20 -144.01 -179.51 6.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.151 -1.055 . . . . 1.21 108.151 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.22 150.18 1.13 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 113.518 0.933 . . . . 1.11 113.518 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HG3' ' A' ' 40' ' ' GLU . 30.9 mm -101.0 -45.72 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.787 -1.097 . . . . 1.1 110.449 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -167.96 -170.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.531 -0.759 . . . . 1.73 110.623 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.36 -5.13 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.081 0.4 . . . . 2.93 112.081 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.28 -56.12 2.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.628 0.232 . . . . 2.36 111.628 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.768 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 p90 -120.97 133.86 55.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.174 0.512 . . . . 2.69 111.733 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.2 m-30 -93.24 -177.16 4.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.458 -0.792 . . . . 3.28 111.25 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.567 ' HG3' HG12 ' A' ' 34' ' ' ILE . 25.3 mt-10 -141.31 144.62 34.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 1.32 111.764 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.43 -163.73 21.84 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.362 -0.836 . . . . 0.24 111.444 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.81 154.78 49.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.294 0.569 . . . . 1.93 111.588 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 20' ' ' LEU . 4.8 tp -140.21 123.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.185 -0.916 . . . . 1.48 110.042 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.8 t60 67.38 -75.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.069 -0.514 . . . . 3.05 110.773 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.43 30.64 0.47 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 1.26 112.735 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -144.03 147.32 33.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.975 0.417 . . . . 2.76 111.503 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.6 m -108.02 161.4 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 1.26 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.83 174.03 39.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.958 -0.639 . . . . 0.3 112.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -104.28 153.85 20.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.862 0.331 . . . . 1.55 111.101 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 p90 -153.74 103.96 2.51 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.162 -0.472 . . . . 4.33 111.817 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -49.3 144.76 16.77 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.98 2.454 . . . . 0.48 112.429 177.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.91 -22.69 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.612 -0.722 . . . . 0.83 111.633 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -73.9 12.96 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 2.3 111.775 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -132.92 -9.3 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 4.47 111.109 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 HG12 ' HA2' ' A' ' 8' ' ' GLY . 34.1 m -140.01 174.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.43 111.212 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -133.99 101.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 2.09 109.676 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 57.8 t -60.4 116.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.077 -0.511 . . . . 1.18 111.383 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.66 -48.11 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.688 -0.687 . . . . 1.31 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.43 106.13 54.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 1.54 111.115 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.499 2.133 . . . . 1.61 112.296 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' HG13 ' A' ' 59' ' ' VAL . 46.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.709 0.212 . . . . 0.93 112.271 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.2 m -135.79 178.83 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.972 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.5 p -161.08 174.63 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.27 111.025 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HG2' HG12 ' A' ' 27' ' ' ILE . 99.7 mtt180 -139.54 135.45 33.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.88 -0.6 . . . . 3.13 111.408 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.84 128.78 9.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.839 -0.696 . . . . 0.27 112.705 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.8 mm? -78.24 -36.68 46.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 1.34 110.84 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.49 148.87 50.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 3.28 110.953 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.6 p-10 -65.35 167.98 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.221 0.534 . . . . 2.01 111.684 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.86 118.3 1.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 1.27 111.265 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.74 113.68 59.55 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.78 -0.646 . . . . 3.0 110.059 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 85.3 Cg_exo -46.64 130.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.485 2.124 . . . . 1.3 112.803 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.96 -28.97 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 3.06 110.667 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -110.63 131.39 55.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 2.12 110.79 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.85 124.65 21.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.27 110.931 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.09 -26.57 11.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 0.54 112.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -76.51 165.91 24.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 1.51 110.763 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 40.3 tp -112.56 135.33 53.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 1.2 111.174 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 14' ' ' PRO . . . -101.61 149.26 18.14 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.919 -0.657 . . . . 0.85 112.092 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -175.0 156.38 2.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 4.08 111.274 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -107.72 179.54 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 2.84 111.052 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -63.48 138.71 58.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.517 -0.765 . . . . 2.24 110.796 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.11 -5.56 66.23 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.948 -0.644 . . . . 0.37 113.085 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.65 147.93 45.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 2.3 111.053 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.415 HG12 ' HG2' ' A' ' 7' ' ' ARG . 67.9 mt -111.27 134.07 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 1.09 111.217 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD13 HD12 ' A' ' 43' ' ' ILE . 39.3 mm -126.22 141.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 1.19 110.83 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.8 p -89.67 128.82 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.587 -0.278 . . . . 0.48 110.445 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 31' ' ' THR . 2.6 tt -96.14 127.25 41.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 1.8 110.772 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.483 ' N ' HD23 ' A' ' 30' ' ' LEU . 7.8 t -166.2 17.62 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.07 0.462 . . . . 0.49 111.171 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.574 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 21.8 m120 -150.89 -179.46 7.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.942 -0.762 . . . . 1.21 108.942 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.6 mt-30 -174.75 149.77 1.24 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.644 0.609 . . . . 1.11 112.644 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 49' ' ' PHE . 45.9 mm -116.23 -29.59 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.315 -0.857 . . . . 1.1 111.54 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -156.91 170.3 22.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.259 -0.428 . . . . 1.73 110.831 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -61.34 -26.14 67.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 2.93 111.085 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.43 -38.66 8.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.27 -0.423 . . . . 2.36 111.28 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -96.36 125.67 41.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 2.69 110.815 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 18.6 m-30 -105.97 171.93 7.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.267 -0.424 . . . . 3.28 110.087 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 40.0 tt0 -139.97 137.73 34.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 1.32 111.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.43 -176.14 23.15 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.04 -0.982 . . . . 0.24 111.745 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -134.17 160.41 37.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.526 0.679 . . . . 1.93 111.896 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 HD13 ' A' ' 28' ' ' ILE . 14.0 tt -155.91 140.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.684 -1.143 . . . . 1.48 109.745 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.0 m80 64.31 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 3.05 110.839 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.54 30.68 0.41 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.488 -0.863 . . . . 1.26 113.134 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -159.34 149.13 18.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.01 0.433 . . . . 2.76 111.537 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 41.7 t -110.01 170.06 8.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.477 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . -176.49 166.1 36.83 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.904 -0.589 . . . . 0.3 112.065 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HB3' HG13 ' A' ' 34' ' ' ILE . 21.4 p90 -99.07 157.34 16.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.822 0.344 . . . . 1.55 111.318 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 24.6 p90 -175.78 111.83 0.26 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 4.33 111.428 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 6.1 Cg_endo -52.67 156.89 8.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.55 2.167 . . . . 0.48 112.26 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.01 -18.69 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.662 . . . . 0.83 111.389 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.13 -5.32 6.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 2.3 111.885 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -117.64 -8.36 10.92 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.125 0.417 . . . . 4.47 112.125 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.3 m -141.85 176.76 3.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.28 0.562 . . . . 0.43 112.003 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 9.9 pt-20 -134.23 101.56 5.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 2.09 109.989 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.409 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 94.0 t -59.13 114.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 1.18 111.263 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.12 -41.41 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 1.31 110.985 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 4' ' ' PRO . 2.7 p -143.71 123.43 7.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.54 110.955 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.356 2.037 . . . . 1.61 112.314 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 61.1 Cg_endo . . . . . 0 N--CA 1.466 -0.108 0 CA-C-O 120.724 0.219 . . . . 0.93 112.238 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p -141.29 151.51 43.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 1.34 110.863 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 12.9 p -131.91 174.92 9.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.27 110.986 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 58' ' ' ILE . 12.4 ptp180 -142.15 136.74 30.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 3.13 110.945 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.45 137.49 20.39 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.73 -0.747 . . . . 0.27 112.838 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.8 mm? -92.13 -33.07 14.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 1.34 110.734 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -125.36 146.2 49.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 3.28 110.787 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 p-10 -77.76 161.76 27.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.308 0.575 . . . . 2.01 111.835 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 133.02 2.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.101 -0.954 . . . . 1.27 111.453 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.1 86.75 11.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.65 134.87 39.66 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.515 2.143 . . . . 1.3 112.752 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 6.62 38.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 3.06 110.636 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -115.75 134.31 55.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 2.12 110.793 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.13 139.59 58.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 2.27 111.107 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.8 -25.72 12.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.925 -0.655 . . . . 0.54 112.529 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HG2' ' CE1' ' A' ' 49' ' ' PHE . 6.8 mt-10 -88.83 161.86 16.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 1.51 110.708 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -100.25 122.12 42.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 1.2 110.522 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.08 134.97 12.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.85 112.952 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -175.7 -170.3 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.693 0.282 . . . . 4.08 110.703 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -132.55 172.87 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 2.84 111.505 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -49.7 148.44 3.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 2.24 110.818 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.77 -2.73 82.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.938 -0.649 . . . . 0.37 112.942 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.7 145.66 45.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 2.3 111.153 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -120.36 123.07 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 1.09 110.252 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.44 141.68 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.552 -0.294 . . . . 1.19 111.454 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.3 p -85.52 129.99 34.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.36 -0.382 . . . . 0.48 110.085 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 10.9 mp -96.24 132.86 41.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.121 0.486 . . . . 1.8 111.708 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.486 HG23 ' OD1' ' A' ' 32' ' ' ASN . 9.4 t -167.09 17.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.571 -0.741 . . . . 0.49 110.739 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 22.9 m120 -152.3 175.8 12.28 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.642 -0.873 . . . . 1.21 108.642 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.566 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.0 mt-30 -175.12 150.05 1.14 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.072 0.767 . . . . 1.11 113.072 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.412 HG12 ' HG3' ' A' ' 40' ' ' GLU . 32.4 mm -103.65 -37.37 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.076 -0.966 . . . . 1.1 110.915 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -168.08 175.94 6.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.616 . . . . 1.73 110.516 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.51 -10.96 5.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 2.93 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.0 -54.99 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.463 . . . . 2.36 111.19 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.15 134.96 38.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 2.69 111.257 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.566 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.2 m-85 -110.74 168.13 9.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 3.28 110.253 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 35.5 mt-10 -137.71 142.31 41.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.504 0.668 . . . . 1.32 112.076 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.2 -173.35 34.53 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.019 -0.991 . . . . 0.24 111.474 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.428 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.6 ptm -143.35 161.1 39.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.447 0.642 . . . . 1.93 111.558 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.58 133.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.144 -0.935 . . . . 1.48 110.36 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.3 t60 65.24 -78.81 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.104 -0.498 . . . . 3.05 110.974 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.76 30.1 0.55 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 1.26 112.89 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.25 143.08 25.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.358 . . . . 2.76 111.233 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 83.6 p -117.82 170.05 9.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.322 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.78 166.18 30.91 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.3 111.896 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 19' ' ' GLU . 30.8 p90 -100.1 159.7 14.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.896 0.379 . . . . 1.55 111.154 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.51 112.0 0.4 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.942 -0.572 . . . . 4.33 110.725 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.3 Cg_endo -58.07 157.55 24.71 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.618 2.212 . . . . 0.48 112.569 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 mt -61.01 -18.42 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 0.83 111.403 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -67.49 4.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 2.3 111.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -135.42 -5.77 2.28 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.629 0.233 . . . . 4.47 111.629 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.7 m -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.43 111.32 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HB2' HD21 ' A' ' 9' ' ' LEU . 37.9 tt0 -135.01 102.78 5.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 2.09 109.996 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.46 101.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.18 110.912 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' A' ' 7' ' ' ARG . 59.4 mt -61.97 -35.91 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 1.31 111.126 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 35.5 t -125.38 97.82 36.31 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 1.54 111.161 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.446 2.097 . . . . 1.61 112.265 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 59' ' ' VAL . 51.3 Cg_exo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.705 0.211 . . . . 0.93 112.248 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.9 m -127.25 176.29 7.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 1.34 111.074 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.6 p -155.46 174.73 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.27 110.747 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -141.94 144.58 33.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.084 -0.507 . . . . 3.13 111.23 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -78.21 135.66 16.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.929 -0.653 . . . . 0.27 112.811 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.16 -36.56 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 1.34 110.563 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -140.92 147.0 38.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.652 . . . . 3.28 110.496 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -58.17 159.45 5.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.235 0.54 . . . . 2.01 111.698 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -160.64 127.05 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.205 -0.907 . . . . 1.27 111.28 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -98.43 133.3 22.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 3.0 109.493 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 73.6 Cg_endo -74.77 133.65 17.23 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.965 1.777 . . . . 1.3 112.449 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -83.33 -38.41 22.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 3.06 110.896 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -132.06 173.64 11.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 2.12 110.789 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -73.89 144.53 45.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 2.27 110.946 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.24 -27.19 11.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.804 -0.712 . . . . 0.54 112.62 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.91 171.1 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.345 . . . . 1.51 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -109.81 123.28 49.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.95 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.613 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -113.4 124.85 6.72 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.804 -0.712 . . . . 0.85 112.598 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 13.3 m-85 -163.89 -169.66 1.94 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.69 0.281 . . . . 4.08 110.662 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -125.06 173.02 8.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.456 0.646 . . . . 2.84 112.018 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.91 149.2 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.068 -0.969 . . . . 2.24 111.042 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.24 69.4 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.756 -0.656 . . . . 0.37 112.916 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' OD2' HD11 ' A' ' 28' ' ' ILE . 38.4 t70 -79.73 132.21 36.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 2.3 110.824 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.42 128.13 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 1.09 111.324 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.409 HD11 ' OD2' ' A' ' 26' ' ' ASP . 45.2 mm -128.54 142.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.19 110.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.6 p -89.87 135.39 33.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.59 -0.277 . . . . 0.48 110.519 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 39' ' ' TYR . 15.2 tp -96.33 132.92 41.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.325 -0.398 . . . . 1.8 110.781 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.435 HG23 ' OD1' ' A' ' 32' ' ' ASN . 8.9 t -166.72 17.24 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.49 111.378 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 20.5 m120 -151.35 170.22 20.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.682 -0.859 . . . . 1.21 108.682 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mt-30 -174.94 149.62 1.15 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.689 0.625 . . . . 1.11 112.689 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.6 mp -105.66 -32.88 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.184 -0.916 . . . . 1.1 110.655 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -167.93 -170.92 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.81 -0.632 . . . . 1.73 110.785 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.46 -14.41 61.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 2.93 111.419 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.3 -54.29 2.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 2.36 111.62 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -95.22 126.57 40.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.853 0.359 . . . . 2.69 111.035 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.615 ' HB3' HD11 ' A' ' 30' ' ' LEU . 14.4 m-30 -108.73 175.4 5.48 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.069 -0.514 . . . . 3.28 110.501 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -150.76 143.86 24.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.47 0.652 . . . . 1.32 111.974 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.18 -171.0 24.42 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.24 111.855 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 24.7 ptt? -143.3 163.13 33.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.393 0.616 . . . . 1.93 111.531 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 tp -144.58 126.12 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.009 -0.996 . . . . 1.48 110.415 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t60 64.98 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 3.05 111.106 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.89 31.51 0.67 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.596 -0.812 . . . . 1.26 112.874 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.36 135.12 19.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 2.76 111.159 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 80.7 p -106.8 170.28 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.5 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.01 150.1 8.14 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.3 111.88 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -113.08 160.17 18.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.351 . . . . 1.55 111.404 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER 177.29 132.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.625 -0.716 . . . . 4.33 110.841 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.6 Cg_endo -47.2 160.89 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.172 2.581 . . . . 0.48 112.965 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.481 ' C ' ' H ' ' A' ' 54' ' ' TYR . 24.8 mt -58.03 -20.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.397 -0.819 . . . . 0.83 111.693 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.12 7.26 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.564 -0.289 . . . . 2.3 111.35 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HG13 ' A' ' 55' ' ' VAL . 9.7 t80 -116.41 -30.89 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.365 -0.38 . . . . 4.47 111.233 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 8' ' ' GLY . 15.8 m -141.48 175.61 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.39 0.614 . . . . 0.43 111.861 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.43 113.37 8.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.248 -0.887 . . . . 2.09 109.604 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 6.1 p -55.04 120.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 1.18 111.181 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.8 mt -80.83 -47.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.737 -0.665 . . . . 1.31 111.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 4' ' ' PRO . 3.2 p -126.74 111.41 22.51 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.038 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.518 2.145 . . . . 1.61 112.487 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.508 ' HA ' HG13 ' A' ' 59' ' ' VAL . 32.8 Cg_exo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.659 0.191 . . . . 0.93 112.185 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.83 169.46 19.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 1.34 111.337 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 16.3 p -150.17 175.19 11.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.27 110.64 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HD2' ' HA2' ' A' ' 25' ' ' GLY . 37.4 ttp180 -139.67 121.44 15.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 3.13 111.178 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -70.41 135.58 25.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 0.27 112.542 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -84.27 -31.26 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.34 110.717 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -125.53 154.04 42.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.81 -0.632 . . . . 3.28 110.857 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.93 147.88 24.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.203 -0.453 . . . . 2.01 110.341 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.93 133.58 17.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 1.27 111.366 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -94.19 132.02 30.17 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 3.0 109.801 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.49 129.54 26.76 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.317 2.012 . . . . 1.3 112.331 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.04 -34.13 3.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 3.06 110.924 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -111.21 159.38 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 2.12 110.972 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -77.95 124.08 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 2.27 110.936 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.33 -20.14 35.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.938 -0.649 . . . . 0.54 112.561 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.62 165.28 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 1.51 110.541 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.3 tp -113.49 134.59 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 1.2 111.126 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.55 148.37 16.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 0.85 112.03 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -170.07 -172.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 4.08 111.219 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -133.68 -179.7 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 2.84 111.425 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.05 138.78 58.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.28 -0.873 . . . . 2.24 110.15 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 7' ' ' ARG . . . 81.57 -19.13 9.43 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.729 . . . . 0.37 112.623 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 18.6 t70 -60.75 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 2.3 111.077 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.484 ' O ' HD13 ' A' ' 43' ' ' ILE . 66.2 mt -93.77 126.69 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 1.09 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.98 143.85 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 1.19 111.24 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.6 p -92.69 127.73 38.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.359 -0.382 . . . . 0.48 110.464 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 8.4 mp -96.59 133.3 41.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 1.8 111.484 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -166.97 14.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.49 111.591 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.9 m-20 -151.09 179.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.53 -0.915 . . . . 1.21 108.53 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 5.4 mt-30 -174.76 149.89 1.24 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.871 0.693 . . . . 1.11 112.871 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 38' ' ' TRP . 47.9 mm -109.66 -32.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.057 -0.974 . . . . 1.1 111.018 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.11 167.38 12.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.73 110.627 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.17 -8.84 6.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.41 -0.359 . . . . 2.93 110.875 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -96.19 -52.77 3.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.133 -0.485 . . . . 2.36 110.981 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.795 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -115.58 134.47 55.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 2.69 111.257 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 39.8 p90 -100.32 -177.98 3.68 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.986 -0.552 . . . . 3.28 111.221 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 38.2 tt0 -144.67 137.02 26.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.396 0.617 . . . . 1.32 111.563 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.31 -161.81 10.97 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.24 111.734 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 23.6 ptp -143.37 156.68 44.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 1.93 111.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.77 132.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.261 -0.881 . . . . 1.48 110.306 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 65.38 -77.27 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.09 -0.504 . . . . 3.05 111.275 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.53 31.58 0.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.568 -0.825 . . . . 1.26 112.997 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.14 144.76 23.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 2.76 111.343 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 44.7 t -107.5 168.73 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 1.26 111.278 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 170.06 35.82 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.793 -0.639 . . . . 0.3 111.875 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 24.5 p90 -111.61 158.55 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 1.55 111.29 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -173.06 122.79 0.43 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.217 -0.447 . . . . 4.33 111.713 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.795 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 84.2 Cg_exo -44.85 139.17 8.0 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.18 2.587 . . . . 0.48 113.258 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 52' ' ' ILE . 22.0 mt -64.04 -18.64 23.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.328 -0.851 . . . . 0.83 111.581 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.61 -6.57 3.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 2.3 112.213 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -117.37 12.07 14.15 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.298 0.481 . . . . 4.47 112.298 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 23.0 m -144.7 175.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.21 0.529 . . . . 0.43 111.457 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.2 tp10 -133.49 96.47 3.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 2.09 109.804 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 p -55.82 118.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 1.18 111.226 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -73.16 -36.34 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 1.31 110.968 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 4' ' ' PRO . 7.1 p -150.76 131.71 7.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 1.54 110.865 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.355 2.037 . . . . 1.61 112.248 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.745 0.227 . . . . 0.93 112.205 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 29' ' ' THR . 83.4 m -144.81 179.43 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.34 111.087 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 20.6 p -155.45 174.33 15.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.912 -0.585 . . . . 0.27 110.491 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.545 ' HE ' HD11 ' A' ' 58' ' ' ILE . 8.1 ptp180 -142.49 133.19 25.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 3.13 111.46 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -73.23 137.63 24.13 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.839 -0.696 . . . . 0.27 112.894 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -87.55 -28.76 21.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.399 . . . . 1.34 110.754 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -136.92 146.8 45.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 3.28 110.685 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 t70 -67.61 160.31 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 2.01 111.602 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.18 119.4 1.52 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.014 -0.994 . . . . 1.27 110.835 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.73 135.54 49.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 3.0 109.841 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 45.9 Cg_endo -69.4 138.7 39.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 1.3 112.431 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -126.0 -45.85 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 3.06 110.996 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.62 153.33 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.927 0.394 . . . . 2.12 111.121 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -77.51 124.97 28.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.023 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.07 -2.62 35.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.716 . . . . 0.54 112.807 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -95.81 165.75 12.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 1.51 110.813 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -106.91 119.22 38.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 1.2 111.059 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.524 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -105.76 135.39 12.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.835 -0.698 . . . . 0.85 112.559 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.99 -173.55 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.734 0.302 . . . . 4.08 110.935 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -121.0 174.67 6.48 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.363 0.601 . . . . 2.84 111.962 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.21 149.36 12.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 2.24 110.983 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.64 -11.31 62.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.962 -0.637 . . . . 0.37 112.586 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.02 126.32 30.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.817 0.342 . . . . 2.3 110.606 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 43' ' ' ILE . 41.6 mt -100.34 108.22 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 1.09 111.382 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.461 HD13 HD13 ' A' ' 20' ' ' LEU . 77.9 mt -96.46 139.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.19 111.105 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' SG ' ' A' ' 5' ' ' CYS . 42.8 p -90.67 120.3 31.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.48 110.321 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -95.61 142.66 27.67 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.381 0.61 . . . . 1.8 112.512 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 t -167.65 17.42 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.069 -0.969 . . . . 0.49 110.748 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 23.4 m120 -149.6 176.37 10.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.473 -0.936 . . . . 1.21 108.473 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.3 mt-30 -175.28 149.8 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.751 0.649 . . . . 1.11 112.751 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.7 mp -109.21 -28.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.435 -0.802 . . . . 1.1 110.488 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.87 166.68 21.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 1.73 110.485 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.12 -12.16 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 2.93 111.09 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.92 -57.7 1.99 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 2.36 110.979 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.2 m95 -87.55 125.52 34.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.415 -0.357 . . . . 2.69 110.571 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.3 m-85 -102.78 178.48 4.56 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.832 0.349 . . . . 3.28 110.67 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 32' ' ' ASN . 36.5 tt0 -151.27 140.1 20.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 1.32 111.834 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.4 -159.04 11.61 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.464 -0.789 . . . . 0.24 111.736 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.97 156.93 46.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.332 0.587 . . . . 1.93 111.442 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.02 128.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.186 -0.916 . . . . 1.48 110.07 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 67.29 -76.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 3.05 110.688 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.31 29.7 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 1.26 112.804 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -144.83 147.69 33.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 2.76 111.465 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -109.33 162.99 13.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.15 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' HG ' ' A' ' 20' ' ' LEU . . . 172.75 173.16 39.05 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.926 -0.654 . . . . 0.3 112.386 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.17 162.34 13.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.735 0.302 . . . . 1.55 111.187 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -178.36 106.05 0.21 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.903 -0.59 . . . . 4.33 110.812 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.5 Cg_endo -59.46 159.94 21.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.725 2.283 . . . . 0.48 113.3 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.77 -18.35 22.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.427 -0.806 . . . . 0.83 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -62.87 -2.27 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 2.3 111.78 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -131.71 -4.48 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.749 0.277 . . . . 4.47 111.749 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.7 m -139.83 174.32 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.16 0.505 . . . . 0.43 111.216 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.0 tp10 -134.34 105.0 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 2.09 109.91 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 45.9 t -55.69 122.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 1.18 111.179 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD11 ' HE ' ' A' ' 7' ' ' ARG . 58.0 mt -85.04 -38.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 1.31 111.222 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 39.6 t -110.22 115.57 54.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 1.54 111.205 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.426 2.084 . . . . 1.61 112.28 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.754 0.231 . . . . 0.93 112.342 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.73 179.64 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 1.34 110.825 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 p -163.18 174.78 11.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.27 110.963 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -142.13 134.39 27.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.13 111.305 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -76.56 139.11 23.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.27 112.609 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -97.32 -32.06 12.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 1.34 110.893 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -122.67 146.48 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.904 -0.589 . . . . 3.28 110.728 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.82 167.21 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.405 0.622 . . . . 2.01 111.956 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.99 119.44 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.015 -0.993 . . . . 1.27 110.963 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -81.9 128.49 68.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 3.0 110.298 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.06 129.91 33.99 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.315 2.01 . . . . 1.3 112.496 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.64 -35.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 3.06 110.681 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.83 137.13 32.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.115 -0.493 . . . . 2.12 110.772 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.0 121.57 21.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 2.27 110.996 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.23 14.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.54 112.626 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 29.1 tt0 -81.23 168.21 18.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 1.51 110.713 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 28' ' ' ILE . 30.8 tp -116.72 132.58 56.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 1.2 110.853 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.42 141.71 16.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.671 -0.776 . . . . 0.85 112.725 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -175.24 -176.11 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.433 -0.21 . . . . 4.08 110.433 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -118.78 169.79 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.27 0.557 . . . . 2.84 112.034 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -48.76 149.38 1.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.162 -0.926 . . . . 2.24 111.34 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.23 -6.0 69.75 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.37 113.023 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -73.94 124.17 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 2.3 111.117 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -92.79 125.18 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 1.09 110.74 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 43' ' ' ILE . 62.5 mt -123.92 135.5 63.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 1.19 111.401 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -95.9 116.67 29.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.48 109.928 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 pp -94.94 149.56 21.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.369 0.604 . . . . 1.8 112.393 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 t -167.48 17.13 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.029 -0.987 . . . . 0.49 110.787 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 87.1 m-20 -147.99 -179.99 7.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.437 -0.949 . . . . 1.21 108.437 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.7 mt-30 -175.28 149.85 1.09 Allowed 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.523 0.564 . . . . 1.11 112.523 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.58 -23.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.404 -0.816 . . . . 1.1 111.032 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -166.95 165.06 16.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 1.73 110.464 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -61.95 -7.1 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 2.93 110.79 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.402 ' HB2' ' OE2' ' A' ' 36' ' ' GLU . 50.5 t-20 -110.22 -51.99 2.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 2.36 110.617 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 m95 -92.67 125.94 37.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.472 -0.331 . . . . 2.69 110.525 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.587 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.0 m-30 -100.08 177.16 5.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.887 0.375 . . . . 3.28 110.918 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -147.4 137.41 23.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.96 -0.563 . . . . 1.32 111.265 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.33 -158.9 14.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.585 -0.734 . . . . 0.24 111.859 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 mtm -141.12 148.94 40.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 1.93 111.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 28' ' ' ILE . 12.3 tt -126.43 118.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 1.48 110.08 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.9 t60 67.89 -73.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 3.05 110.716 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.01 27.5 0.51 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.663 -0.78 . . . . 1.26 112.832 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -136.68 142.05 43.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.71 0.29 . . . . 2.76 111.222 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.6 p -105.8 155.54 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 1.26 111.016 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.8 169.59 38.29 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.796 -0.716 . . . . 0.3 112.552 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -97.6 151.14 20.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.55 0.214 . . . . 1.55 110.566 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 16.0 p90 -167.93 103.97 0.56 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.002 0.371 . . . . 4.33 112.002 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 10.5 Cg_endo -57.64 165.1 6.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.516 2.144 . . . . 0.48 112.415 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 52' ' ' ILE . 19.0 mt -66.26 -20.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.83 111.64 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -69.89 2.06 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.59 -0.277 . . . . 2.3 111.555 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -124.62 -11.8 7.25 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 4.47 111.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 34.7 m -140.21 177.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.309 0.576 . . . . 0.43 111.772 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -137.64 102.39 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 2.09 109.749 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.37 117.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.18 111.244 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.68 -47.08 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 1.31 111.146 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.83 97.68 9.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.371 -0.377 . . . . 1.54 111.317 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.58 2.186 . . . . 1.61 112.174 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.8 0.25 . . . . 0.93 112.182 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.7 m -140.71 169.82 16.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 1.34 111.196 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 21.1 p -144.93 174.67 10.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.27 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.532 ' HG2' HG12 ' A' ' 27' ' ' ILE . 91.1 mtt180 -138.9 137.43 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 3.13 111.414 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.61 136.47 21.03 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.952 -0.642 . . . . 0.27 112.921 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -82.85 -29.78 29.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.34 110.724 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -149.11 155.04 40.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 3.28 110.859 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.8 p30 -70.55 166.36 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.586 0.708 . . . . 2.01 112.8 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.33 130.76 2.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.589 -1.187 . . . . 1.27 111.06 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -111.7 88.86 10.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.641 -0.709 . . . . 3.0 109.961 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 156.78 6.56 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.747 2.298 . . . . 1.3 112.576 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.52 9.03 10.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 3.06 110.794 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -138.94 154.66 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 2.12 110.827 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.37 141.8 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 2.27 110.922 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.29 -27.45 10.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.995 -0.622 . . . . 0.54 112.299 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.18 163.58 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 28' ' ' ILE . 17.3 tp -107.66 113.13 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 1.2 111.044 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.56 140.75 15.21 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.935 -0.65 . . . . 0.85 112.641 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.82 -170.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 4.08 110.942 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -132.14 168.11 18.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 2.84 111.546 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.71 148.6 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.606 -0.724 . . . . 2.24 110.935 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.48 78.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.826 -0.625 . . . . 0.37 112.908 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.8 p-10 -76.98 138.69 39.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.677 0.275 . . . . 2.3 110.774 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 7' ' ' ARG . 66.5 mt -107.61 127.58 63.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.09 110.836 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 HD23 ' A' ' 20' ' ' LEU . 37.9 mt -123.57 139.83 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 1.19 111.508 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -86.19 127.94 34.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.48 110.2 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 39' ' ' TYR . 24.2 tp -96.29 127.81 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 1.8 111.513 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.45 HG23 ' OD1' ' A' ' 32' ' ' ASN . 12.5 t -166.99 17.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.49 111.586 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 25.0 m120 -149.7 175.19 11.8 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.775 -0.824 . . . . 1.21 108.775 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.3 mt-30 -175.1 150.34 1.18 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.085 0.772 . . . . 1.11 113.085 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.04 -32.03 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.194 -0.912 . . . . 1.1 110.917 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -165.51 170.92 13.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 1.73 110.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.28 -10.88 5.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 2.93 111.106 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.11 -55.34 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 2.36 111.109 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.698 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -91.86 127.37 37.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.432 -0.349 . . . . 2.69 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 2.8 m-85 -106.89 172.17 6.97 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.274 -0.421 . . . . 3.28 111.082 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -140.58 145.69 37.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.526 0.679 . . . . 1.32 112.11 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.04 -171.69 28.49 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.157 -0.929 . . . . 0.24 111.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.481 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 17.3 mtm -134.4 156.78 47.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.234 0.54 . . . . 1.93 111.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' N ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -146.97 131.44 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.298 -0.864 . . . . 1.48 109.952 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.605 ' N ' HD13 ' A' ' 43' ' ' ILE . 73.3 t60 64.33 -78.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 3.05 111.007 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.08 31.62 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.758 . . . . 1.26 112.917 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.57 148.41 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 2.76 111.211 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 42' ' ' MET . 85.9 p -105.75 169.71 8.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 1.26 111.481 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.58 169.55 42.06 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.745 -0.661 . . . . 0.3 111.941 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -114.37 158.66 21.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.888 0.344 . . . . 1.55 111.326 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER 176.06 119.97 0.14 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.735 -0.666 . . . . 4.33 111.312 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 9.2 Cg_endo -52.66 162.83 2.17 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.48 113.418 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 54' ' ' TYR . 25.7 mt -62.98 -23.29 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 115.369 -0.832 . . . . 0.83 112.116 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -69.57 8.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.654 0.264 . . . . 2.3 111.523 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 52' ' ' ILE . 45.0 t80 -114.63 -24.55 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.333 . . . . 4.47 111.09 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.8 m -138.15 179.5 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.43 111.785 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 9' ' ' LEU . 11.2 tp10 -134.36 102.07 5.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.244 -0.889 . . . . 2.09 109.896 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 40.0 t -64.59 112.63 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 1.18 111.201 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.08 -49.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 1.31 111.06 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 59.9 t -100.38 123.83 45.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 1.54 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 35.2 Cg_exo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.421 2.081 . . . . 1.61 112.257 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.849 0.27 . . . . 0.93 112.36 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.8 m -128.48 161.08 30.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 1.34 110.804 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 19.7 p -150.67 174.08 13.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.089 0.471 . . . . 0.27 111.252 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.423 ' NE ' HD11 ' A' ' 58' ' ' ILE . 34.3 ptt180 -141.68 128.03 19.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.689 -0.687 . . . . 3.13 110.977 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -56.15 144.7 35.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.984 -0.626 . . . . 0.27 113.007 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mt -100.46 -38.95 8.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.123 0.487 . . . . 1.34 111.468 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -135.02 147.94 49.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 3.28 110.475 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.3 p-10 -64.59 161.07 18.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.418 0.628 . . . . 2.01 112.126 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -164.83 121.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.799 -1.091 . . . . 1.27 110.807 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 tp10 -92.75 125.1 56.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 3.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.501 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 71.5 Cg_exo -46.38 135.49 15.72 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.42 2.08 . . . . 1.3 112.565 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 45.5 mt-10 -133.28 -38.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.06 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -111.73 133.36 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 2.12 110.746 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 2.27 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.89 -27.29 15.01 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.784 -0.722 . . . . 0.54 112.372 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.52 165.32 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.67 0.271 . . . . 1.51 110.411 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.3 tp -108.08 134.25 51.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 1.2 111.304 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.501 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -125.05 132.67 8.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.841 -0.695 . . . . 0.85 112.668 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -166.92 -173.9 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.581 0.229 . . . . 4.08 110.437 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -120.4 166.77 13.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.236 0.541 . . . . 2.84 111.818 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.53 148.8 3.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.305 -0.862 . . . . 2.24 111.352 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.55 -5.69 67.88 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 115.72 -0.673 . . . . 0.37 113.118 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -76.48 132.27 39.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 2.3 111.006 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.5 mt -93.95 133.07 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 1.09 110.352 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.6 mt -128.24 138.95 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 1.19 111.584 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -95.57 126.25 40.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.48 109.881 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.54 143.97 27.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 1.8 111.872 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -167.1 13.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.75 . . . . 0.49 111.202 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.559 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 90.5 m-20 -148.82 167.58 25.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.442 -0.947 . . . . 1.21 108.442 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.584 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.0 mt-30 -174.43 149.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.962 0.727 . . . . 1.11 112.962 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -103.71 -35.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.206 -0.906 . . . . 1.1 110.528 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -167.79 177.0 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.301 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.24 -5.77 3.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.588 -0.278 . . . . 2.93 111.211 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -105.51 -60.36 1.63 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.282 . . . . 2.36 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -91.89 127.37 37.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.486 -0.325 . . . . 2.69 110.824 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 11.4 m-30 -110.96 171.57 7.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.803 0.335 . . . . 3.28 110.986 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.0 mt-10 -142.85 147.76 35.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.218 0.532 . . . . 1.32 111.578 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.99 -169.09 35.12 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.634 -0.712 . . . . 0.24 112.195 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.0 ptt? -143.26 160.91 39.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.265 0.555 . . . . 1.93 111.285 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.56 144.18 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.261 -0.882 . . . . 1.48 110.662 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 65.62 -79.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.018 -0.537 . . . . 3.05 110.954 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.76 31.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.67 -0.776 . . . . 1.26 112.91 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -162.45 149.05 13.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 2.76 111.514 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 90.9 p -115.02 169.93 8.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 1.26 110.728 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.65 172.76 44.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.847 -0.692 . . . . 0.3 112.33 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -110.51 155.06 22.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.659 0.266 . . . . 1.55 111.306 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.91 121.47 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.738 -0.664 . . . . 4.33 111.361 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 18.0 Cg_endo -59.5 170.16 3.53 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.812 2.341 . . . . 0.48 113.196 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 54' ' ' TYR . 39.4 mt -58.49 -18.93 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.535 -0.757 . . . . 0.83 111.28 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.31 7.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 2.3 111.74 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 52' ' ' ILE . 31.4 t80 -124.68 -23.34 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 4.47 111.479 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.8 m -137.1 176.87 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.279 0.561 . . . . 0.43 111.908 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -125.47 97.22 5.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.284 -0.871 . . . . 2.09 109.8 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 48.6 t -61.45 108.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 1.18 111.366 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.423 HD11 ' NE ' ' A' ' 7' ' ' ARG . 50.0 mm -70.68 -35.51 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 1.31 110.772 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -130.49 97.41 21.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.768 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.404 2.069 . . . . 1.61 112.256 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.23 0.114 0 CA-C-O 120.881 0.284 . . . . 0.93 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.5 m -137.96 165.4 26.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.595 . . . . 1.34 110.422 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 p -146.27 174.97 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.27 111.118 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -141.8 136.88 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.85 -0.614 . . . . 3.13 111.161 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -75.53 143.52 30.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.867 -0.682 . . . . 0.27 112.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -102.64 -31.58 10.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.865 0.364 . . . . 1.34 110.895 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -115.57 146.41 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.28 110.794 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.7 t70 -79.06 157.97 27.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.522 0.677 . . . . 2.01 112.038 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.26 119.39 1.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.678 -1.146 . . . . 1.27 110.881 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -86.18 121.56 72.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.352 -0.385 . . . . 3.0 110.289 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 135.82 29.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.987 1.791 . . . . 1.3 112.233 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.81 -13.31 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 3.06 110.989 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -133.55 130.92 39.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.232 -0.44 . . . . 2.12 110.862 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -61.59 141.37 57.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 2.27 111.128 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.44 -22.44 17.51 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.985 -0.626 . . . . 0.54 112.336 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt-10 -102.97 160.1 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 1.51 110.634 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 28' ' ' ILE . 15.0 mt -99.09 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.2 110.515 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.17 130.32 9.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.85 112.977 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.43 -179.13 1.23 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 4.08 110.688 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.29 174.99 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.198 0.523 . . . . 2.84 111.591 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -53.34 148.91 8.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.394 -0.821 . . . . 2.24 110.981 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.94 65.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.977 -0.63 . . . . 0.37 112.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.24 139.47 46.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 2.3 110.82 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 43' ' ' ILE . 28.8 mm -112.62 130.29 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 1.09 110.744 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 20' ' ' LEU . 62.8 mt -127.86 145.57 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.379 -0.373 . . . . 1.19 110.788 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.9 p -87.48 133.5 33.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.48 110.974 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 39' ' ' TYR . 20.3 tp -96.34 130.56 43.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.8 110.99 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 32' ' ' ASN . 5.5 t -166.88 16.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.023 0.439 . . . . 0.49 111.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 23.6 m120 -153.68 175.73 12.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.966 -0.753 . . . . 1.21 108.966 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.596 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 5.6 mt-30 -175.29 149.71 1.07 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.533 0.568 . . . . 1.11 112.533 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 mm -108.37 -34.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.355 -0.838 . . . . 1.1 110.916 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -157.86 171.19 20.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.722 -0.672 . . . . 1.73 110.422 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.94 -10.01 8.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.387 -0.369 . . . . 2.93 111.112 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.58 -55.84 2.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.342 -0.39 . . . . 2.36 111.128 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.2 m95 -86.91 125.22 33.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.519 -0.31 . . . . 2.69 110.235 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 6.4 m-30 -102.0 177.78 4.8 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.938 0.399 . . . . 3.28 111.095 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 27.8 mt-10 -146.82 138.42 24.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.363 0.601 . . . . 1.32 111.284 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.19 -168.41 19.68 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.443 -0.799 . . . . 0.24 111.66 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 8.1 mtt -137.93 155.19 49.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.506 0.669 . . . . 1.93 111.372 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' GLY . 7.5 tp -140.31 153.83 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.837 -1.074 . . . . 1.48 109.166 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.444 ' N ' HG13 ' A' ' 43' ' ' ILE . 85.2 m-70 -30.81 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.653 0.596 . . . . 3.05 111.951 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ILE . . . -78.93 -60.09 2.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.784 -0.722 . . . . 1.26 113.06 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.486 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -168.39 173.73 7.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.697 0.76 . . . . 2.76 112.101 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 93.6 p -105.19 148.66 26.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.6 -1.182 . . . . 1.26 111.273 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.46 -172.6 36.26 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.3 111.916 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' GLU . 52.2 p90 -105.26 158.1 16.84 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.974 0.387 . . . . 1.55 111.181 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -174.38 104.74 0.28 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.924 -0.58 . . . . 4.33 110.836 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 13.1 Cg_endo -58.45 163.46 10.48 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.733 2.289 . . . . 0.48 112.97 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 mt -65.97 -18.76 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.54 -0.755 . . . . 0.83 111.204 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.07 -5.06 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 2.3 111.642 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.17 -5.51 6.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.046 0.388 . . . . 4.47 112.046 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG12 ' HA2' ' A' ' 8' ' ' GLY . 28.7 m -136.69 175.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.161 0.505 . . . . 0.43 111.592 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 106.53 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.453 -0.794 . . . . 2.09 109.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.22 123.8 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.18 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mt -76.91 -53.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.985 -0.552 . . . . 1.31 110.958 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -103.69 108.17 58.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.974 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.361 2.041 . . . . 1.61 112.383 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.898 0.38 . . . . 6.48 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -161.85 133.0 5.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 5.1 110.702 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -134.33 87.55 32.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 3.44 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.99 158.56 14.05 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.541 2.16 . . . . 0.93 112.229 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.2 m -133.67 166.88 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 1.34 111.284 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 21.9 p -145.86 174.84 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 0.27 110.615 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -141.79 132.17 25.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.983 0.421 . . . . 3.13 111.347 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.54 135.08 18.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.882 -0.675 . . . . 0.27 112.934 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.4 mm? -84.35 -31.55 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.072 0.463 . . . . 1.34 110.469 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -131.26 146.06 52.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 3.28 110.476 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.5 p-10 -74.76 161.88 29.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.374 0.607 . . . . 2.01 111.892 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 127.73 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.018 -0.992 . . . . 1.27 111.094 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.08 128.62 49.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.609 -0.515 . . . . 3.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 38.0 Cg_endo -66.29 130.56 24.25 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.08 1.853 . . . . 1.3 112.316 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.02 -16.61 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 3.06 111.24 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -115.04 134.49 55.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 2.12 110.797 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.35 135.82 57.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 2.27 111.101 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.65 -26.86 22.65 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.829 -0.7 . . . . 0.54 112.726 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.56 166.68 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 1.51 110.676 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.501 HD11 HG22 ' A' ' 43' ' ' ILE . 20.1 tp -117.25 127.08 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.987 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -89.27 149.75 20.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.85 112.534 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -174.68 169.72 3.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.645 0.259 . . . . 4.08 110.796 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -124.87 -167.79 1.72 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.481 0.657 . . . . 2.84 111.894 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 125.83 27.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.937 -1.029 . . . . 2.24 110.692 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.45 81.94 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.37 112.593 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.06 122.22 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 2.3 111.088 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.4 121.76 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.97 -0.559 . . . . 1.09 110.603 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.93 142.33 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 1.19 111.314 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.3 p -96.35 113.17 24.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.48 110.069 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.28 144.61 25.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.5 0.667 . . . . 1.8 112.698 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.5 t -167.47 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.766 -1.106 . . . . 0.49 110.475 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.6 m-20 -144.01 -179.51 6.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.151 -1.055 . . . . 1.21 108.151 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.22 150.18 1.13 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 113.518 0.933 . . . . 1.11 113.518 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HG3' ' A' ' 40' ' ' GLU . 30.9 mm -101.0 -45.72 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.787 -1.097 . . . . 1.1 110.449 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -167.96 -170.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.531 -0.759 . . . . 1.73 110.623 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.36 -5.13 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.081 0.4 . . . . 2.93 112.081 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.28 -56.12 2.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.628 0.232 . . . . 2.36 111.628 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.768 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 p90 -120.97 133.86 55.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.174 0.512 . . . . 2.69 111.733 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.2 m-30 -93.24 -177.16 4.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.458 -0.792 . . . . 3.28 111.25 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.567 ' HG3' HG12 ' A' ' 34' ' ' ILE . 25.3 mt-10 -141.31 144.62 34.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 1.32 111.764 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.43 -163.73 21.84 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.362 -0.836 . . . . 0.24 111.444 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.81 154.78 49.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.294 0.569 . . . . 1.93 111.588 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 20' ' ' LEU . 4.8 tp -140.21 123.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.185 -0.916 . . . . 1.48 110.042 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.8 t60 67.38 -75.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.069 -0.514 . . . . 3.05 110.773 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.43 30.64 0.47 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 1.26 112.735 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -144.03 147.32 33.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.975 0.417 . . . . 2.76 111.503 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.6 m -108.02 161.4 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 1.26 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.83 174.03 39.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.958 -0.639 . . . . 0.3 112.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -104.28 153.85 20.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.862 0.331 . . . . 1.55 111.101 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 p90 -153.74 103.96 2.51 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.162 -0.472 . . . . 4.33 111.817 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -49.3 144.76 16.77 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.98 2.454 . . . . 0.48 112.429 177.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.91 -22.69 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.612 -0.722 . . . . 0.83 111.633 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -73.9 12.96 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 2.3 111.775 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -132.92 -9.3 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 4.47 111.109 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 HG12 ' HA2' ' A' ' 8' ' ' GLY . 34.1 m -140.01 174.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.43 111.212 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -133.99 101.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 2.09 109.676 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 57.8 t -60.4 116.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.077 -0.511 . . . . 1.18 111.383 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.66 -48.11 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.688 -0.687 . . . . 1.31 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.43 106.13 54.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 1.54 111.115 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.499 2.133 . . . . 1.61 112.296 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.976 0.417 . . . . 6.48 110.676 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.87 135.66 37.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.035 -0.529 . . . . 5.1 110.941 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -69.17 152.32 96.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 3.44 110.95 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' HG13 ' A' ' 59' ' ' VAL . 46.8 Cg_endo -68.62 124.33 11.44 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.48 2.12 . . . . 0.93 112.271 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.2 m -135.79 178.83 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.972 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.5 p -161.08 174.63 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.27 111.025 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HG2' HG12 ' A' ' 27' ' ' ILE . 99.7 mtt180 -139.54 135.45 33.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.88 -0.6 . . . . 3.13 111.408 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.84 128.78 9.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.839 -0.696 . . . . 0.27 112.705 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.8 mm? -78.24 -36.68 46.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 1.34 110.84 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.49 148.87 50.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 3.28 110.953 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.6 p-10 -65.35 167.98 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.221 0.534 . . . . 2.01 111.684 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.86 118.3 1.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 1.27 111.265 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.74 113.68 59.55 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.78 -0.646 . . . . 3.0 110.059 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 85.3 Cg_exo -46.64 130.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.485 2.124 . . . . 1.3 112.803 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.96 -28.97 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 3.06 110.667 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -110.63 131.39 55.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 2.12 110.79 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.85 124.65 21.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.27 110.931 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.09 -26.57 11.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 0.54 112.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -76.51 165.91 24.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 1.51 110.763 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 40.3 tp -112.56 135.33 53.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 1.2 111.174 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 14' ' ' PRO . . . -101.61 149.26 18.14 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.919 -0.657 . . . . 0.85 112.092 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -175.0 156.38 2.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 4.08 111.274 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -107.72 179.54 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 2.84 111.052 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -63.48 138.71 58.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.517 -0.765 . . . . 2.24 110.796 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.11 -5.56 66.23 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.948 -0.644 . . . . 0.37 113.085 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.65 147.93 45.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 2.3 111.053 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.415 HG12 ' HG2' ' A' ' 7' ' ' ARG . 67.9 mt -111.27 134.07 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 1.09 111.217 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD13 HD12 ' A' ' 43' ' ' ILE . 39.3 mm -126.22 141.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 1.19 110.83 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.8 p -89.67 128.82 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.587 -0.278 . . . . 0.48 110.445 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 31' ' ' THR . 2.6 tt -96.14 127.25 41.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 1.8 110.772 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.483 ' N ' HD23 ' A' ' 30' ' ' LEU . 7.8 t -166.2 17.62 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.07 0.462 . . . . 0.49 111.171 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.574 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 21.8 m120 -150.89 -179.46 7.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.942 -0.762 . . . . 1.21 108.942 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.6 mt-30 -174.75 149.77 1.24 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.644 0.609 . . . . 1.11 112.644 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 49' ' ' PHE . 45.9 mm -116.23 -29.59 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.315 -0.857 . . . . 1.1 111.54 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -156.91 170.3 22.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.259 -0.428 . . . . 1.73 110.831 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -61.34 -26.14 67.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 2.93 111.085 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.43 -38.66 8.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.27 -0.423 . . . . 2.36 111.28 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -96.36 125.67 41.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 2.69 110.815 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 18.6 m-30 -105.97 171.93 7.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.267 -0.424 . . . . 3.28 110.087 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 40.0 tt0 -139.97 137.73 34.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 1.32 111.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.43 -176.14 23.15 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.04 -0.982 . . . . 0.24 111.745 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -134.17 160.41 37.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.526 0.679 . . . . 1.93 111.896 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 HD13 ' A' ' 28' ' ' ILE . 14.0 tt -155.91 140.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.684 -1.143 . . . . 1.48 109.745 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.0 m80 64.31 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 3.05 110.839 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.54 30.68 0.41 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.488 -0.863 . . . . 1.26 113.134 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -159.34 149.13 18.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.01 0.433 . . . . 2.76 111.537 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 41.7 t -110.01 170.06 8.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.477 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . -176.49 166.1 36.83 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.904 -0.589 . . . . 0.3 112.065 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HB3' HG13 ' A' ' 34' ' ' ILE . 21.4 p90 -99.07 157.34 16.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.822 0.344 . . . . 1.55 111.318 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 24.6 p90 -175.78 111.83 0.26 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 4.33 111.428 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 6.1 Cg_endo -52.67 156.89 8.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.55 2.167 . . . . 0.48 112.26 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.01 -18.69 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.662 . . . . 0.83 111.389 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.13 -5.32 6.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 2.3 111.885 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -117.64 -8.36 10.92 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.125 0.417 . . . . 4.47 112.125 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.3 m -141.85 176.76 3.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.28 0.562 . . . . 0.43 112.003 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 9.9 pt-20 -134.23 101.56 5.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 2.09 109.989 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 94.0 t -59.13 114.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 1.18 111.263 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.12 -41.41 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 1.31 110.985 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 4' ' ' PRO . 2.7 p -143.71 123.43 7.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.54 110.955 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.356 2.037 . . . . 1.61 112.314 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.844 0.354 . . . . 6.48 111.049 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -139.78 40.44 2.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 5.1 110.691 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -103.21 130.39 23.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 3.44 110.922 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 61.1 Cg_endo -72.28 127.84 13.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.416 2.077 . . . . 0.93 112.238 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p -141.29 151.51 43.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 1.34 110.863 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 12.9 p -131.91 174.92 9.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.27 110.986 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 58' ' ' ILE . 12.4 ptp180 -142.15 136.74 30.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 3.13 110.945 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.45 137.49 20.39 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.73 -0.747 . . . . 0.27 112.838 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.8 mm? -92.13 -33.07 14.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 1.34 110.734 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -125.36 146.2 49.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 3.28 110.787 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 p-10 -77.76 161.76 27.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.308 0.575 . . . . 2.01 111.835 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 133.02 2.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.101 -0.954 . . . . 1.27 111.453 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.1 86.75 11.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.65 134.87 39.66 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.515 2.143 . . . . 1.3 112.752 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 6.62 38.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 3.06 110.636 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -115.75 134.31 55.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 2.12 110.793 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.13 139.59 58.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 2.27 111.107 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.8 -25.72 12.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.925 -0.655 . . . . 0.54 112.529 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HG2' ' CE1' ' A' ' 49' ' ' PHE . 6.8 mt-10 -88.83 161.86 16.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 1.51 110.708 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -100.25 122.12 42.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 1.2 110.522 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.08 134.97 12.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.85 112.952 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -175.7 -170.3 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.693 0.282 . . . . 4.08 110.703 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -132.55 172.87 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 2.84 111.505 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -49.7 148.44 3.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 2.24 110.818 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.77 -2.73 82.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.938 -0.649 . . . . 0.37 112.942 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.7 145.66 45.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 2.3 111.153 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -120.36 123.07 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 1.09 110.252 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.44 141.68 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.552 -0.294 . . . . 1.19 111.454 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.3 p -85.52 129.99 34.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.36 -0.382 . . . . 0.48 110.085 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 10.9 mp -96.24 132.86 41.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.121 0.486 . . . . 1.8 111.708 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.486 HG23 ' OD1' ' A' ' 32' ' ' ASN . 9.4 t -167.09 17.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.571 -0.741 . . . . 0.49 110.739 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 22.9 m120 -152.3 175.8 12.28 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.642 -0.873 . . . . 1.21 108.642 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.0 mt-30 -175.12 150.05 1.14 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.072 0.767 . . . . 1.11 113.072 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.412 HG12 ' HG3' ' A' ' 40' ' ' GLU . 32.4 mm -103.65 -37.37 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.076 -0.966 . . . . 1.1 110.915 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -168.08 175.94 6.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.616 . . . . 1.73 110.516 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.51 -10.96 5.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 2.93 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.0 -54.99 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.463 . . . . 2.36 111.19 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.15 134.96 38.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 2.69 111.257 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.566 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.2 m-85 -110.74 168.13 9.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 3.28 110.253 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 35.5 mt-10 -137.71 142.31 41.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.504 0.668 . . . . 1.32 112.076 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.2 -173.35 34.53 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.019 -0.991 . . . . 0.24 111.474 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.428 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.6 ptm -143.35 161.1 39.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.447 0.642 . . . . 1.93 111.558 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.58 133.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.144 -0.935 . . . . 1.48 110.36 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.3 t60 65.24 -78.81 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.104 -0.498 . . . . 3.05 110.974 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.76 30.1 0.55 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 1.26 112.89 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.25 143.08 25.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.358 . . . . 2.76 111.233 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 83.6 p -117.82 170.05 9.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.322 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.78 166.18 30.91 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.3 111.896 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 19' ' ' GLU . 30.8 p90 -100.1 159.7 14.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.896 0.379 . . . . 1.55 111.154 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.51 112.0 0.4 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.942 -0.572 . . . . 4.33 110.725 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.3 Cg_endo -58.07 157.55 24.71 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.618 2.212 . . . . 0.48 112.569 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 mt -61.01 -18.42 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 0.83 111.403 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -67.49 4.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 2.3 111.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -135.42 -5.77 2.28 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.629 0.233 . . . . 4.47 111.629 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.7 m -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.43 111.32 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HB2' HD21 ' A' ' 9' ' ' LEU . 37.9 tt0 -135.01 102.78 5.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 2.09 109.996 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.46 101.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.18 110.912 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' A' ' 7' ' ' ARG . 59.4 mt -61.97 -35.91 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 1.31 111.126 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 35.5 t -125.38 97.82 36.31 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 1.54 111.161 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.446 2.097 . . . . 1.61 112.265 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.803 0.335 . . . . 6.48 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -99.82 13.63 33.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 5.1 110.776 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 61.21 102.49 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.907 -0.588 . . . . 3.44 111.26 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 59' ' ' VAL . 51.3 Cg_exo -53.82 135.68 63.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.442 2.094 . . . . 0.93 112.248 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.9 m -127.25 176.29 7.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 1.34 111.074 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.6 p -155.46 174.73 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.27 110.747 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -141.94 144.58 33.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.084 -0.507 . . . . 3.13 111.23 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -78.21 135.66 16.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.929 -0.653 . . . . 0.27 112.811 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.16 -36.56 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 1.34 110.563 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -140.92 147.0 38.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.652 . . . . 3.28 110.496 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -58.17 159.45 5.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.235 0.54 . . . . 2.01 111.698 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -160.64 127.05 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.205 -0.907 . . . . 1.27 111.28 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -98.43 133.3 22.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 3.0 109.493 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 73.6 Cg_endo -74.77 133.65 17.23 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.965 1.777 . . . . 1.3 112.449 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -83.33 -38.41 22.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 3.06 110.896 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -132.06 173.64 11.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 2.12 110.789 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -73.89 144.53 45.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 2.27 110.946 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.24 -27.19 11.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.804 -0.712 . . . . 0.54 112.62 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.91 171.1 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.345 . . . . 1.51 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -109.81 123.28 49.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.95 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.613 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -113.4 124.85 6.72 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.804 -0.712 . . . . 0.85 112.598 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 13.3 m-85 -163.89 -169.66 1.94 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.69 0.281 . . . . 4.08 110.662 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -125.06 173.02 8.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.456 0.646 . . . . 2.84 112.018 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.91 149.2 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.068 -0.969 . . . . 2.24 111.042 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.24 69.4 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.756 -0.656 . . . . 0.37 112.916 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' OD2' HD11 ' A' ' 28' ' ' ILE . 38.4 t70 -79.73 132.21 36.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 2.3 110.824 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.42 128.13 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 1.09 111.324 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.409 HD11 ' OD2' ' A' ' 26' ' ' ASP . 45.2 mm -128.54 142.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.19 110.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.6 p -89.87 135.39 33.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.59 -0.277 . . . . 0.48 110.519 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 39' ' ' TYR . 15.2 tp -96.33 132.92 41.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.325 -0.398 . . . . 1.8 110.781 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.435 HG23 ' OD1' ' A' ' 32' ' ' ASN . 8.9 t -166.72 17.24 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.49 111.378 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 20.5 m120 -151.35 170.22 20.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.682 -0.859 . . . . 1.21 108.682 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mt-30 -174.94 149.62 1.15 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.689 0.625 . . . . 1.11 112.689 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.6 mp -105.66 -32.88 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.184 -0.916 . . . . 1.1 110.655 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -167.93 -170.92 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.81 -0.632 . . . . 1.73 110.785 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.46 -14.41 61.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 2.93 111.419 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -101.3 -54.29 2.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 2.36 111.62 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -95.22 126.57 40.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.853 0.359 . . . . 2.69 111.035 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.615 ' HB3' HD11 ' A' ' 30' ' ' LEU . 14.4 m-30 -108.73 175.4 5.48 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.069 -0.514 . . . . 3.28 110.501 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -150.76 143.86 24.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.47 0.652 . . . . 1.32 111.974 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.18 -171.0 24.42 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.24 111.855 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 24.7 ptt? -143.3 163.13 33.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.393 0.616 . . . . 1.93 111.531 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 tp -144.58 126.12 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.009 -0.996 . . . . 1.48 110.415 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t60 64.98 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 3.05 111.106 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.89 31.51 0.67 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.596 -0.812 . . . . 1.26 112.874 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.36 135.12 19.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 2.76 111.159 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 80.7 p -106.8 170.28 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.5 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.01 150.1 8.14 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.3 111.88 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -113.08 160.17 18.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.351 . . . . 1.55 111.404 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER 177.29 132.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.625 -0.716 . . . . 4.33 110.841 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.6 Cg_endo -47.2 160.89 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.172 2.581 . . . . 0.48 112.965 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.481 ' C ' ' H ' ' A' ' 54' ' ' TYR . 24.8 mt -58.03 -20.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.397 -0.819 . . . . 0.83 111.693 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.12 7.26 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.564 -0.289 . . . . 2.3 111.35 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HG13 ' A' ' 55' ' ' VAL . 9.7 t80 -116.41 -30.89 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.365 -0.38 . . . . 4.47 111.233 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 8' ' ' GLY . 15.8 m -141.48 175.61 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.39 0.614 . . . . 0.43 111.861 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.43 113.37 8.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.248 -0.887 . . . . 2.09 109.604 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 6.1 p -55.04 120.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 1.18 111.181 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.8 mt -80.83 -47.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.737 -0.665 . . . . 1.31 111.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 4' ' ' PRO . 3.2 p -126.74 111.41 22.51 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.038 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.518 2.145 . . . . 1.61 112.487 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.801 0.334 . . . . 6.48 110.836 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.04 117.98 11.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 5.1 110.885 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 56.3 tp60 -88.39 -49.39 0.42 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.082 -0.508 . . . . 3.44 111.565 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 3' ' ' GLN . 32.8 Cg_exo -59.51 123.88 14.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.109 1.872 . . . . 0.93 112.185 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.83 169.46 19.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 1.34 111.337 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 16.3 p -150.17 175.19 11.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.27 110.64 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HD2' ' HA2' ' A' ' 25' ' ' GLY . 37.4 ttp180 -139.67 121.44 15.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 3.13 111.178 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -70.41 135.58 25.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 0.27 112.542 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -84.27 -31.26 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.34 110.717 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -125.53 154.04 42.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.81 -0.632 . . . . 3.28 110.857 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.93 147.88 24.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.203 -0.453 . . . . 2.01 110.341 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.93 133.58 17.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 1.27 111.366 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -94.19 132.02 30.17 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 3.0 109.801 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.49 129.54 26.76 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.317 2.012 . . . . 1.3 112.331 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.04 -34.13 3.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 3.06 110.924 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -111.21 159.38 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 2.12 110.972 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -77.95 124.08 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 2.27 110.936 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.33 -20.14 35.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.938 -0.649 . . . . 0.54 112.561 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.62 165.28 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 1.51 110.541 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.3 tp -113.49 134.59 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 1.2 111.126 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.55 148.37 16.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 0.85 112.03 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -170.07 -172.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 4.08 111.219 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -133.68 -179.7 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 2.84 111.425 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.05 138.78 58.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.28 -0.873 . . . . 2.24 110.15 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 7' ' ' ARG . . . 81.57 -19.13 9.43 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.729 . . . . 0.37 112.623 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 18.6 t70 -60.75 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 2.3 111.077 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.484 ' O ' HD13 ' A' ' 43' ' ' ILE . 66.2 mt -93.77 126.69 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 1.09 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.98 143.85 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 1.19 111.24 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.6 p -92.69 127.73 38.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.359 -0.382 . . . . 0.48 110.464 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 8.4 mp -96.59 133.3 41.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 1.8 111.484 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -166.97 14.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.49 111.591 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.9 m-20 -151.09 179.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.53 -0.915 . . . . 1.21 108.53 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 5.4 mt-30 -174.76 149.89 1.24 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.871 0.693 . . . . 1.11 112.871 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 38' ' ' TRP . 47.9 mm -109.66 -32.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.057 -0.974 . . . . 1.1 111.018 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.11 167.38 12.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.73 110.627 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.17 -8.84 6.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.41 -0.359 . . . . 2.93 110.875 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -96.19 -52.77 3.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.133 -0.485 . . . . 2.36 110.981 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.795 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -115.58 134.47 55.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 2.69 111.257 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 39.8 p90 -100.32 -177.98 3.68 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.986 -0.552 . . . . 3.28 111.221 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 38.2 tt0 -144.67 137.02 26.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.396 0.617 . . . . 1.32 111.563 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.31 -161.81 10.97 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.24 111.734 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 23.6 ptp -143.37 156.68 44.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 1.93 111.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.77 132.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.261 -0.881 . . . . 1.48 110.306 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 65.38 -77.27 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.09 -0.504 . . . . 3.05 111.275 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.53 31.58 0.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.568 -0.825 . . . . 1.26 112.997 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.14 144.76 23.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 2.76 111.343 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 44.7 t -107.5 168.73 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 1.26 111.278 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 170.06 35.82 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.793 -0.639 . . . . 0.3 111.875 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 24.5 p90 -111.61 158.55 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 1.55 111.29 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -173.06 122.79 0.43 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.217 -0.447 . . . . 4.33 111.713 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.795 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 84.2 Cg_exo -44.85 139.17 8.0 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.18 2.587 . . . . 0.48 113.258 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 52' ' ' ILE . 22.0 mt -64.04 -18.64 23.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.328 -0.851 . . . . 0.83 111.581 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.61 -6.57 3.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 2.3 112.213 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -117.37 12.07 14.15 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.298 0.481 . . . . 4.47 112.298 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 23.0 m -144.7 175.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.21 0.529 . . . . 0.43 111.457 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.2 tp10 -133.49 96.47 3.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 2.09 109.804 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 p -55.82 118.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 1.18 111.226 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -73.16 -36.34 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 1.31 110.968 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 4' ' ' PRO . 7.1 p -150.76 131.71 7.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 1.54 110.865 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.355 2.037 . . . . 1.61 112.248 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.812 0.339 . . . . 6.48 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.5 t70 56.99 25.39 10.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 5.1 111.018 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 86.1 mm-40 -94.81 -49.41 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.132 -0.485 . . . . 3.44 111.535 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.3 Cg_exo -54.9 132.86 54.61 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.151 1.9 . . . . 0.93 112.205 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 29' ' ' THR . 83.4 m -144.81 179.43 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.34 111.087 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 20.6 p -155.45 174.33 15.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.912 -0.585 . . . . 0.27 110.491 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.545 ' HE ' HD11 ' A' ' 58' ' ' ILE . 8.1 ptp180 -142.49 133.19 25.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 3.13 111.46 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -73.23 137.63 24.13 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.839 -0.696 . . . . 0.27 112.894 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -87.55 -28.76 21.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.399 . . . . 1.34 110.754 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -136.92 146.8 45.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 3.28 110.685 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 t70 -67.61 160.31 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 2.01 111.602 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.18 119.4 1.52 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.014 -0.994 . . . . 1.27 110.835 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.73 135.54 49.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 3.0 109.841 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 45.9 Cg_endo -69.4 138.7 39.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 1.3 112.431 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -126.0 -45.85 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 3.06 110.996 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.62 153.33 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.927 0.394 . . . . 2.12 111.121 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -77.51 124.97 28.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.023 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.07 -2.62 35.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.716 . . . . 0.54 112.807 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -95.81 165.75 12.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 1.51 110.813 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -106.91 119.22 38.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 1.2 111.059 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.524 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -105.76 135.39 12.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.835 -0.698 . . . . 0.85 112.559 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.99 -173.55 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.734 0.302 . . . . 4.08 110.935 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -121.0 174.67 6.48 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.363 0.601 . . . . 2.84 111.962 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.21 149.36 12.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 2.24 110.983 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.64 -11.31 62.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.962 -0.637 . . . . 0.37 112.586 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.02 126.32 30.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.817 0.342 . . . . 2.3 110.606 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 43' ' ' ILE . 41.6 mt -100.34 108.22 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 1.09 111.382 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.461 HD13 HD13 ' A' ' 20' ' ' LEU . 77.9 mt -96.46 139.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.19 111.105 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' SG ' ' A' ' 5' ' ' CYS . 42.8 p -90.67 120.3 31.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.48 110.321 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -95.61 142.66 27.67 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.381 0.61 . . . . 1.8 112.512 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 t -167.65 17.42 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.069 -0.969 . . . . 0.49 110.748 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 23.4 m120 -149.6 176.37 10.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.473 -0.936 . . . . 1.21 108.473 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.3 mt-30 -175.28 149.8 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.751 0.649 . . . . 1.11 112.751 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.7 mp -109.21 -28.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.435 -0.802 . . . . 1.1 110.488 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.87 166.68 21.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 1.73 110.485 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.12 -12.16 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 2.93 111.09 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.92 -57.7 1.99 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 2.36 110.979 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.2 m95 -87.55 125.52 34.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.415 -0.357 . . . . 2.69 110.571 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.3 m-85 -102.78 178.48 4.56 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.832 0.349 . . . . 3.28 110.67 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 32' ' ' ASN . 36.5 tt0 -151.27 140.1 20.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 1.32 111.834 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.4 -159.04 11.61 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.464 -0.789 . . . . 0.24 111.736 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.97 156.93 46.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.332 0.587 . . . . 1.93 111.442 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.02 128.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.186 -0.916 . . . . 1.48 110.07 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 67.29 -76.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 3.05 110.688 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.31 29.7 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 1.26 112.804 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -144.83 147.69 33.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 2.76 111.465 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -109.33 162.99 13.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.15 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' HG ' ' A' ' 20' ' ' LEU . . . 172.75 173.16 39.05 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.926 -0.654 . . . . 0.3 112.386 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.17 162.34 13.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.735 0.302 . . . . 1.55 111.187 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -178.36 106.05 0.21 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.903 -0.59 . . . . 4.33 110.812 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.5 Cg_endo -59.46 159.94 21.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.725 2.283 . . . . 0.48 113.3 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.77 -18.35 22.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.427 -0.806 . . . . 0.83 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -62.87 -2.27 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 2.3 111.78 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -131.71 -4.48 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.749 0.277 . . . . 4.47 111.749 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.7 m -139.83 174.32 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.16 0.505 . . . . 0.43 111.216 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.0 tp10 -134.34 105.0 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 2.09 109.91 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 45.9 t -55.69 122.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 1.18 111.179 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD11 ' HE ' ' A' ' 7' ' ' ARG . 58.0 mt -85.04 -38.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 1.31 111.222 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 39.6 t -110.22 115.57 54.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 1.54 111.205 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.426 2.084 . . . . 1.61 112.28 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.735 0.302 . . . . 6.48 110.855 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 57.12 -161.31 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 5.1 111.002 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 66.87 143.62 0.09 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.041 -0.527 . . . . 3.44 111.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.39 132.58 27.81 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.425 2.084 . . . . 0.93 112.342 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.73 179.64 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 1.34 110.825 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 p -163.18 174.78 11.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.27 110.963 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -142.13 134.39 27.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.13 111.305 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -76.56 139.11 23.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.27 112.609 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -97.32 -32.06 12.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 1.34 110.893 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -122.67 146.48 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.904 -0.589 . . . . 3.28 110.728 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.82 167.21 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.405 0.622 . . . . 2.01 111.956 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.99 119.44 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.015 -0.993 . . . . 1.27 110.963 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -81.9 128.49 68.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 3.0 110.298 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.06 129.91 33.99 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.315 2.01 . . . . 1.3 112.496 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.64 -35.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 3.06 110.681 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.83 137.13 32.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.115 -0.493 . . . . 2.12 110.772 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.0 121.57 21.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 2.27 110.996 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.23 14.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.54 112.626 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 29.1 tt0 -81.23 168.21 18.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 1.51 110.713 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 28' ' ' ILE . 30.8 tp -116.72 132.58 56.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 1.2 110.853 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.42 141.71 16.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.671 -0.776 . . . . 0.85 112.725 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -175.24 -176.11 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.433 -0.21 . . . . 4.08 110.433 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -118.78 169.79 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.27 0.557 . . . . 2.84 112.034 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -48.76 149.38 1.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.162 -0.926 . . . . 2.24 111.34 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.23 -6.0 69.75 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.37 113.023 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -73.94 124.17 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 2.3 111.117 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -92.79 125.18 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 1.09 110.74 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 43' ' ' ILE . 62.5 mt -123.92 135.5 63.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 1.19 111.401 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -95.9 116.67 29.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.48 109.928 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 pp -94.94 149.56 21.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.369 0.604 . . . . 1.8 112.393 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 t -167.48 17.13 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.029 -0.987 . . . . 0.49 110.787 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 87.1 m-20 -147.99 -179.99 7.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.437 -0.949 . . . . 1.21 108.437 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.7 mt-30 -175.28 149.85 1.09 Allowed 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.523 0.564 . . . . 1.11 112.523 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.58 -23.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.404 -0.816 . . . . 1.1 111.032 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -166.95 165.06 16.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 1.73 110.464 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -61.95 -7.1 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 2.93 110.79 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.402 ' HB2' ' OE2' ' A' ' 36' ' ' GLU . 50.5 t-20 -110.22 -51.99 2.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 2.36 110.617 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 m95 -92.67 125.94 37.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.472 -0.331 . . . . 2.69 110.525 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.587 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.0 m-30 -100.08 177.16 5.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.887 0.375 . . . . 3.28 110.918 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -147.4 137.41 23.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.96 -0.563 . . . . 1.32 111.265 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.33 -158.9 14.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.585 -0.734 . . . . 0.24 111.859 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 mtm -141.12 148.94 40.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 1.93 111.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 28' ' ' ILE . 12.3 tt -126.43 118.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 1.48 110.08 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.9 t60 67.89 -73.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 3.05 110.716 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.01 27.5 0.51 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.663 -0.78 . . . . 1.26 112.832 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -136.68 142.05 43.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.71 0.29 . . . . 2.76 111.222 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.6 p -105.8 155.54 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 1.26 111.016 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.8 169.59 38.29 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.796 -0.716 . . . . 0.3 112.552 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -97.6 151.14 20.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.55 0.214 . . . . 1.55 110.566 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 16.0 p90 -167.93 103.97 0.56 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.002 0.371 . . . . 4.33 112.002 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 10.5 Cg_endo -57.64 165.1 6.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.516 2.144 . . . . 0.48 112.415 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 52' ' ' ILE . 19.0 mt -66.26 -20.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.83 111.64 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -69.89 2.06 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.59 -0.277 . . . . 2.3 111.555 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -124.62 -11.8 7.25 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 4.47 111.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 34.7 m -140.21 177.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.309 0.576 . . . . 0.43 111.772 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -137.64 102.39 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 2.09 109.749 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.37 117.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.18 111.244 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.68 -47.08 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 1.31 111.146 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.83 97.68 9.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.371 -0.377 . . . . 1.54 111.317 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.58 2.186 . . . . 1.61 112.174 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.71 0.291 . . . . 6.48 110.713 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.07 142.41 38.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 5.1 110.855 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.08 129.67 12.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 3.44 110.759 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 59.0 Cg_endo -71.21 132.73 21.54 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.405 2.07 . . . . 0.93 112.182 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.7 m -140.71 169.82 16.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 1.34 111.196 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 21.1 p -144.93 174.67 10.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.27 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.532 ' HG2' HG12 ' A' ' 27' ' ' ILE . 91.1 mtt180 -138.9 137.43 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 3.13 111.414 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.61 136.47 21.03 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.952 -0.642 . . . . 0.27 112.921 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -82.85 -29.78 29.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.34 110.724 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -149.11 155.04 40.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 3.28 110.859 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.8 p30 -70.55 166.36 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.586 0.708 . . . . 2.01 112.8 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.33 130.76 2.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.589 -1.187 . . . . 1.27 111.06 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -111.7 88.86 10.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.641 -0.709 . . . . 3.0 109.961 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 156.78 6.56 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.747 2.298 . . . . 1.3 112.576 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.52 9.03 10.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 3.06 110.794 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -138.94 154.66 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 2.12 110.827 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.37 141.8 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 2.27 110.922 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.29 -27.45 10.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.995 -0.622 . . . . 0.54 112.299 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.18 163.58 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 28' ' ' ILE . 17.3 tp -107.66 113.13 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 1.2 111.044 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.56 140.75 15.21 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.935 -0.65 . . . . 0.85 112.641 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.82 -170.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 4.08 110.942 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -132.14 168.11 18.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 2.84 111.546 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.71 148.6 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.606 -0.724 . . . . 2.24 110.935 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.48 78.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.826 -0.625 . . . . 0.37 112.908 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.8 p-10 -76.98 138.69 39.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.677 0.275 . . . . 2.3 110.774 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 7' ' ' ARG . 66.5 mt -107.61 127.58 63.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.09 110.836 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 HD23 ' A' ' 20' ' ' LEU . 37.9 mt -123.57 139.83 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 1.19 111.508 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -86.19 127.94 34.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.48 110.2 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 39' ' ' TYR . 24.2 tp -96.29 127.81 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 1.8 111.513 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.45 HG23 ' OD1' ' A' ' 32' ' ' ASN . 12.5 t -166.99 17.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.49 111.586 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 25.0 m120 -149.7 175.19 11.8 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.775 -0.824 . . . . 1.21 108.775 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.3 mt-30 -175.1 150.34 1.18 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.085 0.772 . . . . 1.11 113.085 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.04 -32.03 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.194 -0.912 . . . . 1.1 110.917 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -165.51 170.92 13.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 1.73 110.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.28 -10.88 5.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 2.93 111.106 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.11 -55.34 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 2.36 111.109 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.698 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -91.86 127.37 37.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.432 -0.349 . . . . 2.69 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 2.8 m-85 -106.89 172.17 6.97 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.274 -0.421 . . . . 3.28 111.082 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -140.58 145.69 37.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.526 0.679 . . . . 1.32 112.11 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.04 -171.69 28.49 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.157 -0.929 . . . . 0.24 111.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.481 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 17.3 mtm -134.4 156.78 47.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.234 0.54 . . . . 1.93 111.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' N ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -146.97 131.44 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.298 -0.864 . . . . 1.48 109.952 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.605 ' N ' HD13 ' A' ' 43' ' ' ILE . 73.3 t60 64.33 -78.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 3.05 111.007 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.08 31.62 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.758 . . . . 1.26 112.917 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.57 148.41 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 2.76 111.211 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 42' ' ' MET . 85.9 p -105.75 169.71 8.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 1.26 111.481 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.58 169.55 42.06 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.745 -0.661 . . . . 0.3 111.941 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -114.37 158.66 21.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.888 0.344 . . . . 1.55 111.326 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER 176.06 119.97 0.14 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.735 -0.666 . . . . 4.33 111.312 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 9.2 Cg_endo -52.66 162.83 2.17 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.48 113.418 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 54' ' ' TYR . 25.7 mt -62.98 -23.29 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 115.369 -0.832 . . . . 0.83 112.116 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -69.57 8.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.654 0.264 . . . . 2.3 111.523 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 52' ' ' ILE . 45.0 t80 -114.63 -24.55 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.333 . . . . 4.47 111.09 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.8 m -138.15 179.5 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.43 111.785 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 9' ' ' LEU . 11.2 tp10 -134.36 102.07 5.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.244 -0.889 . . . . 2.09 109.896 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 40.0 t -64.59 112.63 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 1.18 111.201 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.08 -49.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 1.31 111.06 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 59.9 t -100.38 123.83 45.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 1.54 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 35.2 Cg_exo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.421 2.081 . . . . 1.61 112.257 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.79 0.328 . . . . 6.48 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.13 130.54 53.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 5.1 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -135.75 86.77 26.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 3.44 110.871 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.64 124.63 12.63 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.49 2.127 . . . . 0.93 112.36 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.8 m -128.48 161.08 30.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 1.34 110.804 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 19.7 p -150.67 174.08 13.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.089 0.471 . . . . 0.27 111.252 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' NE ' HD11 ' A' ' 58' ' ' ILE . 34.3 ptt180 -141.68 128.03 19.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.689 -0.687 . . . . 3.13 110.977 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -56.15 144.7 35.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.984 -0.626 . . . . 0.27 113.007 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mt -100.46 -38.95 8.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.123 0.487 . . . . 1.34 111.468 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -135.02 147.94 49.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 3.28 110.475 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.3 p-10 -64.59 161.07 18.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.418 0.628 . . . . 2.01 112.126 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -164.83 121.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.799 -1.091 . . . . 1.27 110.807 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 tp10 -92.75 125.1 56.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 3.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.501 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 71.5 Cg_exo -46.38 135.49 15.72 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.42 2.08 . . . . 1.3 112.565 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 45.5 mt-10 -133.28 -38.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.06 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -111.73 133.36 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 2.12 110.746 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 2.27 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.89 -27.29 15.01 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.784 -0.722 . . . . 0.54 112.372 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.52 165.32 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.67 0.271 . . . . 1.51 110.411 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.3 tp -108.08 134.25 51.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 1.2 111.304 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.501 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -125.05 132.67 8.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.841 -0.695 . . . . 0.85 112.668 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -166.92 -173.9 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.581 0.229 . . . . 4.08 110.437 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -120.4 166.77 13.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.236 0.541 . . . . 2.84 111.818 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.53 148.8 3.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.305 -0.862 . . . . 2.24 111.352 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.55 -5.69 67.88 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 115.72 -0.673 . . . . 0.37 113.118 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -76.48 132.27 39.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 2.3 111.006 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.5 mt -93.95 133.07 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 1.09 110.352 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.6 mt -128.24 138.95 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 1.19 111.584 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -95.57 126.25 40.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.48 109.881 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.54 143.97 27.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 1.8 111.872 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -167.1 13.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.75 . . . . 0.49 111.202 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.559 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 90.5 m-20 -148.82 167.58 25.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.442 -0.947 . . . . 1.21 108.442 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.584 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.0 mt-30 -174.43 149.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.962 0.727 . . . . 1.11 112.962 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -103.71 -35.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.206 -0.906 . . . . 1.1 110.528 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -167.79 177.0 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.301 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.24 -5.77 3.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.588 -0.278 . . . . 2.93 111.211 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -105.51 -60.36 1.63 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.282 . . . . 2.36 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -91.89 127.37 37.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.486 -0.325 . . . . 2.69 110.824 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 11.4 m-30 -110.96 171.57 7.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.803 0.335 . . . . 3.28 110.986 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.0 mt-10 -142.85 147.76 35.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.218 0.532 . . . . 1.32 111.578 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.99 -169.09 35.12 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.634 -0.712 . . . . 0.24 112.195 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.0 ptt? -143.26 160.91 39.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.265 0.555 . . . . 1.93 111.285 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.56 144.18 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.261 -0.882 . . . . 1.48 110.662 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 65.62 -79.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.018 -0.537 . . . . 3.05 110.954 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.76 31.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.67 -0.776 . . . . 1.26 112.91 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -162.45 149.05 13.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 2.76 111.514 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 90.9 p -115.02 169.93 8.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 1.26 110.728 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.65 172.76 44.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.847 -0.692 . . . . 0.3 112.33 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -110.51 155.06 22.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.659 0.266 . . . . 1.55 111.306 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.91 121.47 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.738 -0.664 . . . . 4.33 111.361 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 18.0 Cg_endo -59.5 170.16 3.53 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.812 2.341 . . . . 0.48 113.196 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 54' ' ' TYR . 39.4 mt -58.49 -18.93 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.535 -0.757 . . . . 0.83 111.28 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.31 7.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 2.3 111.74 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 52' ' ' ILE . 31.4 t80 -124.68 -23.34 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 4.47 111.479 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.8 m -137.1 176.87 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.279 0.561 . . . . 0.43 111.908 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -125.47 97.22 5.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.284 -0.871 . . . . 2.09 109.8 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 48.6 t -61.45 108.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 1.18 111.366 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.423 HD11 ' NE ' ' A' ' 7' ' ' ARG . 50.0 mm -70.68 -35.51 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 1.31 110.772 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -130.49 97.41 21.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.768 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.404 2.069 . . . . 1.61 112.256 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttm . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.949 0.404 . . . . 6.48 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -76.22 126.05 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 5.1 110.823 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -103.84 135.32 19.37 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 3.44 110.842 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.29 150.25 52.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.433 2.089 . . . . 0.93 112.566 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.5 m -137.96 165.4 26.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.595 . . . . 1.34 110.422 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 p -146.27 174.97 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.27 111.118 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -141.8 136.88 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.85 -0.614 . . . . 3.13 111.161 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -75.53 143.52 30.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.867 -0.682 . . . . 0.27 112.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -102.64 -31.58 10.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.865 0.364 . . . . 1.34 110.895 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -115.57 146.41 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.28 110.794 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.7 t70 -79.06 157.97 27.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.522 0.677 . . . . 2.01 112.038 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.26 119.39 1.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.678 -1.146 . . . . 1.27 110.881 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -86.18 121.56 72.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.352 -0.385 . . . . 3.0 110.289 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 135.82 29.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.987 1.791 . . . . 1.3 112.233 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.81 -13.31 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 3.06 110.989 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -133.55 130.92 39.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.232 -0.44 . . . . 2.12 110.862 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -61.59 141.37 57.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 2.27 111.128 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.44 -22.44 17.51 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.985 -0.626 . . . . 0.54 112.336 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt-10 -102.97 160.1 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 1.51 110.634 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 28' ' ' ILE . 15.0 mt -99.09 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.2 110.515 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.17 130.32 9.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.85 112.977 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.43 -179.13 1.23 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 4.08 110.688 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.29 174.99 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.198 0.523 . . . . 2.84 111.591 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -53.34 148.91 8.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.394 -0.821 . . . . 2.24 110.981 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.94 65.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.977 -0.63 . . . . 0.37 112.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.24 139.47 46.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 2.3 110.82 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 43' ' ' ILE . 28.8 mm -112.62 130.29 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 1.09 110.744 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 20' ' ' LEU . 62.8 mt -127.86 145.57 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.379 -0.373 . . . . 1.19 110.788 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.9 p -87.48 133.5 33.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.48 110.974 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 39' ' ' TYR . 20.3 tp -96.34 130.56 43.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.8 110.99 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.458 HG23 ' OD1' ' A' ' 32' ' ' ASN . 5.5 t -166.88 16.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.023 0.439 . . . . 0.49 111.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.568 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 23.6 m120 -153.68 175.73 12.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.966 -0.753 . . . . 1.21 108.966 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.596 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 5.6 mt-30 -175.29 149.71 1.07 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.533 0.568 . . . . 1.11 112.533 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 mm -108.37 -34.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.355 -0.838 . . . . 1.1 110.916 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -157.86 171.19 20.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.722 -0.672 . . . . 1.73 110.422 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.94 -10.01 8.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.387 -0.369 . . . . 2.93 111.112 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.58 -55.84 2.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.342 -0.39 . . . . 2.36 111.128 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.2 m95 -86.91 125.22 33.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.519 -0.31 . . . . 2.69 110.235 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 6.4 m-30 -102.0 177.78 4.8 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.938 0.399 . . . . 3.28 111.095 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 27.8 mt-10 -146.82 138.42 24.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.363 0.601 . . . . 1.32 111.284 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.19 -168.41 19.68 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.443 -0.799 . . . . 0.24 111.66 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 8.1 mtt -137.93 155.19 49.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.506 0.669 . . . . 1.93 111.372 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' GLY . 7.5 tp -140.31 153.83 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.837 -1.074 . . . . 1.48 109.166 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.444 ' N ' HG13 ' A' ' 43' ' ' ILE . 85.2 m-70 -30.81 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.653 0.596 . . . . 3.05 111.951 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ILE . . . -78.93 -60.09 2.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.784 -0.722 . . . . 1.26 113.06 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.486 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -168.39 173.73 7.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.697 0.76 . . . . 2.76 112.101 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 93.6 p -105.19 148.66 26.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.6 -1.182 . . . . 1.26 111.273 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.46 -172.6 36.26 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.3 111.916 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' GLU . 52.2 p90 -105.26 158.1 16.84 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.974 0.387 . . . . 1.55 111.181 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -174.38 104.74 0.28 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.924 -0.58 . . . . 4.33 110.836 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 13.1 Cg_endo -58.45 163.46 10.48 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.733 2.289 . . . . 0.48 112.97 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 mt -65.97 -18.76 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.54 -0.755 . . . . 0.83 111.204 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.07 -5.06 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 2.3 111.642 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.17 -5.51 6.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.046 0.388 . . . . 4.47 112.046 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG12 ' HA2' ' A' ' 8' ' ' GLY . 28.7 m -136.69 175.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.161 0.505 . . . . 0.43 111.592 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 106.53 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.453 -0.794 . . . . 2.09 109.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.22 123.8 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.18 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mt -76.91 -53.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.985 -0.552 . . . . 1.31 110.958 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -103.69 108.17 58.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.974 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.361 2.041 . . . . 1.61 112.383 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.799 0.25 . . . . 0.93000000000000005 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.2 m -133.67 166.88 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 1.3400000000000001 111.284 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 21.9 p -145.86 174.84 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 0.27000000000000002 110.615 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -141.79 132.17 25.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.983 0.421 . . . . 3.1299999999999999 111.347 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.54 135.08 18.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.882 -0.675 . . . . 0.27000000000000002 112.934 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.4 mm? -84.35 -31.55 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.072 0.463 . . . . 1.3400000000000001 110.469 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -131.26 146.06 52.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 3.2799999999999998 110.476 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.5 p-10 -74.76 161.88 29.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.374 0.607 . . . . 2.0099999999999998 111.892 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 127.73 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.018 -0.992 . . . . 1.27 111.094 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.08 128.62 49.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.609 -0.515 . . . . 3.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 38.0 Cg_endo -66.29 130.56 24.25 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.08 1.853 . . . . 1.3 112.316 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.02 -16.61 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 3.0600000000000001 111.24 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -115.04 134.49 55.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 2.1200000000000001 110.797 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.35 135.82 57.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 2.27 111.101 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.65 -26.86 22.65 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.829 -0.7 . . . . 0.54000000000000004 112.726 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.56 166.68 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 1.51 110.676 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.501 HD11 HG22 ' A' ' 43' ' ' ILE . 20.1 tp -117.25 127.08 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.987 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -89.27 149.75 20.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.84999999999999998 112.534 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -174.68 169.72 3.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.645 0.259 . . . . 4.0800000000000001 110.796 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -124.87 -167.79 1.72 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.481 0.657 . . . . 2.8399999999999999 111.894 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 125.83 27.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.937 -1.029 . . . . 2.2400000000000002 110.692 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.45 81.94 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.37 112.593 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.06 122.22 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 2.2999999999999998 111.088 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.4 121.76 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.97 -0.559 . . . . 1.0900000000000001 110.603 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.93 142.33 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 1.1899999999999999 111.314 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.3 p -96.35 113.17 24.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.47999999999999998 110.069 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.28 144.61 25.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.5 0.667 . . . . 1.8 112.698 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.5 t -167.47 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.766 -1.106 . . . . 0.48999999999999999 110.475 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.6 m-20 -144.01 -179.51 6.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.151 -1.055 . . . . 1.21 108.151 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.22 150.18 1.13 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 113.518 0.933 . . . . 1.1100000000000001 113.518 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HG3' ' A' ' 40' ' ' GLU . 30.9 mm -101.0 -45.72 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.787 -1.097 . . . . 1.1000000000000001 110.449 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -167.96 -170.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.531 -0.759 . . . . 1.73 110.623 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.36 -5.13 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.081 0.4 . . . . 2.9300000000000002 112.081 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -98.28 -56.12 2.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.628 0.232 . . . . 2.3599999999999999 111.628 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.768 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 p90 -120.97 133.86 55.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.174 0.512 . . . . 2.6899999999999999 111.733 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.2 m-30 -93.24 -177.16 4.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.458 -0.792 . . . . 3.2799999999999998 111.25 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.567 ' HG3' HG12 ' A' ' 34' ' ' ILE . 25.3 mt-10 -141.31 144.62 34.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 1.3200000000000001 111.764 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.43 -163.73 21.84 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.362 -0.836 . . . . 0.23999999999999999 111.444 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.81 154.78 49.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.294 0.569 . . . . 1.9299999999999999 111.588 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 20' ' ' LEU . 4.8 tp -140.21 123.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.185 -0.916 . . . . 1.48 110.042 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.8 t60 67.38 -75.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.069 -0.514 . . . . 3.0499999999999998 110.773 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.43 30.64 0.47 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 1.26 112.735 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -144.03 147.32 33.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.975 0.417 . . . . 2.7599999999999998 111.503 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.6 m -108.02 161.4 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 1.26 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.83 174.03 39.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.958 -0.639 . . . . 0.29999999999999999 112.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -104.28 153.85 20.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.862 0.331 . . . . 1.55 111.101 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 p90 -153.74 103.96 2.51 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.162 -0.472 . . . . 4.3300000000000001 111.817 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -49.3 144.76 16.77 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.98 2.454 . . . . 0.47999999999999998 112.429 177.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.91 -22.69 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.612 -0.722 . . . . 0.82999999999999996 111.633 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -73.9 12.96 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 2.2999999999999998 111.775 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -132.92 -9.3 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 4.4699999999999998 111.109 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 HG12 ' HA2' ' A' ' 8' ' ' GLY . 34.1 m -140.01 174.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.42999999999999999 111.212 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -133.99 101.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 2.0899999999999999 109.676 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 57.8 t -60.4 116.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.077 -0.511 . . . . 1.1799999999999999 111.383 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.66 -48.11 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.688 -0.687 . . . . 1.3100000000000001 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.43 106.13 54.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 1.54 111.115 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.499 2.133 . . . . 1.6100000000000001 112.296 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' HG13 ' A' ' 59' ' ' VAL . 46.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.709 0.212 . . . . 0.93000000000000005 112.271 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.2 m -135.79 178.83 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 1.3400000000000001 110.972 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.5 p -161.08 174.63 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.27000000000000002 111.025 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HG2' HG12 ' A' ' 27' ' ' ILE . 99.7 mtt180 -139.54 135.45 33.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.88 -0.6 . . . . 3.1299999999999999 111.408 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.84 128.78 9.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.839 -0.696 . . . . 0.27000000000000002 112.705 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.8 mm? -78.24 -36.68 46.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 1.3400000000000001 110.84 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.49 148.87 50.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 3.2799999999999998 110.953 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.6 p-10 -65.35 167.98 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.221 0.534 . . . . 2.0099999999999998 111.684 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.86 118.3 1.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 1.27 111.265 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.74 113.68 59.55 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.78 -0.646 . . . . 3.0 110.059 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 85.3 Cg_exo -46.64 130.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.485 2.124 . . . . 1.3 112.803 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.96 -28.97 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 3.0600000000000001 110.667 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -110.63 131.39 55.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 2.1200000000000001 110.79 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.85 124.65 21.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.27 110.931 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.09 -26.57 11.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 0.54000000000000004 112.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -76.51 165.91 24.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 1.51 110.763 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 40.3 tp -112.56 135.33 53.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 1.2 111.174 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 14' ' ' PRO . . . -101.61 149.26 18.14 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.919 -0.657 . . . . 0.84999999999999998 112.092 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -175.0 156.38 2.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 4.0800000000000001 111.274 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -107.72 179.54 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 2.8399999999999999 111.052 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -63.48 138.71 58.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.517 -0.765 . . . . 2.2400000000000002 110.796 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.11 -5.56 66.23 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.948 -0.644 . . . . 0.37 113.085 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.65 147.93 45.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 2.2999999999999998 111.053 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.415 HG12 ' HG2' ' A' ' 7' ' ' ARG . 67.9 mt -111.27 134.07 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 1.0900000000000001 111.217 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD13 HD12 ' A' ' 43' ' ' ILE . 39.3 mm -126.22 141.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 1.1899999999999999 110.83 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.8 p -89.67 128.82 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.587 -0.278 . . . . 0.47999999999999998 110.445 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 31' ' ' THR . 2.6 tt -96.14 127.25 41.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 1.8 110.772 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.6 HG23 ' ND2' ' A' ' 32' ' ' ASN . 7.8 t -166.2 17.62 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.07 0.462 . . . . 0.48999999999999999 111.171 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.6 ' ND2' HG23 ' A' ' 31' ' ' THR . 56.1 m-80 -150.89 -179.46 7.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.942 -0.762 . . . . 1.21 108.942 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.6 mt-30 -174.75 149.77 1.24 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.644 0.609 . . . . 1.1100000000000001 112.644 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 49' ' ' PHE . 45.9 mm -116.23 -29.59 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.315 -0.857 . . . . 1.1000000000000001 111.54 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -156.91 170.3 22.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.259 -0.428 . . . . 1.73 110.831 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -61.34 -26.14 67.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 2.9300000000000002 111.085 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.43 -38.66 8.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.27 -0.423 . . . . 2.3599999999999999 111.28 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -96.36 125.67 41.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 2.6899999999999999 110.815 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 18.6 m-30 -105.97 171.93 7.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.267 -0.424 . . . . 3.2799999999999998 110.087 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 40.0 tt0 -139.97 137.73 34.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 1.3200000000000001 111.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.43 -176.14 23.15 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.04 -0.982 . . . . 0.23999999999999999 111.745 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -134.17 160.41 37.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.526 0.679 . . . . 1.9299999999999999 111.896 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 HD13 ' A' ' 28' ' ' ILE . 14.0 tt -155.91 140.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.684 -1.143 . . . . 1.48 109.745 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 64.31 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 3.0499999999999998 110.839 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.54 30.68 0.41 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.488 -0.863 . . . . 1.26 113.134 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -159.34 149.13 18.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.01 0.433 . . . . 2.7599999999999998 111.537 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 41.7 t -110.01 170.06 8.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.477 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . -176.49 166.1 36.83 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.904 -0.589 . . . . 0.29999999999999999 112.065 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HB3' HG13 ' A' ' 34' ' ' ILE . 21.4 p90 -99.07 157.34 16.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.822 0.344 . . . . 1.55 111.318 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 24.6 p90 -175.78 111.83 0.26 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 4.3300000000000001 111.428 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 6.1 Cg_endo -52.67 156.89 8.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.55 2.167 . . . . 0.47999999999999998 112.26 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.01 -18.69 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.662 . . . . 0.82999999999999996 111.389 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.13 -5.32 6.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 2.2999999999999998 111.885 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -117.64 -8.36 10.92 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.125 0.417 . . . . 4.4699999999999998 112.125 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.3 m -141.85 176.76 3.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.28 0.562 . . . . 0.42999999999999999 112.003 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 9.9 pt-20 -134.23 101.56 5.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 2.0899999999999999 109.989 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.409 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 94.0 t -59.13 114.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 1.1799999999999999 111.263 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.12 -41.41 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 1.3100000000000001 110.985 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 4' ' ' PRO . 2.7 p -143.71 123.43 7.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.54 110.955 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.356 2.037 . . . . 1.6100000000000001 112.314 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 61.1 Cg_endo . . . . . 0 N--CA 1.466 -0.108 0 CA-C-O 120.724 0.219 . . . . 0.93000000000000005 112.238 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p -141.29 151.51 43.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 1.3400000000000001 110.863 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 12.9 p -131.91 174.92 9.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.27000000000000002 110.986 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 58' ' ' ILE . 12.4 ptp180 -142.15 136.74 30.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 3.1299999999999999 110.945 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.45 137.49 20.39 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.73 -0.747 . . . . 0.27000000000000002 112.838 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.8 mm? -92.13 -33.07 14.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 1.3400000000000001 110.734 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -125.36 146.2 49.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 3.2799999999999998 110.787 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 p-10 -77.76 161.76 27.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.308 0.575 . . . . 2.0099999999999998 111.835 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 133.02 2.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.101 -0.954 . . . . 1.27 111.453 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.1 86.75 11.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.65 134.87 39.66 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.515 2.143 . . . . 1.3 112.752 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 6.62 38.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 3.0600000000000001 110.636 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -115.75 134.31 55.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 2.1200000000000001 110.793 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.13 139.59 58.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 2.27 111.107 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.8 -25.72 12.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.925 -0.655 . . . . 0.54000000000000004 112.529 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HG2' ' CE1' ' A' ' 49' ' ' PHE . 6.8 mt-10 -88.83 161.86 16.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 1.51 110.708 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -100.25 122.12 42.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 1.2 110.522 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.08 134.97 12.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.84999999999999998 112.952 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -175.7 -170.3 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.693 0.282 . . . . 4.0800000000000001 110.703 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -132.55 172.87 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 2.8399999999999999 111.505 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -49.7 148.44 3.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 2.2400000000000002 110.818 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.77 -2.73 82.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.938 -0.649 . . . . 0.37 112.942 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.7 145.66 45.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 2.2999999999999998 111.153 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -120.36 123.07 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 1.0900000000000001 110.252 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.44 141.68 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.552 -0.294 . . . . 1.1899999999999999 111.454 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.3 p -85.52 129.99 34.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.36 -0.382 . . . . 0.47999999999999998 110.085 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 10.9 mp -96.24 132.86 41.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.121 0.486 . . . . 1.8 111.708 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.637 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.4 t -167.09 17.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.571 -0.741 . . . . 0.48999999999999999 110.739 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 31' ' ' THR . 57.9 m-80 -152.3 175.8 12.28 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.642 -0.873 . . . . 1.21 108.642 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.566 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.0 mt-30 -175.12 150.05 1.14 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.072 0.767 . . . . 1.1100000000000001 113.072 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.412 HG12 ' HG3' ' A' ' 40' ' ' GLU . 32.4 mm -103.65 -37.37 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.076 -0.966 . . . . 1.1000000000000001 110.915 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -168.08 175.94 6.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.616 . . . . 1.73 110.516 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.51 -10.96 5.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 2.9300000000000002 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.0 -54.99 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.463 . . . . 2.3599999999999999 111.19 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.15 134.96 38.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 2.6899999999999999 111.257 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.566 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.2 m-85 -110.74 168.13 9.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 3.2799999999999998 110.253 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 35.5 mt-10 -137.71 142.31 41.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.504 0.668 . . . . 1.3200000000000001 112.076 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.2 -173.35 34.53 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.019 -0.991 . . . . 0.23999999999999999 111.474 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.428 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.6 ptm -143.35 161.1 39.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.447 0.642 . . . . 1.9299999999999999 111.558 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.58 133.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.144 -0.935 . . . . 1.48 110.36 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.3 t60 65.24 -78.81 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.104 -0.498 . . . . 3.0499999999999998 110.974 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.76 30.1 0.55 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 1.26 112.89 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.25 143.08 25.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.358 . . . . 2.7599999999999998 111.233 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 83.6 p -117.82 170.05 9.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.322 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.78 166.18 30.91 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.29999999999999999 111.896 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 19' ' ' GLU . 30.8 p90 -100.1 159.7 14.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.896 0.379 . . . . 1.55 111.154 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.51 112.0 0.4 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.942 -0.572 . . . . 4.3300000000000001 110.725 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.3 Cg_endo -58.07 157.55 24.71 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.618 2.212 . . . . 0.47999999999999998 112.569 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 mt -61.01 -18.42 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 0.82999999999999996 111.403 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.49 4.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 2.2999999999999998 111.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -135.42 -5.77 2.28 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.629 0.233 . . . . 4.4699999999999998 111.629 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.7 m -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.42999999999999999 111.32 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HB2' HD21 ' A' ' 9' ' ' LEU . 37.9 tt0 -135.01 102.78 5.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 2.0899999999999999 109.996 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.46 101.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.1799999999999999 110.912 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' A' ' 7' ' ' ARG . 59.4 mt -61.97 -35.91 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 1.3100000000000001 111.126 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 35.5 t -125.38 97.82 36.31 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 1.54 111.161 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.446 2.097 . . . . 1.6100000000000001 112.265 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 59' ' ' VAL . 51.3 Cg_exo . . . . . 0 C--O 1.232 0.201 0 CA-C-O 120.705 0.211 . . . . 0.93000000000000005 112.248 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.9 m -127.25 176.29 7.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 1.3400000000000001 111.074 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.6 p -155.46 174.73 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.27000000000000002 110.747 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -141.94 144.58 33.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.084 -0.507 . . . . 3.1299999999999999 111.23 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -78.21 135.66 16.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.929 -0.653 . . . . 0.27000000000000002 112.811 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.16 -36.56 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 1.3400000000000001 110.563 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -140.92 147.0 38.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.652 . . . . 3.2799999999999998 110.496 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -58.17 159.45 5.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.235 0.54 . . . . 2.0099999999999998 111.698 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -160.64 127.05 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.205 -0.907 . . . . 1.27 111.28 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -98.43 133.3 22.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 3.0 109.493 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 73.6 Cg_endo -74.77 133.65 17.23 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.965 1.777 . . . . 1.3 112.449 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -83.33 -38.41 22.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 3.0600000000000001 110.896 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -132.06 173.64 11.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 2.1200000000000001 110.789 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -73.89 144.53 45.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 2.27 110.946 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.24 -27.19 11.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.804 -0.712 . . . . 0.54000000000000004 112.62 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.91 171.1 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.345 . . . . 1.51 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -109.81 123.28 49.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.95 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.613 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -113.4 124.85 6.72 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.804 -0.712 . . . . 0.84999999999999998 112.598 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 13.3 m-85 -163.89 -169.66 1.94 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.69 0.281 . . . . 4.0800000000000001 110.662 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -125.06 173.02 8.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.456 0.646 . . . . 2.8399999999999999 112.018 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.91 149.2 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.068 -0.969 . . . . 2.2400000000000002 111.042 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.24 69.4 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.756 -0.656 . . . . 0.37 112.916 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' OD2' HD11 ' A' ' 28' ' ' ILE . 38.4 t70 -79.73 132.21 36.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 2.2999999999999998 110.824 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.42 128.13 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 1.0900000000000001 111.324 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.409 HD11 ' OD2' ' A' ' 26' ' ' ASP . 45.2 mm -128.54 142.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.1899999999999999 110.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.6 p -89.87 135.39 33.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.59 -0.277 . . . . 0.47999999999999998 110.519 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 39' ' ' TYR . 15.2 tp -96.33 132.92 41.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.325 -0.398 . . . . 1.8 110.781 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.435 HG23 ' OD1' ' A' ' 32' ' ' ASN . 8.9 t -166.72 17.24 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.48999999999999999 111.378 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 20.5 m120 -151.35 170.22 20.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.682 -0.859 . . . . 1.21 108.682 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mt-30 -174.94 149.62 1.15 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.689 0.625 . . . . 1.1100000000000001 112.689 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.6 mp -105.66 -32.88 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.184 -0.916 . . . . 1.1000000000000001 110.655 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -167.93 -170.92 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.81 -0.632 . . . . 1.73 110.785 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.46 -14.41 61.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 2.9300000000000002 111.419 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -101.3 -54.29 2.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 2.3599999999999999 111.62 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -95.22 126.57 40.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.853 0.359 . . . . 2.6899999999999999 111.035 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.615 ' HB3' HD11 ' A' ' 30' ' ' LEU . 14.4 m-30 -108.73 175.4 5.48 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.069 -0.514 . . . . 3.2799999999999998 110.501 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -150.76 143.86 24.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.47 0.652 . . . . 1.3200000000000001 111.974 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.18 -171.0 24.42 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.23999999999999999 111.855 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 24.7 ptt? -143.3 163.13 33.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.393 0.616 . . . . 1.9299999999999999 111.531 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 tp -144.58 126.12 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.009 -0.996 . . . . 1.48 110.415 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t60 64.98 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 3.0499999999999998 111.106 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.89 31.51 0.67 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.596 -0.812 . . . . 1.26 112.874 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.36 135.12 19.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 2.7599999999999998 111.159 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 80.7 p -106.8 170.28 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.5 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.01 150.1 8.14 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 111.88 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -113.08 160.17 18.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.351 . . . . 1.55 111.404 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER 177.29 132.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.625 -0.716 . . . . 4.3300000000000001 110.841 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.6 Cg_endo -47.2 160.89 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.172 2.581 . . . . 0.47999999999999998 112.965 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.481 ' C ' ' H ' ' A' ' 54' ' ' TYR . 24.8 mt -58.03 -20.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.397 -0.819 . . . . 0.82999999999999996 111.693 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -66.12 7.26 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.564 -0.289 . . . . 2.2999999999999998 111.35 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HG13 ' A' ' 55' ' ' VAL . 9.7 t80 -116.41 -30.89 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.365 -0.38 . . . . 4.4699999999999998 111.233 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 8' ' ' GLY . 15.8 m -141.48 175.61 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.39 0.614 . . . . 0.42999999999999999 111.861 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.43 113.37 8.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.248 -0.887 . . . . 2.0899999999999999 109.604 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 6.1 p -55.04 120.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 1.1799999999999999 111.181 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.8 mt -80.83 -47.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.737 -0.665 . . . . 1.3100000000000001 111.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 4' ' ' PRO . 3.2 p -126.74 111.41 22.51 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.038 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.518 2.145 . . . . 1.6100000000000001 112.487 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.508 ' HA ' HG13 ' A' ' 59' ' ' VAL . 32.8 Cg_exo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.659 0.191 . . . . 0.93000000000000005 112.185 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.83 169.46 19.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 1.3400000000000001 111.337 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 16.3 p -150.17 175.19 11.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.27000000000000002 110.64 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HD2' ' HA2' ' A' ' 25' ' ' GLY . 37.4 ttp180 -139.67 121.44 15.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 3.1299999999999999 111.178 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -70.41 135.58 25.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 0.27000000000000002 112.542 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -84.27 -31.26 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.3400000000000001 110.717 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -125.53 154.04 42.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.81 -0.632 . . . . 3.2799999999999998 110.857 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.93 147.88 24.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.203 -0.453 . . . . 2.0099999999999998 110.341 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.93 133.58 17.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 1.27 111.366 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -94.19 132.02 30.17 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 3.0 109.801 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.49 129.54 26.76 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.317 2.012 . . . . 1.3 112.331 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.04 -34.13 3.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 3.0600000000000001 110.924 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -111.21 159.38 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 2.1200000000000001 110.972 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -77.95 124.08 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 2.27 110.936 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.33 -20.14 35.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.938 -0.649 . . . . 0.54000000000000004 112.561 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.62 165.28 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 1.51 110.541 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.3 tp -113.49 134.59 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 1.2 111.126 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.55 148.37 16.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 0.84999999999999998 112.03 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -170.07 -172.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 4.0800000000000001 111.219 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -133.68 -179.7 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 2.8399999999999999 111.425 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.05 138.78 58.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.28 -0.873 . . . . 2.2400000000000002 110.15 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 7' ' ' ARG . . . 81.57 -19.13 9.43 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.729 . . . . 0.37 112.623 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 18.6 t70 -60.75 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 2.2999999999999998 111.077 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.484 ' O ' HD13 ' A' ' 43' ' ' ILE . 66.2 mt -93.77 126.69 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 1.0900000000000001 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.98 143.85 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 1.1899999999999999 111.24 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.6 p -92.69 127.73 38.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.359 -0.382 . . . . 0.47999999999999998 110.464 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 8.4 mp -96.59 133.3 41.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 1.8 111.484 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -166.97 14.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.48999999999999999 111.591 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.9 m-20 -151.09 179.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.53 -0.915 . . . . 1.21 108.53 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 5.4 mt-30 -174.76 149.89 1.24 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.871 0.693 . . . . 1.1100000000000001 112.871 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 38' ' ' TRP . 47.9 mm -109.66 -32.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.057 -0.974 . . . . 1.1000000000000001 111.018 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.11 167.38 12.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.73 110.627 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.17 -8.84 6.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.41 -0.359 . . . . 2.9300000000000002 110.875 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -96.19 -52.77 3.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.133 -0.485 . . . . 2.3599999999999999 110.981 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.795 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -115.58 134.47 55.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 2.6899999999999999 111.257 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 39.8 p90 -100.32 -177.98 3.68 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.986 -0.552 . . . . 3.2799999999999998 111.221 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 38.2 tt0 -144.67 137.02 26.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.396 0.617 . . . . 1.3200000000000001 111.563 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.31 -161.81 10.97 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.23999999999999999 111.734 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 23.6 ptp -143.37 156.68 44.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 1.9299999999999999 111.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.77 132.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.261 -0.881 . . . . 1.48 110.306 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 65.38 -77.27 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.09 -0.504 . . . . 3.0499999999999998 111.275 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.53 31.58 0.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.568 -0.825 . . . . 1.26 112.997 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.14 144.76 23.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 2.7599999999999998 111.343 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 44.7 t -107.5 168.73 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 1.26 111.278 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 170.06 35.82 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.793 -0.639 . . . . 0.29999999999999999 111.875 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 24.5 p90 -111.61 158.55 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 1.55 111.29 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -173.06 122.79 0.43 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.217 -0.447 . . . . 4.3300000000000001 111.713 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.795 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 84.2 Cg_exo -44.85 139.17 8.0 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.18 2.587 . . . . 0.47999999999999998 113.258 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 52' ' ' ILE . 22.0 mt -64.04 -18.64 23.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.328 -0.851 . . . . 0.82999999999999996 111.581 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.61 -6.57 3.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 2.2999999999999998 112.213 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -117.37 12.07 14.15 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.298 0.481 . . . . 4.4699999999999998 112.298 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 23.0 m -144.7 175.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.21 0.529 . . . . 0.42999999999999999 111.457 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.2 tp10 -133.49 96.47 3.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 2.0899999999999999 109.804 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 p -55.82 118.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 1.1799999999999999 111.226 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -73.16 -36.34 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 1.3100000000000001 110.968 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 4' ' ' PRO . 7.1 p -150.76 131.71 7.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 1.54 110.865 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.355 2.037 . . . . 1.6100000000000001 112.248 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.3 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.745 0.227 . . . . 0.93000000000000005 112.205 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 29' ' ' THR . 83.4 m -144.81 179.43 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.3400000000000001 111.087 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 20.6 p -155.45 174.33 15.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.912 -0.585 . . . . 0.27000000000000002 110.491 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.545 ' HE ' HD11 ' A' ' 58' ' ' ILE . 8.1 ptp180 -142.49 133.19 25.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 3.1299999999999999 111.46 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -73.23 137.63 24.13 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.839 -0.696 . . . . 0.27000000000000002 112.894 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -87.55 -28.76 21.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.399 . . . . 1.3400000000000001 110.754 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -136.92 146.8 45.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 3.2799999999999998 110.685 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 t70 -67.61 160.31 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 2.0099999999999998 111.602 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.18 119.4 1.52 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.014 -0.994 . . . . 1.27 110.835 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.73 135.54 49.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 3.0 109.841 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 45.9 Cg_endo -69.4 138.7 39.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 1.3 112.431 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -126.0 -45.85 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 3.0600000000000001 110.996 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.62 153.33 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.927 0.394 . . . . 2.1200000000000001 111.121 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -77.51 124.97 28.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.023 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.07 -2.62 35.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.716 . . . . 0.54000000000000004 112.807 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -95.81 165.75 12.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 1.51 110.813 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -106.91 119.22 38.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 1.2 111.059 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.524 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -105.76 135.39 12.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.835 -0.698 . . . . 0.84999999999999998 112.559 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.99 -173.55 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.734 0.302 . . . . 4.0800000000000001 110.935 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -121.0 174.67 6.48 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.363 0.601 . . . . 2.8399999999999999 111.962 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.21 149.36 12.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 2.2400000000000002 110.983 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.64 -11.31 62.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.962 -0.637 . . . . 0.37 112.586 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.02 126.32 30.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.817 0.342 . . . . 2.2999999999999998 110.606 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 43' ' ' ILE . 41.6 mt -100.34 108.22 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 1.0900000000000001 111.382 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.461 HD13 HD13 ' A' ' 20' ' ' LEU . 77.9 mt -96.46 139.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.1899999999999999 111.105 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' SG ' ' A' ' 5' ' ' CYS . 42.8 p -90.67 120.3 31.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.47999999999999998 110.321 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -95.61 142.66 27.67 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.381 0.61 . . . . 1.8 112.512 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.526 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.7 t -167.65 17.42 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.069 -0.969 . . . . 0.48999999999999999 110.748 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 58.2 m-80 -149.6 176.37 10.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.473 -0.936 . . . . 1.21 108.473 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.3 mt-30 -175.28 149.8 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.751 0.649 . . . . 1.1100000000000001 112.751 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.7 mp -109.21 -28.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.435 -0.802 . . . . 1.1000000000000001 110.488 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.87 166.68 21.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 1.73 110.485 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.12 -12.16 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 2.9300000000000002 111.09 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.92 -57.7 1.99 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 2.3599999999999999 110.979 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.2 m95 -87.55 125.52 34.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.415 -0.357 . . . . 2.6899999999999999 110.571 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.3 m-85 -102.78 178.48 4.56 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.832 0.349 . . . . 3.2799999999999998 110.67 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 32' ' ' ASN . 36.5 tt0 -151.27 140.1 20.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 1.3200000000000001 111.834 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.4 -159.04 11.61 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.464 -0.789 . . . . 0.23999999999999999 111.736 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.97 156.93 46.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.332 0.587 . . . . 1.9299999999999999 111.442 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.02 128.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.186 -0.916 . . . . 1.48 110.07 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 67.29 -76.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 3.0499999999999998 110.688 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.31 29.7 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 1.26 112.804 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -144.83 147.69 33.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 2.7599999999999998 111.465 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -109.33 162.99 13.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.15 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' HG ' ' A' ' 20' ' ' LEU . . . 172.75 173.16 39.05 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.926 -0.654 . . . . 0.29999999999999999 112.386 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.17 162.34 13.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.735 0.302 . . . . 1.55 111.187 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -178.36 106.05 0.21 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.903 -0.59 . . . . 4.3300000000000001 110.812 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.5 Cg_endo -59.46 159.94 21.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.725 2.283 . . . . 0.47999999999999998 113.3 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.77 -18.35 22.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.427 -0.806 . . . . 0.82999999999999996 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.87 -2.27 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 2.2999999999999998 111.78 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -131.71 -4.48 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.749 0.277 . . . . 4.4699999999999998 111.749 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.7 m -139.83 174.32 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.16 0.505 . . . . 0.42999999999999999 111.216 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.0 tp10 -134.34 105.0 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 2.0899999999999999 109.91 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 45.9 t -55.69 122.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 1.1799999999999999 111.179 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD11 ' HE ' ' A' ' 7' ' ' ARG . 58.0 mt -85.04 -38.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 1.3100000000000001 111.222 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 39.6 t -110.22 115.57 54.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 1.54 111.205 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.426 2.084 . . . . 1.6100000000000001 112.28 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.754 0.231 . . . . 0.93000000000000005 112.342 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.73 179.64 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 1.3400000000000001 110.825 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 p -163.18 174.78 11.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.27000000000000002 110.963 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -142.13 134.39 27.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.1299999999999999 111.305 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -76.56 139.11 23.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.27000000000000002 112.609 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -97.32 -32.06 12.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 1.3400000000000001 110.893 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -122.67 146.48 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.904 -0.589 . . . . 3.2799999999999998 110.728 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.82 167.21 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.405 0.622 . . . . 2.0099999999999998 111.956 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.99 119.44 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.015 -0.993 . . . . 1.27 110.963 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -81.9 128.49 68.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 3.0 110.298 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.06 129.91 33.99 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.315 2.01 . . . . 1.3 112.496 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 11.8 pt-20 -151.64 -35.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 3.0600000000000001 110.681 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 15' ' ' GLU . 39.5 m-80 -90.83 137.13 32.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.115 -0.493 . . . . 2.1200000000000001 110.772 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.0 121.57 21.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 2.27 110.996 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.23 14.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.54000000000000004 112.626 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 29.1 tt0 -81.23 168.21 18.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 1.51 110.713 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 28' ' ' ILE . 30.8 tp -116.72 132.58 56.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 1.2 110.853 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.42 141.71 16.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.671 -0.776 . . . . 0.84999999999999998 112.725 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -175.24 -176.11 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.433 -0.21 . . . . 4.0800000000000001 110.433 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -118.78 169.79 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.27 0.557 . . . . 2.8399999999999999 112.034 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -48.76 149.38 1.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.162 -0.926 . . . . 2.2400000000000002 111.34 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.23 -6.0 69.75 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.37 113.023 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -73.94 124.17 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 2.2999999999999998 111.117 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -92.79 125.18 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 1.0900000000000001 110.74 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 43' ' ' ILE . 62.5 mt -123.92 135.5 63.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 1.1899999999999999 111.401 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -95.9 116.67 29.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.47999999999999998 109.928 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 pp -94.94 149.56 21.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.369 0.604 . . . . 1.8 112.393 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 t -167.48 17.13 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.029 -0.987 . . . . 0.48999999999999999 110.787 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 14.0 m120 -147.99 -179.99 7.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.437 -0.949 . . . . 1.21 108.437 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.7 mt-30 -175.28 149.85 1.09 Allowed 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.523 0.564 . . . . 1.1100000000000001 112.523 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.58 -23.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.404 -0.816 . . . . 1.1000000000000001 111.032 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -166.95 165.06 16.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 1.73 110.464 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -61.95 -7.1 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 2.9300000000000002 110.79 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.402 ' HB2' ' OE2' ' A' ' 36' ' ' GLU . 50.5 t-20 -110.22 -51.99 2.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 2.3599999999999999 110.617 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 m95 -92.67 125.94 37.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.472 -0.331 . . . . 2.6899999999999999 110.525 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.587 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.0 m-30 -100.08 177.16 5.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.887 0.375 . . . . 3.2799999999999998 110.918 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -147.4 137.41 23.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.96 -0.563 . . . . 1.3200000000000001 111.265 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.33 -158.9 14.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.585 -0.734 . . . . 0.23999999999999999 111.859 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 mtm -141.12 148.94 40.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 1.9299999999999999 111.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 28' ' ' ILE . 12.3 tt -126.43 118.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 1.48 110.08 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.9 t60 67.89 -73.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 3.0499999999999998 110.716 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.01 27.5 0.51 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.663 -0.78 . . . . 1.26 112.832 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -136.68 142.05 43.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.71 0.29 . . . . 2.7599999999999998 111.222 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.6 p -105.8 155.54 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 1.26 111.016 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.8 169.59 38.29 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.796 -0.716 . . . . 0.29999999999999999 112.552 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -97.6 151.14 20.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.55 0.214 . . . . 1.55 110.566 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 16.0 p90 -167.93 103.97 0.56 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.002 0.371 . . . . 4.3300000000000001 112.002 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 10.5 Cg_endo -57.64 165.1 6.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.516 2.144 . . . . 0.47999999999999998 112.415 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 52' ' ' ILE . 19.0 mt -66.26 -20.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.82999999999999996 111.64 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -69.89 2.06 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.59 -0.277 . . . . 2.2999999999999998 111.555 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -124.62 -11.8 7.25 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 4.4699999999999998 111.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 34.7 m -140.21 177.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.309 0.576 . . . . 0.42999999999999999 111.772 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -137.64 102.39 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 2.0899999999999999 109.749 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.37 117.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 111.244 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.68 -47.08 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 1.3100000000000001 111.146 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.83 97.68 9.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.371 -0.377 . . . . 1.54 111.317 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.58 2.186 . . . . 1.6100000000000001 112.174 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 59.0 Cg_endo . . . . . 0 C--O 1.231 0.167 0 CA-C-O 120.8 0.25 . . . . 0.93000000000000005 112.182 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.7 m -140.71 169.82 16.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 1.3400000000000001 111.196 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 21.1 p -144.93 174.67 10.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.27000000000000002 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.532 ' HG2' HG12 ' A' ' 27' ' ' ILE . 91.1 mtt180 -138.9 137.43 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 3.1299999999999999 111.414 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.61 136.47 21.03 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.952 -0.642 . . . . 0.27000000000000002 112.921 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -82.85 -29.78 29.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.3400000000000001 110.724 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -149.11 155.04 40.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 3.2799999999999998 110.859 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.8 p30 -70.55 166.36 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.586 0.708 . . . . 2.0099999999999998 112.8 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.33 130.76 2.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.589 -1.187 . . . . 1.27 111.06 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -111.7 88.86 10.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.641 -0.709 . . . . 3.0 109.961 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 156.78 6.56 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.747 2.298 . . . . 1.3 112.576 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.52 9.03 10.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 3.0600000000000001 110.794 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 17' ' ' GLN . 2.8 t-20 -138.94 154.66 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 2.1200000000000001 110.827 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.447 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 7.5 tt0 -78.37 141.8 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 2.27 110.922 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.29 -27.45 10.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.995 -0.622 . . . . 0.54000000000000004 112.299 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.18 163.58 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 28' ' ' ILE . 17.3 tp -107.66 113.13 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 1.2 111.044 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.56 140.75 15.21 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.935 -0.65 . . . . 0.84999999999999998 112.641 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.82 -170.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 4.0800000000000001 110.942 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -132.14 168.11 18.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 2.8399999999999999 111.546 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.71 148.6 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.606 -0.724 . . . . 2.2400000000000002 110.935 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.48 78.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.826 -0.625 . . . . 0.37 112.908 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.8 p-10 -76.98 138.69 39.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.677 0.275 . . . . 2.2999999999999998 110.774 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 7' ' ' ARG . 66.5 mt -107.61 127.58 63.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.0900000000000001 110.836 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 HD23 ' A' ' 20' ' ' LEU . 37.9 mt -123.57 139.83 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 1.1899999999999999 111.508 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -86.19 127.94 34.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.47999999999999998 110.2 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 39' ' ' TYR . 24.2 tp -96.29 127.81 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 1.8 111.513 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.6 HG23 ' ND2' ' A' ' 32' ' ' ASN . 12.5 t -166.99 17.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.48999999999999999 111.586 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.6 ' ND2' HG23 ' A' ' 31' ' ' THR . 57.8 m-80 -149.7 175.19 11.8 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.775 -0.824 . . . . 1.21 108.775 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.3 mt-30 -175.1 150.34 1.18 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.085 0.772 . . . . 1.1100000000000001 113.085 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.04 -32.03 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.194 -0.912 . . . . 1.1000000000000001 110.917 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -165.51 170.92 13.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 1.73 110.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.28 -10.88 5.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 2.9300000000000002 111.106 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.11 -55.34 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 2.3599999999999999 111.109 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.698 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -91.86 127.37 37.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.432 -0.349 . . . . 2.6899999999999999 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 2.8 m-85 -106.89 172.17 6.97 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.274 -0.421 . . . . 3.2799999999999998 111.082 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -140.58 145.69 37.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.526 0.679 . . . . 1.3200000000000001 112.11 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.04 -171.69 28.49 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.157 -0.929 . . . . 0.23999999999999999 111.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.481 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 17.3 mtm -134.4 156.78 47.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.234 0.54 . . . . 1.9299999999999999 111.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' N ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -146.97 131.44 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.298 -0.864 . . . . 1.48 109.952 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.605 ' N ' HD13 ' A' ' 43' ' ' ILE . 73.3 t60 64.33 -78.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 3.0499999999999998 111.007 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.08 31.62 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.758 . . . . 1.26 112.917 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.57 148.41 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 2.7599999999999998 111.211 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 42' ' ' MET . 85.9 p -105.75 169.71 8.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 1.26 111.481 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.58 169.55 42.06 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.745 -0.661 . . . . 0.29999999999999999 111.941 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -114.37 158.66 21.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.888 0.344 . . . . 1.55 111.326 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER 176.06 119.97 0.14 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.735 -0.666 . . . . 4.3300000000000001 111.312 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 9.2 Cg_endo -52.66 162.83 2.17 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.47999999999999998 113.418 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 54' ' ' TYR . 25.7 mt -62.98 -23.29 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 115.369 -0.832 . . . . 0.82999999999999996 112.116 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -69.57 8.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.654 0.264 . . . . 2.2999999999999998 111.523 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 52' ' ' ILE . 45.0 t80 -114.63 -24.55 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.333 . . . . 4.4699999999999998 111.09 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.8 m -138.15 179.5 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.42999999999999999 111.785 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 9' ' ' LEU . 11.2 tp10 -134.36 102.07 5.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.244 -0.889 . . . . 2.0899999999999999 109.896 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 40.0 t -64.59 112.63 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 1.1799999999999999 111.201 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.08 -49.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 1.3100000000000001 111.06 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 59.9 t -100.38 123.83 45.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 1.54 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 35.2 Cg_exo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.421 2.081 . . . . 1.6100000000000001 112.257 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.849 0.27 . . . . 0.93000000000000005 112.36 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.8 m -128.48 161.08 30.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 1.3400000000000001 110.804 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 19.7 p -150.67 174.08 13.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.089 0.471 . . . . 0.27000000000000002 111.252 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.423 ' NE ' HD11 ' A' ' 58' ' ' ILE . 34.3 ptt180 -141.68 128.03 19.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.689 -0.687 . . . . 3.1299999999999999 110.977 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -56.15 144.7 35.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.984 -0.626 . . . . 0.27000000000000002 113.007 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mt -100.46 -38.95 8.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.123 0.487 . . . . 1.3400000000000001 111.468 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -135.02 147.94 49.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 3.2799999999999998 110.475 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.3 p-10 -64.59 161.07 18.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.418 0.628 . . . . 2.0099999999999998 112.126 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -164.83 121.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.799 -1.091 . . . . 1.27 110.807 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 tp10 -92.75 125.1 56.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 3.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.501 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 71.5 Cg_exo -46.38 135.49 15.72 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.42 2.08 . . . . 1.3 112.565 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 45.5 mt-10 -133.28 -38.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.0600000000000001 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -111.73 133.36 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 2.1200000000000001 110.746 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 2.27 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.89 -27.29 15.01 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.784 -0.722 . . . . 0.54000000000000004 112.372 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.52 165.32 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.67 0.271 . . . . 1.51 110.411 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.3 tp -108.08 134.25 51.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 1.2 111.304 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.501 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -125.05 132.67 8.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.841 -0.695 . . . . 0.84999999999999998 112.668 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -166.92 -173.9 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.581 0.229 . . . . 4.0800000000000001 110.437 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -120.4 166.77 13.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.236 0.541 . . . . 2.8399999999999999 111.818 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.53 148.8 3.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.305 -0.862 . . . . 2.2400000000000002 111.352 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.55 -5.69 67.88 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 115.72 -0.673 . . . . 0.37 113.118 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -76.48 132.27 39.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 2.2999999999999998 111.006 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.5 mt -93.95 133.07 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 1.0900000000000001 110.352 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.6 mt -128.24 138.95 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 1.1899999999999999 111.584 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -95.57 126.25 40.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.47999999999999998 109.881 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.54 143.97 27.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 1.8 111.872 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -167.1 13.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.75 . . . . 0.48999999999999999 111.202 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.559 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 90.5 m-20 -148.82 167.58 25.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.442 -0.947 . . . . 1.21 108.442 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.584 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.0 mt-30 -174.43 149.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.962 0.727 . . . . 1.1100000000000001 112.962 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -103.71 -35.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.206 -0.906 . . . . 1.1000000000000001 110.528 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -167.79 177.0 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.301 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.24 -5.77 3.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.588 -0.278 . . . . 2.9300000000000002 111.211 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -105.51 -60.36 1.63 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.282 . . . . 2.3599999999999999 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -91.89 127.37 37.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.486 -0.325 . . . . 2.6899999999999999 110.824 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 11.4 m-30 -110.96 171.57 7.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.803 0.335 . . . . 3.2799999999999998 110.986 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.0 mt-10 -142.85 147.76 35.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.218 0.532 . . . . 1.3200000000000001 111.578 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.99 -169.09 35.12 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.634 -0.712 . . . . 0.23999999999999999 112.195 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.0 ptt? -143.26 160.91 39.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.265 0.555 . . . . 1.9299999999999999 111.285 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.56 144.18 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.261 -0.882 . . . . 1.48 110.662 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 65.62 -79.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.018 -0.537 . . . . 3.0499999999999998 110.954 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.76 31.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.67 -0.776 . . . . 1.26 112.91 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -162.45 149.05 13.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 2.7599999999999998 111.514 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 90.9 p -115.02 169.93 8.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 1.26 110.728 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.65 172.76 44.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.847 -0.692 . . . . 0.29999999999999999 112.33 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -110.51 155.06 22.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.659 0.266 . . . . 1.55 111.306 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.91 121.47 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.738 -0.664 . . . . 4.3300000000000001 111.361 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 18.0 Cg_endo -59.5 170.16 3.53 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.812 2.341 . . . . 0.47999999999999998 113.196 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 54' ' ' TYR . 39.4 mt -58.49 -18.93 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.535 -0.757 . . . . 0.82999999999999996 111.28 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.31 7.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 2.2999999999999998 111.74 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 52' ' ' ILE . 31.4 t80 -124.68 -23.34 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 4.4699999999999998 111.479 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.8 m -137.1 176.87 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.279 0.561 . . . . 0.42999999999999999 111.908 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -125.47 97.22 5.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.284 -0.871 . . . . 2.0899999999999999 109.8 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 48.6 t -61.45 108.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 1.1799999999999999 111.366 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.423 HD11 ' NE ' ' A' ' 7' ' ' ARG . 50.0 mm -70.68 -35.51 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 1.3100000000000001 110.772 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -130.49 97.41 21.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.768 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.404 2.069 . . . . 1.6100000000000001 112.256 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.23 0.114 0 CA-C-O 120.881 0.284 . . . . 0.93000000000000005 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.5 m -137.96 165.4 26.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.595 . . . . 1.3400000000000001 110.422 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 p -146.27 174.97 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.27000000000000002 111.118 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -141.8 136.88 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.85 -0.614 . . . . 3.1299999999999999 111.161 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -75.53 143.52 30.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.867 -0.682 . . . . 0.27000000000000002 112.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -102.64 -31.58 10.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.865 0.364 . . . . 1.3400000000000001 110.895 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -115.57 146.41 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.2799999999999998 110.794 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.7 t70 -79.06 157.97 27.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.522 0.677 . . . . 2.0099999999999998 112.038 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.26 119.39 1.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.678 -1.146 . . . . 1.27 110.881 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -86.18 121.56 72.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.352 -0.385 . . . . 3.0 110.289 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 135.82 29.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.987 1.791 . . . . 1.3 112.233 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.81 -13.31 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 3.0600000000000001 110.989 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -133.55 130.92 39.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.232 -0.44 . . . . 2.1200000000000001 110.862 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -61.59 141.37 57.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 2.27 111.128 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.44 -22.44 17.51 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.985 -0.626 . . . . 0.54000000000000004 112.336 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt-10 -102.97 160.1 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 1.51 110.634 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 28' ' ' ILE . 15.0 mt -99.09 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.2 110.515 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.17 130.32 9.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.84999999999999998 112.977 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.43 -179.13 1.23 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 4.0800000000000001 110.688 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.29 174.99 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.198 0.523 . . . . 2.8399999999999999 111.591 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -53.34 148.91 8.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.394 -0.821 . . . . 2.2400000000000002 110.981 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.94 65.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.977 -0.63 . . . . 0.37 112.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.24 139.47 46.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 2.2999999999999998 110.82 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 43' ' ' ILE . 28.8 mm -112.62 130.29 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 1.0900000000000001 110.744 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 20' ' ' LEU . 62.8 mt -127.86 145.57 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.379 -0.373 . . . . 1.1899999999999999 110.788 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.9 p -87.48 133.5 33.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.47999999999999998 110.974 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 39' ' ' TYR . 20.3 tp -96.34 130.56 43.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.8 110.99 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.608 HG23 ' ND2' ' A' ' 32' ' ' ASN . 5.5 t -166.88 16.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.023 0.439 . . . . 0.48999999999999999 111.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.608 ' ND2' HG23 ' A' ' 31' ' ' THR . 58.1 m-80 -153.68 175.73 12.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.966 -0.753 . . . . 1.21 108.966 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.596 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.5 mt-30 -175.29 149.71 1.07 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.533 0.568 . . . . 1.1100000000000001 112.533 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 mm -108.37 -34.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.355 -0.838 . . . . 1.1000000000000001 110.916 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -157.86 171.19 20.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.722 -0.672 . . . . 1.73 110.422 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.94 -10.01 8.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.387 -0.369 . . . . 2.9300000000000002 111.112 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.58 -55.84 2.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.342 -0.39 . . . . 2.3599999999999999 111.128 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.2 m95 -86.91 125.22 33.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.519 -0.31 . . . . 2.6899999999999999 110.235 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 6.4 m-30 -102.0 177.78 4.8 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.938 0.399 . . . . 3.2799999999999998 111.095 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 27.8 mt-10 -146.82 138.42 24.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.363 0.601 . . . . 1.3200000000000001 111.284 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.19 -168.41 19.68 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.443 -0.799 . . . . 0.23999999999999999 111.66 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 8.1 mtt -137.93 155.19 49.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.506 0.669 . . . . 1.9299999999999999 111.372 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' GLY . 7.5 tp -140.31 153.83 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.837 -1.074 . . . . 1.48 109.166 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.444 ' N ' HG13 ' A' ' 43' ' ' ILE . 85.2 m-70 -30.81 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.653 0.596 . . . . 3.0499999999999998 111.951 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ILE . . . -78.93 -60.09 2.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.784 -0.722 . . . . 1.26 113.06 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.486 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -168.39 173.73 7.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.697 0.76 . . . . 2.7599999999999998 112.101 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 93.6 p -105.19 148.66 26.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.6 -1.182 . . . . 1.26 111.273 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.46 -172.6 36.26 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.29999999999999999 111.916 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' GLU . 52.2 p90 -105.26 158.1 16.84 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.974 0.387 . . . . 1.55 111.181 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -174.38 104.74 0.28 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.924 -0.58 . . . . 4.3300000000000001 110.836 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 13.1 Cg_endo -58.45 163.46 10.48 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.733 2.289 . . . . 0.47999999999999998 112.97 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 mt -65.97 -18.76 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.54 -0.755 . . . . 0.82999999999999996 111.204 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.07 -5.06 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 2.2999999999999998 111.642 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.17 -5.51 6.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.046 0.388 . . . . 4.4699999999999998 112.046 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG12 ' HA2' ' A' ' 8' ' ' GLY . 28.7 m -136.69 175.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.161 0.505 . . . . 0.42999999999999999 111.592 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 106.53 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.453 -0.794 . . . . 2.0899999999999999 109.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.22 123.8 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.1799999999999999 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mt -76.91 -53.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.985 -0.552 . . . . 1.3100000000000001 110.958 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -103.69 108.17 58.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.974 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.361 2.041 . . . . 1.6100000000000001 112.383 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.898 0.38 . . . . 6.4800000000000004 110.996 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -161.85 133.0 5.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 5.0999999999999996 110.702 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -134.33 87.55 32.7 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 3.4399999999999999 110.866 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.99 158.56 14.05 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.541 2.16 . . . . 0.93000000000000005 112.229 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 67.2 m -133.67 166.88 21.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 1.3400000000000001 111.284 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 21.9 p -145.86 174.84 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 0.27000000000000002 110.615 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -141.79 132.17 25.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.983 0.421 . . . . 3.1299999999999999 111.347 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.54 135.08 18.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.882 -0.675 . . . . 0.27000000000000002 112.934 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.4 mm? -84.35 -31.55 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.072 0.463 . . . . 1.3400000000000001 110.469 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -131.26 146.06 52.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 3.2799999999999998 110.476 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.5 p-10 -74.76 161.88 29.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.374 0.607 . . . . 2.0099999999999998 111.892 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 127.73 2.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.018 -0.992 . . . . 1.27 111.094 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.08 128.62 49.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.609 -0.515 . . . . 3.0 109.609 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 38.0 Cg_endo -66.29 130.56 24.25 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.08 1.853 . . . . 1.3 112.316 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.02 -16.61 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 3.0600000000000001 111.24 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -115.04 134.49 55.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 2.1200000000000001 110.797 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.35 135.82 57.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 2.27 111.101 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.65 -26.86 22.65 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.829 -0.7 . . . . 0.54000000000000004 112.726 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.56 166.68 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 1.51 110.676 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.501 HD11 HG22 ' A' ' 43' ' ' ILE . 20.1 tp -117.25 127.08 53.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.987 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -89.27 149.75 20.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.84999999999999998 112.534 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -174.68 169.72 3.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.645 0.259 . . . . 4.0800000000000001 110.796 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -124.87 -167.79 1.72 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.481 0.657 . . . . 2.8399999999999999 111.894 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 125.83 27.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.937 -1.029 . . . . 2.2400000000000002 110.692 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.45 81.94 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.37 112.593 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -71.06 122.22 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 2.2999999999999998 111.088 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.4 121.76 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.97 -0.559 . . . . 1.0900000000000001 110.603 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.3 mt -110.93 142.33 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 1.1899999999999999 111.314 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.3 p -96.35 113.17 24.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.47999999999999998 110.069 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.28 144.61 25.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.5 0.667 . . . . 1.8 112.698 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.5 t -167.47 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.766 -1.106 . . . . 0.48999999999999999 110.475 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.6 m-20 -144.01 -179.51 6.54 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.151 -1.055 . . . . 1.21 108.151 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.7 mt-30 -175.22 150.18 1.13 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 113.518 0.933 . . . . 1.1100000000000001 113.518 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HG3' ' A' ' 40' ' ' GLU . 30.9 mm -101.0 -45.72 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 114.787 -1.097 . . . . 1.1000000000000001 110.449 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -167.96 -170.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.531 -0.759 . . . . 1.73 110.623 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.36 -5.13 30.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.081 0.4 . . . . 2.9300000000000002 112.081 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -98.28 -56.12 2.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.628 0.232 . . . . 2.3599999999999999 111.628 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.768 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 p90 -120.97 133.86 55.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.174 0.512 . . . . 2.6899999999999999 111.733 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.2 m-30 -93.24 -177.16 4.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.458 -0.792 . . . . 3.2799999999999998 111.25 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.567 ' HG3' HG12 ' A' ' 34' ' ' ILE . 25.3 mt-10 -141.31 144.62 34.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 1.3200000000000001 111.764 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.43 -163.73 21.84 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.362 -0.836 . . . . 0.23999999999999999 111.444 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.7 mtm -137.81 154.78 49.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.294 0.569 . . . . 1.9299999999999999 111.588 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 20' ' ' LEU . 4.8 tp -140.21 123.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.185 -0.916 . . . . 1.48 110.042 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.8 t60 67.38 -75.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.069 -0.514 . . . . 3.0499999999999998 110.773 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.43 30.64 0.47 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 1.26 112.735 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -144.03 147.32 33.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.975 0.417 . . . . 2.7599999999999998 111.503 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.6 m -108.02 161.4 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 1.26 110.862 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.83 174.03 39.72 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.958 -0.639 . . . . 0.29999999999999999 112.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -104.28 153.85 20.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.862 0.331 . . . . 1.55 111.101 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.462 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 11.0 p90 -153.74 103.96 2.51 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.162 -0.472 . . . . 4.3300000000000001 111.817 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -49.3 144.76 16.77 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.98 2.454 . . . . 0.47999999999999998 112.429 177.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.7 mt -61.91 -22.69 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.612 -0.722 . . . . 0.82999999999999996 111.633 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -73.9 12.96 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.377 -0.374 . . . . 2.2999999999999998 111.775 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -132.92 -9.3 3.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.745 0.307 . . . . 4.4699999999999998 111.109 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 HG12 ' HA2' ' A' ' 8' ' ' GLY . 34.1 m -140.01 174.47 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.075 0.464 . . . . 0.42999999999999999 111.212 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -133.99 101.03 4.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 2.0899999999999999 109.676 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 57.8 t -60.4 116.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.077 -0.511 . . . . 1.1799999999999999 111.383 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.66 -48.11 67.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.688 -0.687 . . . . 1.3100000000000001 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.43 106.13 54.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 1.54 111.115 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.499 2.133 . . . . 1.6100000000000001 112.296 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 tpp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.976 0.417 . . . . 6.4800000000000004 110.676 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.87 135.66 37.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.035 -0.529 . . . . 5.0999999999999996 110.941 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -69.17 152.32 96.71 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.521 . . . . 3.4399999999999999 110.95 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.604 ' HA ' HG13 ' A' ' 59' ' ' VAL . 46.8 Cg_endo -68.62 124.33 11.44 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.48 2.12 . . . . 0.93000000000000005 112.271 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 74.2 m -135.79 178.83 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 1.3400000000000001 110.972 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.5 p -161.08 174.63 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.27000000000000002 111.025 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HG2' HG12 ' A' ' 27' ' ' ILE . 99.7 mtt180 -139.54 135.45 33.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.88 -0.6 . . . . 3.1299999999999999 111.408 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.84 128.78 9.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.839 -0.696 . . . . 0.27000000000000002 112.705 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.8 mm? -78.24 -36.68 46.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 1.3400000000000001 110.84 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.49 148.87 50.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 3.2799999999999998 110.953 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.6 p-10 -65.35 167.98 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.221 0.534 . . . . 2.0099999999999998 111.684 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.86 118.3 1.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 1.27 111.265 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -91.74 113.68 59.55 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.78 -0.646 . . . . 3.0 110.059 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 85.3 Cg_exo -46.64 130.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.485 2.124 . . . . 1.3 112.803 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.96 -28.97 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 3.0600000000000001 110.667 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -110.63 131.39 55.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 2.1200000000000001 110.79 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.85 124.65 21.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.27 110.931 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.09 -26.57 11.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 0.54000000000000004 112.525 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -76.51 165.91 24.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 1.51 110.763 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HB2' ' HA3' ' A' ' 48' ' ' GLY . 40.3 tp -112.56 135.33 53.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 1.2 111.174 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 14' ' ' PRO . . . -101.61 149.26 18.14 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.919 -0.657 . . . . 0.84999999999999998 112.092 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -175.0 156.38 2.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 4.0800000000000001 111.274 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -107.72 179.54 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 2.8399999999999999 111.052 179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -63.48 138.71 58.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.517 -0.765 . . . . 2.2400000000000002 110.796 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.11 -5.56 66.23 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.948 -0.644 . . . . 0.37 113.085 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.65 147.93 45.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.756 0.312 . . . . 2.2999999999999998 111.053 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.415 HG12 ' HG2' ' A' ' 7' ' ' ARG . 67.9 mt -111.27 134.07 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 1.0900000000000001 111.217 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD13 HD12 ' A' ' 43' ' ' ILE . 39.3 mm -126.22 141.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 1.1899999999999999 110.83 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.8 p -89.67 128.82 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.587 -0.278 . . . . 0.47999999999999998 110.445 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 31' ' ' THR . 2.6 tt -96.14 127.25 41.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.477 -0.329 . . . . 1.8 110.772 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.6 HG23 ' ND2' ' A' ' 32' ' ' ASN . 7.8 t -166.2 17.62 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.07 0.462 . . . . 0.48999999999999999 111.171 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.6 ' ND2' HG23 ' A' ' 31' ' ' THR . 56.1 m-80 -150.89 -179.46 7.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.942 -0.762 . . . . 1.21 108.942 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 32' ' ' ASN . 3.6 mt-30 -174.75 149.77 1.24 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 112.644 0.609 . . . . 1.1100000000000001 112.644 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 49' ' ' PHE . 45.9 mm -116.23 -29.59 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.315 -0.857 . . . . 1.1000000000000001 111.54 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -156.91 170.3 22.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.259 -0.428 . . . . 1.73 110.831 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -61.34 -26.14 67.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 2.9300000000000002 111.085 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.43 -38.66 8.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.27 -0.423 . . . . 2.3599999999999999 111.28 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -96.36 125.67 41.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.357 -0.383 . . . . 2.6899999999999999 110.815 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 18.6 m-30 -105.97 171.93 7.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.267 -0.424 . . . . 3.2799999999999998 110.087 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 40.0 tt0 -139.97 137.73 34.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.633 0.73 . . . . 1.3200000000000001 111.816 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.43 -176.14 23.15 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.04 -0.982 . . . . 0.23999999999999999 111.745 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -134.17 160.41 37.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.526 0.679 . . . . 1.9299999999999999 111.896 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 HD13 ' A' ' 28' ' ' ILE . 14.0 tt -155.91 140.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.684 -1.143 . . . . 1.48 109.745 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 64.31 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 3.0499999999999998 110.839 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.54 30.68 0.41 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.488 -0.863 . . . . 1.26 113.134 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -159.34 149.13 18.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.01 0.433 . . . . 2.7599999999999998 111.537 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 41.7 t -110.01 170.06 8.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 1.26 111.477 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 20' ' ' LEU . . . -176.49 166.1 36.83 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.904 -0.589 . . . . 0.29999999999999999 112.065 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HB3' HG13 ' A' ' 34' ' ' ILE . 21.4 p90 -99.07 157.34 16.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.822 0.344 . . . . 1.55 111.318 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.473 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 24.6 p90 -175.78 111.83 0.26 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 4.3300000000000001 111.428 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 6.1 Cg_endo -52.67 156.89 8.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.55 2.167 . . . . 0.47999999999999998 112.26 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.4 mt -60.01 -18.69 16.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.745 -0.662 . . . . 0.82999999999999996 111.389 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.13 -5.32 6.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 2.2999999999999998 111.885 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -117.64 -8.36 10.92 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.125 0.417 . . . . 4.4699999999999998 112.125 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.3 m -141.85 176.76 3.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.28 0.562 . . . . 0.42999999999999999 112.003 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 9.9 pt-20 -134.23 101.56 5.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 2.0899999999999999 109.989 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 94.0 t -59.13 114.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 1.1799999999999999 111.263 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.12 -41.41 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.042 -0.526 . . . . 1.3100000000000001 110.985 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.604 HG13 ' HA ' ' A' ' 4' ' ' PRO . 2.7 p -143.71 123.43 7.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.54 110.955 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.356 2.037 . . . . 1.6100000000000001 112.314 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.844 0.354 . . . . 6.4800000000000004 111.049 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -139.78 40.44 2.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 5.0999999999999996 110.691 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -103.21 130.39 23.71 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 3.4399999999999999 110.922 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 61.1 Cg_endo -72.28 127.84 13.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.416 2.077 . . . . 0.93000000000000005 112.238 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.2 p -141.29 151.51 43.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 1.3400000000000001 110.863 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 12.9 p -131.91 174.92 9.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.27000000000000002 110.986 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 58' ' ' ILE . 12.4 ptp180 -142.15 136.74 30.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 3.1299999999999999 110.945 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -77.45 137.49 20.39 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.73 -0.747 . . . . 0.27000000000000002 112.838 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.8 mm? -92.13 -33.07 14.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.926 0.393 . . . . 1.3400000000000001 110.734 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -125.36 146.2 49.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.866 -0.607 . . . . 3.2799999999999998 110.787 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 p-10 -77.76 161.76 27.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.308 0.575 . . . . 2.0099999999999998 111.835 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.63 133.02 2.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.101 -0.954 . . . . 1.27 111.453 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.1 86.75 11.99 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.927 -0.768 . . . . 3.0 108.927 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.65 134.87 39.66 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.515 2.143 . . . . 1.3 112.752 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 6.62 38.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 3.0600000000000001 110.636 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -115.75 134.31 55.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 2.1200000000000001 110.793 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.13 139.59 58.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 2.27 111.107 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.8 -25.72 12.72 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.925 -0.655 . . . . 0.54000000000000004 112.529 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HG2' ' CE1' ' A' ' 49' ' ' PHE . 6.8 mt-10 -88.83 161.86 16.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 1.51 110.708 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -100.25 122.12 42.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 1.2 110.522 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -103.08 134.97 12.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.84999999999999998 112.952 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -175.7 -170.3 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.693 0.282 . . . . 4.0800000000000001 110.703 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -132.55 172.87 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 2.8399999999999999 111.505 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -49.7 148.44 3.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 2.2400000000000002 110.818 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.77 -2.73 82.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.938 -0.649 . . . . 0.37 112.942 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -73.7 145.66 45.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.734 0.302 . . . . 2.2999999999999998 111.153 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -120.36 123.07 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 1.0900000000000001 110.252 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.9 mm -121.44 141.68 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.552 -0.294 . . . . 1.1899999999999999 111.454 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.3 p -85.52 129.99 34.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.36 -0.382 . . . . 0.47999999999999998 110.085 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 10.9 mp -96.24 132.86 41.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.121 0.486 . . . . 1.8 111.708 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.637 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.4 t -167.09 17.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.571 -0.741 . . . . 0.48999999999999999 110.739 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 31' ' ' THR . 57.9 m-80 -152.3 175.8 12.28 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.642 -0.873 . . . . 1.21 108.642 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.0 mt-30 -175.12 150.05 1.14 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.072 0.767 . . . . 1.1100000000000001 113.072 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.412 HG12 ' HG3' ' A' ' 40' ' ' GLU . 32.4 mm -103.65 -37.37 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.076 -0.966 . . . . 1.1000000000000001 110.915 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -168.08 175.94 6.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.616 . . . . 1.73 110.516 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.51 -10.96 5.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 2.9300000000000002 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.0 -54.99 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.18 -0.463 . . . . 2.3599999999999999 111.19 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.15 134.96 38.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 2.6899999999999999 111.257 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.566 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.2 m-85 -110.74 168.13 9.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 3.2799999999999998 110.253 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 35.5 mt-10 -137.71 142.31 41.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.504 0.668 . . . . 1.3200000000000001 112.076 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.2 -173.35 34.53 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.019 -0.991 . . . . 0.23999999999999999 111.474 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.428 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.6 ptm -143.35 161.1 39.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.447 0.642 . . . . 1.9299999999999999 111.558 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.58 133.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.144 -0.935 . . . . 1.48 110.36 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 83.3 t60 65.24 -78.81 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.104 -0.498 . . . . 3.0499999999999998 110.974 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.76 30.1 0.55 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 1.26 112.89 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.25 143.08 25.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.358 . . . . 2.7599999999999998 111.233 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 83.6 p -117.82 170.05 9.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.094 -0.503 . . . . 1.26 111.322 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.78 166.18 30.91 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.29999999999999999 111.896 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 19' ' ' GLU . 30.8 p90 -100.1 159.7 14.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.896 0.379 . . . . 1.55 111.154 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -171.51 112.0 0.4 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.942 -0.572 . . . . 4.3300000000000001 110.725 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.3 Cg_endo -58.07 157.55 24.71 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.618 2.212 . . . . 0.47999999999999998 112.569 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 mt -61.01 -18.42 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 0.82999999999999996 111.403 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.49 4.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 2.2999999999999998 111.999 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -135.42 -5.77 2.28 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.629 0.233 . . . . 4.4699999999999998 111.629 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.7 m -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.42999999999999999 111.32 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HB2' HD21 ' A' ' 9' ' ' LEU . 37.9 tt0 -135.01 102.78 5.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.49 -0.777 . . . . 2.0899999999999999 109.996 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.46 101.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.1799999999999999 110.912 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' A' ' 7' ' ' ARG . 59.4 mt -61.97 -35.91 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 1.3100000000000001 111.126 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 35.5 t -125.38 97.82 36.31 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 1.54 111.161 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo . . . . . 0 C--O 1.25 1.111 0 C-N-CA 122.446 2.097 . . . . 1.6100000000000001 112.265 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.803 0.335 . . . . 6.4800000000000004 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -99.82 13.63 33.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 5.0999999999999996 110.776 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 61.21 102.49 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.907 -0.588 . . . . 3.4399999999999999 111.26 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HA ' HG13 ' A' ' 59' ' ' VAL . 51.3 Cg_exo -53.82 135.68 63.53 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.442 2.094 . . . . 0.93000000000000005 112.248 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 83.9 m -127.25 176.29 7.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.428 . . . . 1.3400000000000001 111.074 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 16.6 p -155.46 174.73 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.891 -0.595 . . . . 0.27000000000000002 110.747 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -141.94 144.58 33.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.084 -0.507 . . . . 3.1299999999999999 111.23 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -78.21 135.66 16.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.929 -0.653 . . . . 0.27000000000000002 112.811 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.16 -36.56 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 1.3400000000000001 110.563 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -140.92 147.0 38.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.767 -0.652 . . . . 3.2799999999999998 110.496 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -58.17 159.45 5.91 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.235 0.54 . . . . 2.0099999999999998 111.698 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -160.64 127.05 4.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.205 -0.907 . . . . 1.27 111.28 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -98.43 133.3 22.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 3.0 109.493 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 73.6 Cg_endo -74.77 133.65 17.23 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.965 1.777 . . . . 1.3 112.449 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -83.33 -38.41 22.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 3.0600000000000001 110.896 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -132.06 173.64 11.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 2.1200000000000001 110.789 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -73.89 144.53 45.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 2.27 110.946 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.24 -27.19 11.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.804 -0.712 . . . . 0.54000000000000004 112.62 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.91 171.1 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.345 . . . . 1.51 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 tp -109.81 123.28 49.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.95 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.613 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -113.4 124.85 6.72 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.804 -0.712 . . . . 0.84999999999999998 112.598 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 13.3 m-85 -163.89 -169.66 1.94 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.69 0.281 . . . . 4.0800000000000001 110.662 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -125.06 173.02 8.99 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.456 0.646 . . . . 2.8399999999999999 112.018 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.91 149.2 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.068 -0.969 . . . . 2.2400000000000002 111.042 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.24 69.4 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.756 -0.656 . . . . 0.37 112.916 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' OD2' HD11 ' A' ' 28' ' ' ILE . 38.4 t70 -79.73 132.21 36.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.344 . . . . 2.2999999999999998 110.824 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 mm -99.42 128.13 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 1.0900000000000001 111.324 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.409 HD11 ' OD2' ' A' ' 26' ' ' ASP . 45.2 mm -128.54 142.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.005 -0.543 . . . . 1.1899999999999999 110.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.6 p -89.87 135.39 33.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.59 -0.277 . . . . 0.47999999999999998 110.519 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 39' ' ' TYR . 15.2 tp -96.33 132.92 41.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.325 -0.398 . . . . 1.8 110.781 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.435 HG23 ' OD1' ' A' ' 32' ' ' ASN . 8.9 t -166.72 17.24 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.48999999999999999 111.378 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 20.5 m120 -151.35 170.22 20.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.682 -0.859 . . . . 1.21 108.682 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mt-30 -174.94 149.62 1.15 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.689 0.625 . . . . 1.1100000000000001 112.689 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.6 mp -105.66 -32.88 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.184 -0.916 . . . . 1.1000000000000001 110.655 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -167.93 -170.92 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.81 -0.632 . . . . 1.73 110.785 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.46 -14.41 61.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.526 -0.306 . . . . 2.9300000000000002 111.419 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -101.3 -54.29 2.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 2.3599999999999999 111.62 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -95.22 126.57 40.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.853 0.359 . . . . 2.6899999999999999 111.035 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.615 ' HB3' HD11 ' A' ' 30' ' ' LEU . 14.4 m-30 -108.73 175.4 5.48 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.069 -0.514 . . . . 3.2799999999999998 110.501 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -150.76 143.86 24.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.47 0.652 . . . . 1.3200000000000001 111.974 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.18 -171.0 24.42 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.341 -0.845 . . . . 0.23999999999999999 111.855 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 24.7 ptt? -143.3 163.13 33.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.393 0.616 . . . . 1.9299999999999999 111.531 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 tp -144.58 126.12 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.009 -0.996 . . . . 1.48 110.415 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.1 t60 64.98 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.069 -0.514 . . . . 3.0499999999999998 111.106 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -154.89 31.51 0.67 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.596 -0.812 . . . . 1.26 112.874 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.36 135.12 19.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 2.7599999999999998 111.159 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 80.7 p -106.8 170.28 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.5 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.01 150.1 8.14 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 111.88 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -113.08 160.17 18.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.351 . . . . 1.55 111.404 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.409 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER 177.29 132.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.625 -0.716 . . . . 4.3300000000000001 110.841 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 1.6 Cg_endo -47.2 160.89 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.172 2.581 . . . . 0.47999999999999998 112.965 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.481 ' C ' ' H ' ' A' ' 54' ' ' TYR . 24.8 mt -58.03 -20.1 14.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.397 -0.819 . . . . 0.82999999999999996 111.693 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -66.12 7.26 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.564 -0.289 . . . . 2.2999999999999998 111.35 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HG13 ' A' ' 55' ' ' VAL . 9.7 t80 -116.41 -30.89 5.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.365 -0.38 . . . . 4.4699999999999998 111.233 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 ' HA2' ' A' ' 8' ' ' GLY . 15.8 m -141.48 175.61 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.39 0.614 . . . . 0.42999999999999999 111.861 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.43 113.37 8.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.248 -0.887 . . . . 2.0899999999999999 109.604 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 6.1 p -55.04 120.95 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 1.1799999999999999 111.181 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.8 mt -80.83 -47.14 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.737 -0.665 . . . . 1.3100000000000001 111.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 4' ' ' PRO . 3.2 p -126.74 111.41 22.51 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.254 -0.43 . . . . 1.54 111.038 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.518 2.145 . . . . 1.6100000000000001 112.487 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.801 0.334 . . . . 6.4800000000000004 110.836 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -69.04 117.98 11.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 5.0999999999999996 110.885 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 56.3 tp60 -88.39 -49.39 0.42 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.082 -0.508 . . . . 3.4399999999999999 111.565 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 3' ' ' GLN . 32.8 Cg_exo -59.51 123.88 14.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.109 1.872 . . . . 0.93000000000000005 112.185 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.83 169.46 19.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.904 0.383 . . . . 1.3400000000000001 111.337 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 30' ' ' LEU . 16.3 p -150.17 175.19 11.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.27000000000000002 110.64 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HD2' ' HA2' ' A' ' 25' ' ' GLY . 37.4 ttp180 -139.67 121.44 15.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 3.1299999999999999 111.178 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -70.41 135.58 25.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 0.27000000000000002 112.542 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -84.27 -31.26 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.3400000000000001 110.717 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -125.53 154.04 42.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.81 -0.632 . . . . 3.2799999999999998 110.857 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.93 147.88 24.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.203 -0.453 . . . . 2.0099999999999998 110.341 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.93 133.58 17.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 1.27 111.366 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -94.19 132.02 30.17 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 3.0 109.801 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -50.49 129.54 26.76 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.317 2.012 . . . . 1.3 112.331 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -122.04 -34.13 3.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 3.0600000000000001 110.924 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -111.21 159.38 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 2.1200000000000001 110.972 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -77.95 124.08 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 2.27 110.936 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.33 -20.14 35.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.938 -0.649 . . . . 0.54000000000000004 112.561 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.62 165.28 25.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 1.51 110.541 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.3 tp -113.49 134.59 54.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 1.2 111.126 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.55 148.37 16.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.944 -0.646 . . . . 0.84999999999999998 112.03 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -170.07 -172.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 4.0800000000000001 111.219 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -133.68 -179.7 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 2.8399999999999999 111.425 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.05 138.78 58.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.28 -0.873 . . . . 2.2400000000000002 110.15 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 7' ' ' ARG . . . 81.57 -19.13 9.43 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.768 -0.729 . . . . 0.37 112.623 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 18.6 t70 -60.75 126.26 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 2.2999999999999998 111.077 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.484 ' O ' HD13 ' A' ' 43' ' ' ILE . 66.2 mt -93.77 126.69 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 1.0900000000000001 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.98 143.85 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 1.1899999999999999 111.24 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.6 p -92.69 127.73 38.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.359 -0.382 . . . . 0.47999999999999998 110.464 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 8.4 mp -96.59 133.3 41.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 1.8 111.484 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -166.97 14.23 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.48999999999999999 111.591 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 89.9 m-20 -151.09 179.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.53 -0.915 . . . . 1.21 108.53 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.588 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 5.4 mt-30 -174.76 149.89 1.24 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 112.871 0.693 . . . . 1.1100000000000001 112.871 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 38' ' ' TRP . 47.9 mm -109.66 -32.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.057 -0.974 . . . . 1.1000000000000001 111.018 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.11 167.38 12.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 1.73 110.627 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.17 -8.84 6.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.41 -0.359 . . . . 2.9300000000000002 110.875 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -96.19 -52.77 3.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.133 -0.485 . . . . 2.3599999999999999 110.981 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.795 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -115.58 134.47 55.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 2.6899999999999999 111.257 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 39.8 p90 -100.32 -177.98 3.68 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.986 -0.552 . . . . 3.2799999999999998 111.221 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 38.2 tt0 -144.67 137.02 26.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.396 0.617 . . . . 1.3200000000000001 111.563 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.31 -161.81 10.97 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.23999999999999999 111.734 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 23.6 ptp -143.37 156.68 44.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 1.9299999999999999 111.493 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.77 132.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.261 -0.881 . . . . 1.48 110.306 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 65.38 -77.27 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.09 -0.504 . . . . 3.0499999999999998 111.275 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.53 31.58 0.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.568 -0.825 . . . . 1.26 112.997 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.14 144.76 23.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 2.7599999999999998 111.343 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 44.7 t -107.5 168.73 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 1.26 111.278 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.45 170.06 35.82 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.793 -0.639 . . . . 0.29999999999999999 111.875 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 24.5 p90 -111.61 158.55 19.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.722 0.296 . . . . 1.55 111.29 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -173.06 122.79 0.43 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.217 -0.447 . . . . 4.3300000000000001 111.713 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.795 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 84.2 Cg_exo -44.85 139.17 8.0 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.18 2.587 . . . . 0.47999999999999998 113.258 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 52' ' ' ILE . 22.0 mt -64.04 -18.64 23.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.328 -0.851 . . . . 0.82999999999999996 111.581 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.61 -6.57 3.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 2.2999999999999998 112.213 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -117.37 12.07 14.15 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.298 0.481 . . . . 4.4699999999999998 112.298 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 23.0 m -144.7 175.58 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.21 0.529 . . . . 0.42999999999999999 111.457 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.2 tp10 -133.49 96.47 3.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 2.0899999999999999 109.804 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.0 p -55.82 118.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 1.1799999999999999 111.226 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -73.16 -36.34 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 1.3100000000000001 110.968 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.508 HG13 ' HA ' ' A' ' 4' ' ' PRO . 7.1 p -150.76 131.71 7.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 1.54 110.865 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.355 2.037 . . . . 1.6100000000000001 112.248 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.812 0.339 . . . . 6.4800000000000004 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.5 t70 56.99 25.39 10.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 5.0999999999999996 111.018 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 15.6 mm100 -94.81 -49.41 0.26 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.132 -0.485 . . . . 3.4399999999999999 111.535 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 51.3 Cg_exo -54.9 132.86 54.61 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.151 1.9 . . . . 0.93000000000000005 112.205 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 29' ' ' THR . 83.4 m -144.81 179.43 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.3400000000000001 111.087 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 20.6 p -155.45 174.33 15.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.912 -0.585 . . . . 0.27000000000000002 110.491 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.545 ' HE ' HD11 ' A' ' 58' ' ' ILE . 8.1 ptp180 -142.49 133.19 25.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 3.1299999999999999 111.46 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -73.23 137.63 24.13 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.839 -0.696 . . . . 0.27000000000000002 112.894 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -87.55 -28.76 21.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.399 . . . . 1.3400000000000001 110.754 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -136.92 146.8 45.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.56 . . . . 3.2799999999999998 110.685 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.9 t70 -67.61 160.31 28.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 2.0099999999999998 111.602 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.18 119.4 1.52 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.014 -0.994 . . . . 1.27 110.835 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -81.73 135.54 49.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 3.0 109.841 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 45.9 Cg_endo -69.4 138.7 39.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 1.3 112.431 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -126.0 -45.85 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 3.0600000000000001 110.996 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.62 153.33 20.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.927 0.394 . . . . 2.1200000000000001 111.121 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -77.51 124.97 28.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 2.27 111.023 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.07 -2.62 35.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.716 . . . . 0.54000000000000004 112.807 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -95.81 165.75 12.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 1.51 110.813 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HG ' ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -106.91 119.22 38.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 1.2 111.059 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.524 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -105.76 135.39 12.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.835 -0.698 . . . . 0.84999999999999998 112.559 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.99 -173.55 0.7 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.734 0.302 . . . . 4.0800000000000001 110.935 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -121.0 174.67 6.48 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.363 0.601 . . . . 2.8399999999999999 111.962 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.21 149.36 12.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 2.2400000000000002 110.983 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.64 -11.31 62.03 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.962 -0.637 . . . . 0.37 112.586 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.02 126.32 30.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.817 0.342 . . . . 2.2999999999999998 110.606 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' O ' HD13 ' A' ' 43' ' ' ILE . 41.6 mt -100.34 108.22 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 1.0900000000000001 111.382 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.461 HD13 HD13 ' A' ' 20' ' ' LEU . 77.9 mt -96.46 139.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.1899999999999999 111.105 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' SG ' ' A' ' 5' ' ' CYS . 42.8 p -90.67 120.3 31.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.47999999999999998 110.321 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -95.61 142.66 27.67 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.381 0.61 . . . . 1.8 112.512 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.526 HG23 ' ND2' ' A' ' 32' ' ' ASN . 9.7 t -167.65 17.42 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.069 -0.969 . . . . 0.48999999999999999 110.748 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 58.2 m-80 -149.6 176.37 10.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.473 -0.936 . . . . 1.21 108.473 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.3 mt-30 -175.28 149.8 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.751 0.649 . . . . 1.1100000000000001 112.751 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.7 mp -109.21 -28.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.435 -0.802 . . . . 1.1000000000000001 110.488 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.87 166.68 21.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 1.73 110.485 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.12 -12.16 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 2.9300000000000002 111.09 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -103.92 -57.7 1.99 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 2.3599999999999999 110.979 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.2 m95 -87.55 125.52 34.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.415 -0.357 . . . . 2.6899999999999999 110.571 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 3.3 m-85 -102.78 178.48 4.56 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.832 0.349 . . . . 3.2799999999999998 110.67 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 32' ' ' ASN . 36.5 tt0 -151.27 140.1 20.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.229 0.538 . . . . 1.3200000000000001 111.834 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.4 -159.04 11.61 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.464 -0.789 . . . . 0.23999999999999999 111.736 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.97 156.93 46.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.332 0.587 . . . . 1.9299999999999999 111.442 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 27' ' ' ILE . 5.4 tp -145.02 128.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.186 -0.916 . . . . 1.48 110.07 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 67.29 -76.23 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 3.0499999999999998 110.688 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.31 29.7 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 1.26 112.804 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -144.83 147.69 33.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 2.7599999999999998 111.465 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -109.33 162.99 13.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.845 -0.616 . . . . 1.26 111.15 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' HG ' ' A' ' 20' ' ' LEU . . . 172.75 173.16 39.05 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.926 -0.654 . . . . 0.29999999999999999 112.386 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.17 162.34 13.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.735 0.302 . . . . 1.55 111.187 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -178.36 106.05 0.21 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.903 -0.59 . . . . 4.3300000000000001 110.812 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 15.5 Cg_endo -59.46 159.94 21.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.725 2.283 . . . . 0.47999999999999998 113.3 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.77 -18.35 22.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.427 -0.806 . . . . 0.82999999999999996 111.034 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -62.87 -2.27 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 2.2999999999999998 111.78 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -131.71 -4.48 3.66 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.749 0.277 . . . . 4.4699999999999998 111.749 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.7 m -139.83 174.32 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.16 0.505 . . . . 0.42999999999999999 111.216 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' A' ' 9' ' ' LEU . 10.0 tp10 -134.34 105.0 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 2.0899999999999999 109.91 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 45.9 t -55.69 122.08 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 1.1799999999999999 111.179 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD11 ' HE ' ' A' ' 7' ' ' ARG . 58.0 mt -85.04 -38.24 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 1.3100000000000001 111.222 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 39.6 t -110.22 115.57 54.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 1.54 111.205 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--O 1.248 1.004 0 C-N-CA 122.426 2.084 . . . . 1.6100000000000001 112.28 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.735 0.302 . . . . 6.4800000000000004 110.855 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 57.12 -161.31 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 5.0999999999999996 111.002 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 66.87 143.62 0.09 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.041 -0.527 . . . . 3.4399999999999999 111.176 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.39 132.58 27.81 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.425 2.084 . . . . 0.93000000000000005 112.342 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.73 179.64 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 1.3400000000000001 110.825 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 p -163.18 174.78 11.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.27000000000000002 110.963 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -142.13 134.39 27.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 3.1299999999999999 111.305 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 55' ' ' VAL . . . -76.56 139.11 23.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.807 -0.711 . . . . 0.27000000000000002 112.609 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 56' ' ' GLU . 3.9 mm? -97.32 -32.06 12.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 1.3400000000000001 110.893 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -122.67 146.48 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.904 -0.589 . . . . 3.2799999999999998 110.728 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -76.82 167.21 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.405 0.622 . . . . 2.0099999999999998 111.956 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.99 119.44 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.015 -0.993 . . . . 1.27 110.963 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -81.9 128.49 68.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 3.0 110.298 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.06 129.91 33.99 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.315 2.01 . . . . 1.3 112.496 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HG3' ' ND2' ' A' ' 16' ' ' ASN . 11.8 pt-20 -151.64 -35.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.06 -0.518 . . . . 3.0600000000000001 110.681 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.424 ' ND2' ' HG3' ' A' ' 15' ' ' GLU . 39.5 m-80 -90.83 137.13 32.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.115 -0.493 . . . . 2.1200000000000001 110.772 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -74.0 121.57 21.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 2.27 110.996 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.23 14.15 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.54000000000000004 112.626 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 20' ' ' LEU . 29.1 tt0 -81.23 168.21 18.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 1.51 110.713 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 28' ' ' ILE . 30.8 tp -116.72 132.58 56.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 1.2 110.853 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.42 141.71 16.99 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.671 -0.776 . . . . 0.84999999999999998 112.725 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HD1' ' H ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -175.24 -176.11 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.433 -0.21 . . . . 4.0800000000000001 110.433 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -118.78 169.79 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.27 0.557 . . . . 2.8399999999999999 112.034 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -48.76 149.38 1.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.162 -0.926 . . . . 2.2400000000000002 111.34 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.23 -6.0 69.75 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.37 113.023 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -73.94 124.17 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 2.2999999999999998 111.117 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -92.79 125.18 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 1.0900000000000001 110.74 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 43' ' ' ILE . 62.5 mt -123.92 135.5 63.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 1.1899999999999999 111.401 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -95.9 116.67 29.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.47999999999999998 109.928 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 pp -94.94 149.56 21.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.369 0.604 . . . . 1.8 112.393 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 t -167.48 17.13 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.029 -0.987 . . . . 0.48999999999999999 110.787 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 14.0 m120 -147.99 -179.99 7.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.437 -0.949 . . . . 1.21 108.437 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.7 mt-30 -175.28 149.85 1.09 Allowed 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 112.523 0.564 . . . . 1.1100000000000001 112.523 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.58 -23.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.404 -0.816 . . . . 1.1000000000000001 111.032 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -166.95 165.06 16.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 1.73 110.464 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' OE2' ' HB2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -61.95 -7.1 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 2.9300000000000002 110.79 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.402 ' HB2' ' OE2' ' A' ' 36' ' ' GLU . 50.5 t-20 -110.22 -51.99 2.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 2.3599999999999999 110.617 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.4 m95 -92.67 125.94 37.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.472 -0.331 . . . . 2.6899999999999999 110.525 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.587 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 4.0 m-30 -100.08 177.16 5.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.887 0.375 . . . . 3.2799999999999998 110.918 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -147.4 137.41 23.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.96 -0.563 . . . . 1.3200000000000001 111.265 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.33 -158.9 14.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.585 -0.734 . . . . 0.23999999999999999 111.859 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 mtm -141.12 148.94 40.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 1.9299999999999999 111.494 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 28' ' ' ILE . 12.3 tt -126.43 118.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.556 -0.747 . . . . 1.48 110.08 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.9 t60 67.89 -73.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 3.0499999999999998 110.716 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.01 27.5 0.51 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.663 -0.78 . . . . 1.26 112.832 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -136.68 142.05 43.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.71 0.29 . . . . 2.7599999999999998 111.222 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.6 p -105.8 155.54 19.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 1.26 111.016 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.8 169.59 38.29 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.796 -0.716 . . . . 0.29999999999999999 112.552 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -97.6 151.14 20.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.55 0.214 . . . . 1.55 110.566 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 16.0 p90 -167.93 103.97 0.56 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.002 0.371 . . . . 4.3300000000000001 112.002 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 10.5 Cg_endo -57.64 165.1 6.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.516 2.144 . . . . 0.47999999999999998 112.415 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 52' ' ' ILE . 19.0 mt -66.26 -20.78 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.82999999999999996 111.64 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -69.89 2.06 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.59 -0.277 . . . . 2.2999999999999998 111.555 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -124.62 -11.8 7.25 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 4.4699999999999998 111.341 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 34.7 m -140.21 177.05 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.309 0.576 . . . . 0.42999999999999999 111.772 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -137.64 102.39 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.359 -0.837 . . . . 2.0899999999999999 109.749 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.37 117.46 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 111.244 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.68 -47.08 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.99 -0.55 . . . . 1.3100000000000001 111.146 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.83 97.68 9.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.371 -0.377 . . . . 1.54 111.317 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.58 2.186 . . . . 1.6100000000000001 112.174 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.71 0.291 . . . . 6.4800000000000004 110.713 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.07 142.41 38.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 5.0999999999999996 110.855 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -141.08 129.67 12.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 3.4399999999999999 110.759 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.512 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 59.0 Cg_endo -71.21 132.73 21.54 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.405 2.07 . . . . 0.93000000000000005 112.182 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.7 m -140.71 169.82 16.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 1.3400000000000001 111.196 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 21.1 p -144.93 174.67 10.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.27000000000000002 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.532 ' HG2' HG12 ' A' ' 27' ' ' ILE . 91.1 mtt180 -138.9 137.43 36.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 3.1299999999999999 111.414 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -74.61 136.47 21.03 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.952 -0.642 . . . . 0.27000000000000002 112.921 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 56' ' ' GLU . 4.5 mm? -82.85 -29.78 29.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 1.3400000000000001 110.724 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -149.11 155.04 40.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.877 -0.601 . . . . 3.2799999999999998 110.859 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.8 p30 -70.55 166.36 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.586 0.708 . . . . 2.0099999999999998 112.8 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.33 130.76 2.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.589 -1.187 . . . . 1.27 111.06 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -111.7 88.86 10.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.641 -0.709 . . . . 3.0 109.961 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 156.78 6.56 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.747 2.298 . . . . 1.3 112.576 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.52 9.03 10.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 3.0600000000000001 110.794 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 17' ' ' GLN . 2.8 t-20 -138.94 154.66 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 2.1200000000000001 110.827 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.447 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 7.5 tt0 -78.37 141.8 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 2.27 110.922 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.29 -27.45 10.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.995 -0.622 . . . . 0.54000000000000004 112.299 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -85.18 163.58 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 28' ' ' ILE . 17.3 tp -107.66 113.13 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 1.2 111.044 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.56 140.75 15.21 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.935 -0.65 . . . . 0.84999999999999998 112.641 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.82 -170.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 4.0800000000000001 110.942 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -132.14 168.11 18.57 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 2.8399999999999999 111.546 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.71 148.6 1.47 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.606 -0.724 . . . . 2.2400000000000002 110.935 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.48 78.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.826 -0.625 . . . . 0.37 112.908 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.8 p-10 -76.98 138.69 39.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.677 0.275 . . . . 2.2999999999999998 110.774 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 7' ' ' ARG . 66.5 mt -107.61 127.58 63.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.409 -0.36 . . . . 1.0900000000000001 110.836 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 HD23 ' A' ' 20' ' ' LEU . 37.9 mt -123.57 139.83 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 1.1899999999999999 111.508 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.0 p -86.19 127.94 34.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.47999999999999998 110.2 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 39' ' ' TYR . 24.2 tp -96.29 127.81 42.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.41 . . . . 1.8 111.513 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.6 HG23 ' ND2' ' A' ' 32' ' ' ASN . 12.5 t -166.99 17.14 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.369 -0.378 . . . . 0.48999999999999999 111.586 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.6 ' ND2' HG23 ' A' ' 31' ' ' THR . 57.8 m-80 -149.7 175.19 11.8 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.775 -0.824 . . . . 1.21 108.775 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 4.3 mt-30 -175.1 150.34 1.18 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.085 0.772 . . . . 1.1100000000000001 113.085 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.9 mm -109.04 -32.03 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.194 -0.912 . . . . 1.1000000000000001 110.917 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -165.51 170.92 13.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 1.73 110.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.28 -10.88 5.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 2.9300000000000002 111.106 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.11 -55.34 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 2.3599999999999999 111.109 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.698 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -91.86 127.37 37.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.432 -0.349 . . . . 2.6899999999999999 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 2.8 m-85 -106.89 172.17 6.97 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.274 -0.421 . . . . 3.2799999999999998 111.082 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -140.58 145.69 37.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.526 0.679 . . . . 1.3200000000000001 112.11 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.04 -171.69 28.49 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.157 -0.929 . . . . 0.23999999999999999 111.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.481 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 17.3 mtm -134.4 156.78 47.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.234 0.54 . . . . 1.9299999999999999 111.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' N ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -146.97 131.44 10.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.298 -0.864 . . . . 1.48 109.952 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.605 ' N ' HD13 ' A' ' 43' ' ' ILE . 73.3 t60 64.33 -78.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.164 -0.471 . . . . 3.0499999999999998 111.007 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.08 31.62 0.54 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.758 . . . . 1.26 112.917 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.57 148.41 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.018 0.437 . . . . 2.7599999999999998 111.211 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 42' ' ' MET . 85.9 p -105.75 169.71 8.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 1.26 111.481 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.58 169.55 42.06 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.745 -0.661 . . . . 0.29999999999999999 111.941 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -114.37 158.66 21.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.888 0.344 . . . . 1.55 111.326 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER 176.06 119.97 0.14 Allowed Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.735 -0.666 . . . . 4.3300000000000001 111.312 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 9.2 Cg_endo -52.66 162.83 2.17 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.47999999999999998 113.418 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 54' ' ' TYR . 25.7 mt -62.98 -23.29 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 115.369 -0.832 . . . . 0.82999999999999996 112.116 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -69.57 8.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.654 0.264 . . . . 2.2999999999999998 111.523 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 52' ' ' ILE . 45.0 t80 -114.63 -24.55 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.8 0.333 . . . . 4.4699999999999998 111.09 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 8' ' ' GLY . 27.8 m -138.15 179.5 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.42999999999999999 111.785 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HB2' HD21 ' A' ' 9' ' ' LEU . 11.2 tp10 -134.36 102.07 5.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.244 -0.889 . . . . 2.0899999999999999 109.896 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 40.0 t -64.59 112.63 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 1.1799999999999999 111.201 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.08 -49.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 1.3100000000000001 111.06 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 4' ' ' PRO . 59.9 t -100.38 123.83 45.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 1.54 110.916 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' VAL . 35.2 Cg_exo . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.421 2.081 . . . . 1.6100000000000001 112.257 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.79 0.328 . . . . 6.4800000000000004 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.13 130.54 53.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -135.75 86.77 26.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 3.4399999999999999 110.871 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.64 124.63 12.63 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.49 2.127 . . . . 0.93000000000000005 112.36 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.8 m -128.48 161.08 30.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 1.3400000000000001 110.804 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 19.7 p -150.67 174.08 13.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.089 0.471 . . . . 0.27000000000000002 111.252 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' NE ' HD11 ' A' ' 58' ' ' ILE . 34.3 ptt180 -141.68 128.03 19.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.689 -0.687 . . . . 3.1299999999999999 110.977 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -56.15 144.7 35.49 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.984 -0.626 . . . . 0.27000000000000002 113.007 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mt -100.46 -38.95 8.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.123 0.487 . . . . 1.3400000000000001 111.468 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -135.02 147.94 49.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 3.2799999999999998 110.475 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 1.3 p-10 -64.59 161.07 18.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.418 0.628 . . . . 2.0099999999999998 112.126 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -164.83 121.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.799 -1.091 . . . . 1.27 110.807 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' OE2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 tp10 -92.75 125.1 56.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 3.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.501 ' HD3' ' HA3' ' A' ' 21' ' ' GLY . 71.5 Cg_exo -46.38 135.49 15.72 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.42 2.08 . . . . 1.3 112.565 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 45.5 mt-10 -133.28 -38.68 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.0600000000000001 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -111.73 133.36 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 2.1200000000000001 110.746 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -58.54 127.4 31.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 2.27 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.89 -27.29 15.01 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.784 -0.722 . . . . 0.54000000000000004 112.372 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.52 165.32 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.67 0.271 . . . . 1.51 110.411 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.3 tp -108.08 134.25 51.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 1.2 111.304 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.501 ' HA3' ' HD3' ' A' ' 14' ' ' PRO . . . -125.05 132.67 8.18 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.841 -0.695 . . . . 0.84999999999999998 112.668 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -166.92 -173.9 2.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.581 0.229 . . . . 4.0800000000000001 110.437 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -120.4 166.77 13.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.236 0.541 . . . . 2.8399999999999999 111.818 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.53 148.8 3.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.305 -0.862 . . . . 2.2400000000000002 111.352 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.55 -5.69 67.88 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 115.72 -0.673 . . . . 0.37 113.118 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -76.48 132.27 39.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.371 . . . . 2.2999999999999998 111.006 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.5 mt -93.95 133.07 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 1.0900000000000001 110.352 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.6 mt -128.24 138.95 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 1.1899999999999999 111.584 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -95.57 126.25 40.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.47999999999999998 109.881 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.54 143.97 27.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.07 0.462 . . . . 1.8 111.872 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -167.1 13.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.549 -0.75 . . . . 0.48999999999999999 111.202 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.559 ' O ' ' HG3' ' A' ' 33' ' ' GLN . 90.5 m-20 -148.82 167.58 25.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.442 -0.947 . . . . 1.21 108.442 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.584 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.0 mt-30 -174.43 149.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.962 0.727 . . . . 1.1100000000000001 112.962 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.0 mp -103.71 -35.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.206 -0.906 . . . . 1.1000000000000001 110.528 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -167.79 177.0 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 1.73 110.301 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.24 -5.77 3.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.588 -0.278 . . . . 2.9300000000000002 111.211 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -105.51 -60.36 1.63 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.282 . . . . 2.3599999999999999 110.976 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -91.89 127.37 37.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.486 -0.325 . . . . 2.6899999999999999 110.824 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 11.4 m-30 -110.96 171.57 7.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.803 0.335 . . . . 3.2799999999999998 110.986 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 32' ' ' ASN . 5.0 mt-10 -142.85 147.76 35.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.218 0.532 . . . . 1.3200000000000001 111.578 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.99 -169.09 35.12 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.634 -0.712 . . . . 0.23999999999999999 112.195 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 27.0 ptt? -143.26 160.91 39.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.265 0.555 . . . . 1.9299999999999999 111.285 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.56 144.18 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.261 -0.882 . . . . 1.48 110.662 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 65.62 -79.22 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.018 -0.537 . . . . 3.0499999999999998 110.954 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.76 31.55 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.67 -0.776 . . . . 1.26 112.91 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -162.45 149.05 13.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.114 0.483 . . . . 2.7599999999999998 111.514 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 42' ' ' MET . 90.9 p -115.02 169.93 8.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 1.26 110.728 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.65 172.76 44.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.847 -0.692 . . . . 0.29999999999999999 112.33 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -110.51 155.06 22.8 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.659 0.266 . . . . 1.55 111.306 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.91 121.47 0.1 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.738 -0.664 . . . . 4.3300000000000001 111.361 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 18.0 Cg_endo -59.5 170.16 3.53 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.812 2.341 . . . . 0.47999999999999998 113.196 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.443 ' C ' ' H ' ' A' ' 54' ' ' TYR . 39.4 mt -58.49 -18.93 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.535 -0.757 . . . . 0.82999999999999996 111.28 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.31 7.5 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.415 . . . . 2.2999999999999998 111.74 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 52' ' ' ILE . 31.4 t80 -124.68 -23.34 4.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.586 0.231 . . . . 4.4699999999999998 111.479 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 8' ' ' GLY . 35.8 m -137.1 176.87 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.279 0.561 . . . . 0.42999999999999999 111.908 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -125.47 97.22 5.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.284 -0.871 . . . . 2.0899999999999999 109.8 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 48.6 t -61.45 108.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 1.1799999999999999 111.366 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.423 HD11 ' NE ' ' A' ' 7' ' ' ARG . 50.0 mm -70.68 -35.51 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 1.3100000000000001 110.772 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -130.49 97.41 21.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.768 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.404 2.069 . . . . 1.6100000000000001 112.256 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttm . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.949 0.404 . . . . 6.4800000000000004 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -76.22 126.05 30.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 5.0999999999999996 110.823 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -103.84 135.32 19.37 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 3.4399999999999999 110.842 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.29 150.25 52.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.433 2.089 . . . . 0.93000000000000005 112.566 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.5 m -137.96 165.4 26.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.595 . . . . 1.3400000000000001 110.422 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 p -146.27 174.97 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.27000000000000002 111.118 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -141.8 136.88 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.85 -0.614 . . . . 3.1299999999999999 111.161 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.489 ' HA2' HG12 ' A' ' 55' ' ' VAL . . . -75.53 143.52 30.46 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.867 -0.682 . . . . 0.27000000000000002 112.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -102.64 -31.58 10.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.865 0.364 . . . . 1.3400000000000001 110.895 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -115.57 146.41 41.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.2799999999999998 110.794 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.7 t70 -79.06 157.97 27.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.522 0.677 . . . . 2.0099999999999998 112.038 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.26 119.39 1.25 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.678 -1.146 . . . . 1.27 110.881 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -86.18 121.56 72.63 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.352 -0.385 . . . . 3.0 110.289 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.69 135.82 29.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.987 1.791 . . . . 1.3 112.233 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -130.81 -13.31 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 3.0600000000000001 110.989 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -133.55 130.92 39.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.232 -0.44 . . . . 2.1200000000000001 110.862 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -61.59 141.37 57.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.476 . . . . 2.27 111.128 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.44 -22.44 17.51 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.985 -0.626 . . . . 0.54000000000000004 112.336 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt-10 -102.97 160.1 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 1.51 110.634 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 28' ' ' ILE . 15.0 mt -99.09 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.2 110.515 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.17 130.32 9.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.84999999999999998 112.977 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.43 -179.13 1.23 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 4.0800000000000001 110.688 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.29 174.99 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.198 0.523 . . . . 2.8399999999999999 111.591 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -53.34 148.91 8.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.394 -0.821 . . . . 2.2400000000000002 110.981 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.94 65.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.977 -0.63 . . . . 0.37 112.834 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.24 139.47 46.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 2.2999999999999998 110.82 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 43' ' ' ILE . 28.8 mm -112.62 130.29 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 1.0900000000000001 110.744 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 20' ' ' LEU . 62.8 mt -127.86 145.57 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.379 -0.373 . . . . 1.1899999999999999 110.788 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.9 p -87.48 133.5 33.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.47999999999999998 110.974 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 39' ' ' TYR . 20.3 tp -96.34 130.56 43.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.8 110.99 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.608 HG23 ' ND2' ' A' ' 32' ' ' ASN . 5.5 t -166.88 16.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.023 0.439 . . . . 0.48999999999999999 111.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.608 ' ND2' HG23 ' A' ' 31' ' ' THR . 58.1 m-80 -153.68 175.73 12.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.966 -0.753 . . . . 1.21 108.966 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.596 ' HG2' ' HA ' ' A' ' 39' ' ' TYR . 3.5 mt-30 -175.29 149.71 1.07 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.533 0.568 . . . . 1.1100000000000001 112.533 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 mm -108.37 -34.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 115.355 -0.838 . . . . 1.1000000000000001 110.916 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -157.86 171.19 20.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.722 -0.672 . . . . 1.73 110.422 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.94 -10.01 8.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.387 -0.369 . . . . 2.9300000000000002 111.112 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.58 -55.84 2.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.342 -0.39 . . . . 2.3599999999999999 111.128 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.2 m95 -86.91 125.22 33.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.519 -0.31 . . . . 2.6899999999999999 110.235 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 6.4 m-30 -102.0 177.78 4.8 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.938 0.399 . . . . 3.2799999999999998 111.095 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB2' ' N ' ' A' ' 33' ' ' GLN . 27.8 mt-10 -146.82 138.42 24.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.363 0.601 . . . . 1.3200000000000001 111.284 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.19 -168.41 19.68 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.443 -0.799 . . . . 0.23999999999999999 111.66 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 8.1 mtt -137.93 155.19 49.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.506 0.669 . . . . 1.9299999999999999 111.372 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' GLY . 7.5 tp -140.31 153.83 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.837 -1.074 . . . . 1.48 109.166 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.444 ' N ' HG13 ' A' ' 43' ' ' ILE . 85.2 m-70 -30.81 -35.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.653 0.596 . . . . 3.0499999999999998 111.951 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ILE . . . -78.93 -60.09 2.65 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.784 -0.722 . . . . 1.26 113.06 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.486 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -168.39 173.73 7.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.697 0.76 . . . . 2.7599999999999998 112.101 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 93.6 p -105.19 148.66 26.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.6 -1.182 . . . . 1.26 111.273 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.46 -172.6 36.26 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.29999999999999999 111.916 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' GLU . 52.2 p90 -105.26 158.1 16.84 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.974 0.387 . . . . 1.55 111.181 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -174.38 104.74 0.28 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.924 -0.58 . . . . 4.3300000000000001 110.836 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' TRP . 13.1 Cg_endo -58.45 163.46 10.48 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.733 2.289 . . . . 0.47999999999999998 112.97 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 mt -65.97 -18.76 24.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.54 -0.755 . . . . 0.82999999999999996 111.204 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.07 -5.06 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 2.2999999999999998 111.642 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.17 -5.51 6.09 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.046 0.388 . . . . 4.4699999999999998 112.046 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG12 ' HA2' ' A' ' 8' ' ' GLY . 28.7 m -136.69 175.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.161 0.505 . . . . 0.42999999999999999 111.592 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 106.53 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.453 -0.794 . . . . 2.0899999999999999 109.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.22 123.8 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.1799999999999999 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.3 mt -76.91 -53.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.985 -0.552 . . . . 1.3100000000000001 110.958 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.3 t -103.69 108.17 58.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 1.54 110.974 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.361 2.041 . . . . 1.6100000000000001 112.383 -179.939 . . . . . . . . 0 0 . 1 stop_ save_